CN113897390A - Recombinant adenovirus vaccine for African swine fever and construction method thereof - Google Patents

Recombinant adenovirus vaccine for African swine fever and construction method thereof Download PDF

Info

Publication number
CN113897390A
CN113897390A CN202110762389.3A CN202110762389A CN113897390A CN 113897390 A CN113897390 A CN 113897390A CN 202110762389 A CN202110762389 A CN 202110762389A CN 113897390 A CN113897390 A CN 113897390A
Authority
CN
China
Prior art keywords
adenovirus
plasmid
vector
pad5lcl3
i73rhbsag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110762389.3A
Other languages
Chinese (zh)
Other versions
CN113897390B (en
Inventor
李娜
陈平
张婷婷
钟鑫涛
张风苹
张利娟
祝志刚
王暄
李娅芳
李楠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiaxing Anyu Biotechnology Co ltd
Original Assignee
Jiaxing Anyu Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiaxing Anyu Biotechnology Co ltd filed Critical Jiaxing Anyu Biotechnology Co ltd
Publication of CN113897390A publication Critical patent/CN113897390A/en
Application granted granted Critical
Publication of CN113897390B publication Critical patent/CN113897390B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5256Virus expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55516Proteins; Peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351Methods of production or purification of viral material
    • C12N2710/10352Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/12011Asfarviridae
    • C12N2710/12022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/12011Asfarviridae
    • C12N2710/12034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/106Plasmid DNA for vertebrates
    • C12N2800/107Plasmid DNA for vertebrates for mammalian
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/50Vectors for producing vectors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses an African swine fever virus vaccine which is obtained by constructing a recombinant adenovirus vector co-expressed by four antigen genes of the African swine fever virus and packaging the recombinant adenovirus vector by 293TD37 cells. Wherein, the four antigen genes of the African swine fever virus are L8Lubiqutin, I215L, I73Rhbsag and E146L respectively. The construction of the recombinant adenovirus vector co-expressed by four antigen genes of African swine fever virus mainly comprises knocking out E1, E3, E2a and E4 genes of the adenovirus vector through CRISPR/cas9, and constructing shuttle plasmids of E1 and E4 regions, wherein the shuttle plasmids are respectively used for expressing L8Lubiqutin, I215L, I73Rhbsag and E146L genes, so that a brand-new adenovirus vector is obtained. Compared with the first generation adenovirus vector, the vector increases the vector capacity by about 3kb, and then the recombinant adenovirus with higher titer is obtained by packaging through a 293TD37 cell line, and is used for preparing a recombinant adenovirus vaccine of African swine fever. The invention can greatly improve the capacity of the adenovirus vector vaccine, and enhances the specific immune response to the African swine fever virus by using a mode of simultaneously expressing four independent antigens of the African swine fever on one adenovirus vector.

Description

Recombinant adenovirus vaccine for African swine fever and construction method thereof
The application claims priority of the prior application of China, application number 2020106427557, 6/7/2020; all of which are intended to be part of this invention.
Technical Field
The invention relates to the technical field of genetic engineering and the field of immunology, in particular to a recombinant adenovirus vaccine of African swine fever virus and a construction method thereof.
Background
African Swine Fever (ASF) is a highly contagious swine viral disease. High mortality rates approaching 100% can result in domestic pigs. ASF is caused by ASF virus (ASFVrus), which is a large double-stranded DNA virus, mainly replicates in the cytoplasm of macrophages, has a 20-hedral structure, has a diameter of 175-215 nm, has a genome full length of 170-190 kb, contains 151 open reading frames, can encode 150-200 proteins, and is a double-stranded linear DNA virus with an envelope. The structural proteins of ASFV virion are P30, P72, P49, P54, P220, P62, pB602L, CD2v protein, etc., and the vaccine based on one or two subunits has not been able to induce immune power strong enough to have significant protection effect on vaccinees.
China finds ASF epidemic situations in 2018, and huge direct and indirect economic losses are brought. Therefore, the development of a vaccine against ASFV is urgently required. It has been reported that previous studies of ASFV vaccines have mainly focused on inactivated vaccines and attenuated vaccines. However, inactivated vaccines do not induce an effective protective response; the biological safety of attenuated vaccines is a major limiting factor in their use, and attenuated strains are not allowed to be studied in our country. However, in the case where live virus experiments cannot be performed at the present stage, it is necessary to provide a vaccine to elicit an immune response against as many antigens as possible.
Therefore, there is a need to develop a novel ASFV vaccine. Potential vaccine candidates are live vector vaccines. Compared with other vaccines, live vector vaccines offer advantages in that: (1) can actively infect target tissues or cells, and improves the efficiency of foreign genes entering the cells; (2) the carrier has adjuvant effect and can induce the production of cytokines and chemokines; (3) most induce a long-term immune response. Advantageously, it is desirable to deliver as much pathogen protein as possible with as few live vectors as possible.
Live vector vaccines refer to the cloning of a gene encoding a protein of a pathogen into a live viral vector, which is then used to immunize an animal and express the protein in the animal, thereby inducing an immune response against the protein. Adenovirus type 5 has many advantages as a vector for expressing African swine fever antigen protein: firstly, the adenovirus expression vector is replication-defective, can only be produced and prepared in a unique complementary cell line, simultaneously, the adenovirus does not need to be integrated into the host cell genome, the target gene is expressed in a free state outside the host cell genome, the integration mutation carcinogenic possibility is low, the genotoxicity is low, and the safety of vaccine preparation is good; secondly, the recombinant adenovirus vector can obtain higher titer, is beneficial to large-scale production, and has high factory efficiency and low production cost; the research on the structure, the characteristics and the function of the adenovirus type 5 is relatively deep at present, the adenovirus vector is easy to copy, the operation is simple, and the research is facilitated; fourthly, 6K gene is knocked out from the genome of the common generation adenovirus vector, and 7.5K exogenous gene can be inserted into the genome, so that the genome has larger capacity; fifthly, the adenovirus is relatively stable and can be purified, concentrated and stored.
The prior art reports on some live vector vaccines. For example, ASFV p32, p54, p72 and pp62 genes are respectively recombined into a human adenovirus Ad5 vector to carry out 'cocktail' type immunity, and good antigen-specific CTL reaction is obtained; then, 7 ASFV antigen genes including ASFV A151R, B119L, B602L, EP402R delta PRR, B438L and K205R-A104R are recombined into replication-defective adenovirus vectors, and strong humoral immune response and cellular immune response can be induced after mixed immunization in a 'cocktail' manner. However, in the case of "cocktail" immunization, each ASFV antigen gene must be recombined into a replication-defective adenovirus vector, and therefore, the number of vectors required is very large, and there is a risk of immune reaction against the adenovirus vector during the immunization. CN108504686A and CN108504687A provide recombinant adenovirus vectors expressing EP153R and EP402R genes of ASFV, respectively. CN109652449A discloses a recombinant adenovirus vector co-expressed by two antigen genes of EP153R and EP402R, and CN109735567A discloses a recombinant adenovirus vector co-expressed by two antigen genes of EP153R and P54.
However, in order to further enhance the specific immune response to ASF, the antigenic gene capacity of adenoviral vectors needs to be further increased, and as many pathogen proteins as possible need to be delivered with as few live vectors as possible to elicit an immune response against as many antigens as possible.
CN110269932A discloses fusion of 5-7 antigen genes such as A104R, A151R, B119L, B602L, CD2v, K205R and P49 of ASFV based on adenovirus vector for preparing live vector vaccine. However, fusion of multiple antigen genes presents the risk of reduced immunogenicity and possible immune failure, and therefore, it is necessary to express completely independent antigen genes on each adenoviral vector in order to increase vaccine activity.
However, no recombinant adenovirus vector co-expressed by four antigen genes exists in the prior art, and no recombinant adenovirus vector co-expressed by four antigen genes of L8Lubiqutin, I215L, I73Rhbsag and E146L of ASFV is applied to the development of live vector vaccines.
Disclosure of Invention
In order to solve the problems, the invention provides an African swine fever virus vaccine, which is obtained by constructing a recombinant adenovirus vector co-expressed by four antigen genes of the African swine fever virus and packaging the recombinant adenovirus vector by 293TD37 cells; the four antigen genes are respectively L8Lubiqutin, I215L, I73Rhbsag and E146L, wherein L8Lubiqutin is obtained by adding a molecular adjuvant ubiqutin to L8L, I73Rhbsag is obtained by adding a molecular adjuvant hbsag to I73R, L8Lubiqutin and I215L are expressed in an E1 region, and I73Rhbsag and E146L are expressed in an E4 region, so that a recombinant adenovirus vector pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L co-expressed by the four antigen genes is formed.
Wherein, the recombinant adenovirus vector pAd5LCL3-L8Lubiqutin-I215L-I73 Rhbbsag-E146L can realize recombinant adenovirus packaging only through 293TD37 cells constructed by pcDNA3.1+ (hyg) -ORF6-IRES-DBP, and the cell strain preservation number of the 293TD37 cell is as follows: CCTCC NO of C201996, and is preserved in China center for type culture Collection.
Ordinary 293 cells contain E1 gene of adenovirus type 5, and adenoviruses with E1 and E3 knocked-out can replicate in the cell line, but adenoviruses with E4 and E2a knocked-out genes cannot replicate in 293 cells.
293TD37 cell strain invented by the group of the invention, and applied for patent CN201911033247.2, preserved in 5.8.2019 and China center for type culture Collection, with the preservation number of CCTCC NO: C2019111, and classified name being human embryonic kidney transformed cell AY293-TD-37, the cell strain contains E2a-DBP gene and E4-ORF6/7 gene of adenovirus, can be used for packaging E2a-DBP gene and E4 gene-deficient second generation adenovirus to form complete infectious second generation adenovirus particles, compared with the first generation adenovirus, the second generation adenovirus has greatly reduced RCA occurrence probability, lays a foundation for preparing live vector vaccine, and because of deletion of E2a-DBP and E4 gene, the packaging capacity is increased again compared with E2a mutant or E4 deleted second generation adenovirus, further improves the insertion amount of adenovirus vector foreign gene, has important significance for enhancing the application level of the adenovirus vector.
Wherein, L8L, ubiqutin, I215L, I73R, hbsag, E146L and pAd5LCL3 respectively have nucleotide sequences shown in Seq ID No.1, Seq ID No.2, Seq ID No.3, Seq ID No.4, Seq ID No.5, Seq ID No.6 and Seq ID No.7 in the sequence table.
The African swine fever virus has more than 160 antigen genes, and the inventor selects 20 antigen genes with stronger immune effect through a large amount of screening experiments, wherein the 20 antigen genes are respectively as follows: p72, B602L, P30, P54, CP129R, MGF5L6L, CP312R, MGF110-4L, L8L, I215L, I73R, E146L, EP402R, EP153R, I177L, K205R, F317L, a151R, P34, pp 62; the 20 antigen genes are divided into five groups according to the sizes of the gene fragments, and 4 antigen genes in each group can be co-expressed in the recombinant adenovirus vector pAd5LCL3 provided by the invention, namely four antigen genes can be completely and independently expressed in the same vector. The five groups of antigen gene vaccines (including 5 recombinant adenovirus vectors pAd5LCL3) form a complete African swine fever virus vaccine, and a very good immune effect is achieved. The invention selects four antigen genes of L8L, I215L, I73R, E146L and EP402R, and can be well matched and assembled in the same recombinant adenovirus vector, thereby completely and independently expressing the four antigen genes.
The research proves that the expression level of the E3 region for the foreign protein is not high, while the expression level of the antigen gene is higher when the E1 region and the E4 region are used for expressing the antigen genes, so that four antigens can be respectively expressed in the E1 region and the E4 region.
The E3 gene needs to be knocked out to be replication-defective due to the association with replication; the role of E3 is related to the immune escape of adenovirus; the E3 knockout region can increase the capacity of the adenovirus vector; and enables the adenovirus vector to be normally packaged.
On the other hand, the invention also provides a construction method of the recombinant adenovirus vector co-expressed by the four antigen genes of the African swine fever virus, which comprises the following steps:
1) e1 gene of adenovirus circular carrier plasmid is knocked out by CRISPR/cas9, SwaI enzyme cutting site is introduced, fused fragments and carrier are seamlessly cloned, E3 gene is knocked out by CRISPR/cas9, and seamless cloning mode is used for connection, so that adenovirus carrier plasmid pAd5 with E1 and E3 gene deletion is obtained.
2) E4 gene of the adenovirus circular carrier plasmid is knocked out by CRISPR/cas9, PCR amplification is used, I-ceI enzyme cutting sites are introduced, and a seamless cloning method is used to obtain adenovirus carrier plasmid pAd5 delta E4 with deletion of E1, E3 and E4 genes.
On the basis of knocking out E1 and E3 genes, knocking out the E4 gene can improve the capacity of an adenovirus vector and reduce the immunogenicity of the adenovirus vector, and meanwhile, a foreign gene can be inserted into an E4 region and can be expressed in a large amount at the E4 position without influencing the packaging of an adenosis vector. The foreign genes are expressed at the E1 and E4 genes, so that the mutual interference of a plurality of foreign genes in the same region can be avoided, the expression is more facilitated, unnecessary E4 related genes are reduced, the immunogenicity of the adenovirus is reduced, the adenovirus can exist in host cells for a long time, and the foreign genes can be expressed for a long time.
The gene of the E4 region plays a key role in immunogenicity, and expression of a large number of genes of the E4 region can enable a host to generate a stronger immune response and induce generation of antibodies, so that the adenovirus vector can express a target protein in the host for a long time, and therefore, the immunogenicity of the adenovirus vector can be reduced by knocking out unnecessary genes in the E4 region, and the vector can be expressed in a long time.
In order to completely knock out the E4 gene and facilitate the connection of large carrier plasmids, the CRISPR/cas9 method is used for knocking out the Fiber gene at the upstream of the E4 region and the E4 gene, a PCR method is used for amplifying part of the Fiber and introducing an I-ceI single enzyme cutting site, a Gibson seamless cloning method is used for connecting the redundant cut fragment to a carrier, and the carrier plasmid with the I-ceI single enzyme cutting site knocked out by E4 is obtained again. The vector plasmid was linearized using I-sceI, a shuttle plasmid for the E4 region was constructed, and the foreign gene was recombined into the E4 region and expressed in large quantities in the E4 region.
3) E2a gene of adenovirus circular carrier plasmid is knocked out by CRISPR/cas9, ORF6/7 expression frame of E4 region is placed at sequence position where E2a region is knocked out, and then seamless cloning method is used to obtain adenovirus carrier plasmid pAd5LCL3 with E1, E3, E4 and E2a gene deleted.
The sequences of ORF 1-ORF 5 in the E4 region are knocked out, E4promoter, ORF6, ORF7 and polyA sequences are reserved and inserted into the E2a position, so that the E4 position can express foreign genes. The DBP sequence of the E2a region was also knocked out. The adenovirus E2a gene is a DNA binding protein, and is related to the replication of adenovirus, and the structural protein of adenovirus and the packaging of adenovirus are not affected by knocking out the gene. DBP deletion can prevent or greatly reduce back-mutations. The knock-out of the partial sequences of E2a and E4 increased the vector capacity by about 3 kb.
The research finds that the genes related to the replication of the adenovirus are E1, E2, E3 and E4, and the deletion of the genes does not affect the expression of structural proteins of the adenovirus, does not hinder the packaging of the adenovirus, but can prevent the adenovirus from replicating; thus, these replication-associated cell lines are constructed so that replication-defective adenovirus vectors, in which the replication genes have been knocked out, can be packaged for replication in their own cell lines. Meanwhile, research shows that only ORF6 or ORF3 in E4 gene of the expressed adenovirus can replace the whole E4 gene, so that the adenovirus with E4 knocked out can be used for replication and packaging. Through further sequence analysis of the E4 and E2a genes, the E4 gene can be expressed at E2 a. Therefore, the E4 gene is subjected to sequence analysis, a promoter, ORF6/7 and polyA of E4 are found out, the basic elements are integrated into a complete expression frame, the complete expression frame is constructed at the position of the sequence of the E2a knocked out, the ORF6 and ORF7 genes are normally expressed, and finally, a replication-defective adenovirus 5 type vector which is knocked out of E1, E3, E4 and E2a and is provided with the E4 expression frame at the position of E2a is obtained, and the replication-defective adenovirus 5 type vector can be replicated and packaged in 293TD37 cells containing DBP sequences.
The research finds that the E4 gene contains 7 expression frames of ORF1,2,3,4,5,6 and 7, wherein ORF6/7 cannot be deleted, and once deleted, the packaging of adenovirus and the expression of antigen genes are obviously affected, so that ORF6/7 needs to be supplemented back, and meanwhile, in order to obtain larger vector space, ORF6/7 needs to be expressed at E2a, so that an adenovirus vector with larger capacity and better expression effect is prepared.
4) The shuttle plasmid pS5E1 of the adenovirus E1 region is constructed and is respectively connected with L8Lubiqutin, IRES and I215L gene segments through DNA ligase to construct the shuttle plasmid pS5E1-L8Lubiqutin-IRES-I215L of the African swine fever adenovirus 5 type vector E1 region.
The shuttle plasmid pS5E1 is firstly connected with a ribosome entry site IRES fragment to obtain a pS5E1-IRES vector, and then is connected with an I215L fragment to obtain pS5E1-IRES-I215L, and pS5E1-IRES-I215L is subjected to enzyme digestion and connection with an L8Lubiqutin fragment to obtain an E1 region shuttle plasmid pS5E1-L8Lubiqutin-IRES-I215L, and colony PCR verification is carried out.
L8Lubiqutin is formed by adding a molecular adjuvant ubiqutin to L8L, and the molecular adjuvant ubiqutin can help to improve the immune response of the vaccine.
5) The construction of an adenovirus E4 region shuttle plasmid pS5E4-EGFP, I73Rhbsag and 2A, E146L genes obtains an I73Rhbsag-2A-E146L gene fragment by a fusion PCR technology, the I73Rhbsag-2A-E146L gene fragment is knocked out by carrying out enzyme digestion on the shuttle plasmid pS5E4-EGFP, and the I73Rhbsag-2A-E146L gene fragment is seamlessly cloned and connected with DNA ligase to construct an African swine fever adenovirus 5 type-5 vector E4 region shuttle plasmid pS5E4-I73 Rhbsag-2A-E146L.
Through the enzyme digestion of shuttle plasmid pS5E4-EGFP of E4, the deletion of EGFP is replaced by pS5E4-I73Rhbsag-2A-E146L, I73Rhbsag is obtained, and E146L is connected through a 2A sequence. The 2A sequence is added for protein cleavage, the EF1 alpha promoter is expressed in tandem, and the 2A sequence is further cleaved to obtain CP312R and MGF4L antigens.
The I73Rhbsag is formed by adding a molecular adjuvant hbsag to I73R, and the molecular adjuvant hbsag can help to improve the immune response of the vaccine.
6) Homologous recombination of the shuttle plasmid pS5E1-L8Lubiqutin-IRES-I215L and the adenovirus vector plasmid pAd5LCL3 is carried out to obtain the adenovirus vector plasmid pAd5LCL3-L8 Lubiqutin-IRES-I215L.
7) Homologous recombination is carried out on shuttle plasmid pS5E4-I73Rhbsag-2A-E146L and adenovirus vector plasmid pAd5LCL3-L8Lubiqutin-IRES-I215L to obtain recombinant adenovirus vector pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L with four antigen genes co-expressed, wherein the recombinant adenovirus vector with four antigen genes co-expressed has a nucleotide sequence shown as Seq ID No.8 in a sequence table.
Shuttle plasmids are generally adopted in the existing adenovirus vector construction, and a single enzyme cutting site needs to be searched. The invention creatively adopts CRISPR/cas9 to construct a recombinant adenovirus vector, selects proper E1, E3, E4 and E2a knockout sites through comparison, selects the CRISPR sites according to the positions of E1, E3, E4 and E2a sequences, the number of knockout gene bases and designs the optimal gRNA, thereby completing the construction of the recombinant adenovirus vector.
Further, the adenovirus circular vector plasmid in the step 1) is derived from wild type human adenovirus type 5 virus amplified in A549 cells, virus liquid is collected and concentrated, adenovirus type 5 genome is extracted by adopting a HirtVirus DNA Extract method, and linear adenovirus type 5 genome is constructed into circular adenovirus circular vector plasmid by using a cosmid method.
Further, the ORF6/7 expression frame gene in the step 3) has a nucleotide sequence shown as Seq ID NO.9 in the sequence table; the IRES in the step 4) has a nucleotide sequence shown as Seq ID NO.10 in the sequence table; 2A in the step 5) has a nucleotide sequence shown as Seq ID No.11 in the sequence table.
Further, the shuttle plasmid pS5E1 skeleton in the step 4) adopts puc origin, amp and other basic elements, Ad5 left arm ITR partial sequence, right arm PIX, PIVa2 partial sequence and CMV-MCS SV40 early polyA; the framework of the shuttle plasmid pS5E4-EGFP in the E4 region in the step 5) adopts puc origin, amp and other basic elements, an ITR sequence of the left arm of the Ad5E4 region, a fiber gene sequence of the right arm of the Ad5E4 region and an EF1 alpha-EGFP-HBV polyA gene; wherein the basic elements such as puc origin, amp, etc. have the nucleotide sequence shown in Seq ID No.12 in the sequence table, and the EF1 alpha-EGFP-HBV polyA gene has the nucleotide sequence shown in Seq ID No.13 in the sequence table.
The skeleton of the shuttle plasmid pS5E1 was synthesized by Beijing Bomaide Gene technology, Inc., and the synthesis adopted basic elements (2796bp) such as puc origin, amp, etc., partial sequences (400bp) of ITR of Ad5 left arm, partial sequences (2100bp) of PIX of right arm, PIVa2, and CMV-MCS (944bp) SV40 early polyA (160 bp). Carrying out PCR amplification and gene fragment purification, carrying out seamless cloning connection, transforming the connection product to competent cells, coating an ampicillin resistance plate, culturing, selecting positive clones, carrying out enzyme digestion verification, and obtaining the shuttle plasmid pS5E1 in the adenovirus E1 region.
The skeleton of the shuttle plasmid pS5E4 adopts puc origin, amp and other basic elements, the left arm ITR sequence (370bp) of Ad5E4 region, the right arm fiber gene sequence (1746bp) and EF1 alpha-EGFP-HBV polyA gene. Carrying out PCR amplification and gene fragment purification, carrying out seamless cloning connection, transforming the connection product to competent cells, coating an ampicillin resistance plate, culturing, selecting positive clones, carrying out enzyme digestion verification, and obtaining the shuttle plasmid pS5E4-EGFP in the adenovirus E4 region.
Further, in step 6), homologous recombination of shuttle plasmid pS5E1-L8Lubiqutin-IRES-I215L and adenovirus vector plasmid pAd5LCL3 is carried out by carrying out enzyme digestion on shuttle plasmid pS5E1-L8Lubiqutin-IRES-I215L and adenovirus vector plasmid pAd5LCL3 through PacI and SwaI, dephosphorylating the digestion product, carrying out Gel recovery on the vector and the fragment by using OMEGA Ultra-Sepgel Extraction Kit, coating the transformation product on a plate, picking a colony, and carrying out XhoI enzyme digestion verification.
Further, step 7) homologous recombination of shuttle plasmid pS5E4-I73Rhbsag-2A-E146L and adenovirus vector plasmid pAd5LCL3-L8 Lubiqlutin-IRES-I215L is carried out by digesting shuttle plasmid pS5E4-I73Rhbsag-2A-E146L and adenovirus vector plasmid pAd5LCL3-L8 Lubiqlutin-IRES-I215L through PacI and I-sceI, dephosphorylating the digested product, carrying out Gel recovery of vector and fragment by OMEGA Ultra-Sep Gel Extraction Kit, coating the transformed product on a plate, picking colonies and carrying out XhoI enzyme digestion verification.
In another aspect, the present invention provides a method for packaging a recombinant adenovirus vector, which comprises digesting the recombinant adenovirus vector of claim 1 or 2, pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L with PacI, and using the linearized plasmid for transfection; transfecting 293TD37 cells constructed by pcDNA3.1+ (hyg) -ORF6-IRES-DBP, collecting cell suspension, and packaging the recombinant adenovirus. The 293TD37 cell strain is preserved in China center for type culture collection (CCTCC NO: C201996) in 2019, 5, 8 and classified as a human embryonic kidney transformed cell AY293-TD15, and the cell strain contains E2a gene and E4-ORF6/7 gene of adenovirus type 5, is obtained by modifying HEK293 cells through genetic engineering, and can be used for packaging second-generation recombinant adenovirus lacking E2a gene and E4 gene to form complete second-generation adenovirus particles with infectivity.
Further, the packaging method of the recombinant adenovirus vector is prepared by the following steps:
1) carrying out enzyme digestion on pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L co-expression recombinant adenovirus vector by PacI, and using the linearized plasmid for transfection; 293TD37 cells were transfected with PEI transfection reagents;
2) 293TD37 cells after transfection at 37 ℃ with 5% CO2Culturing in an incubator for 72-96 hours, and collecting cell suspension, namely TP0 generation adenovirus;
3) 293TD37 cells were infected with TP0 adenovirus at 37 ℃ and 5% CO2Culturing for 72 hr in incubator, collecting fine powderThe cell suspension is TP1 generation adenovirus;
4) repeat 3), collecting cell suspension, namely TP2 generation adenovirus;
5) the inoculation was continued until TP4 generation adenovirus.
On the other hand, the invention also provides application of the 293TD37 cell in packaging a recombinant adenovirus vector co-expressed by four antigen genes of African swine fever virus, which is characterized in that the four antigen genes are respectively L8Lubiqutin, I215L, I73Rhbsag and E146L, wherein the L8Lubiqutin and I215L are expressed in an E1 region, and the I73Rhbsag and E146L are expressed in an E4 region, so that the recombinant adenovirus vector co-expressed by the four antigen genes is formed, namely d5LCL3-L8Lubiqutin-I215L-I73 Rhbsag-E146L; wherein the 293TD37 cell is constructed by pcDNA3.1+ (hyg) -ORF6-IRES-DBP, and the collection number of the cell strain is as follows: CCTCC NO of C201996, and is preserved in China center for type culture Collection.
The invention provides an African swine fever virus vaccine which is obtained by constructing a recombinant adenovirus vector co-expressed by four antigen genes of the African swine fever virus and packaging the recombinant adenovirus vector by 293TD37 cells. Wherein, the four antigen genes of the African swine fever virus are L8Lubiqutin, I215L, I73Rhbsag and E146L respectively. The construction of the recombinant adenovirus vector co-expressed by four antigen genes of African swine fever virus mainly comprises knocking out E1, E3, E2a and E4 genes of the adenovirus vector through CRISPR/cas9, and constructing shuttle plasmids of E1 and E4 regions, wherein the shuttle plasmids are respectively used for expressing L8Lubiqutin, I215L, I73Rhbsag and E146L genes, so that a brand-new adenovirus vector is obtained. The invention has the following beneficial effects:
the construction method of the adenovirus type 5 vector CRISPR/cas9 is novel, the optimal knockout site is selected, the optimal gRNA is designed, and the problem that a single enzyme cutting site needs to be found due to the fact that shuttle plasmids for constructing the vectors in the past are knocked out is solved.
Secondly, because the gene of the E4 region plays a key role in immunogenicity, the expression of a large number of genes of the E4 region can enable a host to generate stronger immune response and induce the generation of antibodies, and is not beneficial to long-term expression of target proteins of the adenovirus vector in the host, and the deletion of unnecessary genes in the E4 region can reduce the immunogenicity of the adenovirus vector, so that the vector can be expressed in a longer time.
The invention knocks out the sequence of ORF 1-ORF 5 in E4 area, reserves the sequence of E4promoter, ORF6, ORF7 and polyA, and inserts them into E2a position, so that the E4 position can express exogenous gene.
③ the invention also knock out the DBP (E2a) sequence, the DBP deletion can prevent or greatly reduce the reversion. And the knockout of E2a and E4 partial sequences increases the vector capacity of about 3kb relative to the first generation vector.
E2A and E4 of the adenovirus vector are knocked out, and E4promoter-ORF6/7-polyA is placed in an E2a region, so that a cell line complemented with E2a can be used for packaging, meanwhile, exogenous genes can be simultaneously expressed in the E1 and E4 regions without mutual interference, the adenovirus vaccine is rescued in a 293TD37 cell line which is a complementary cell line constructed by our company at present, and the cell line can persistently express DBP protein.
Sixthly, the shuttle plasmid of E1 and E4 regions is constructed and used for expressing exogenous genes of E1 and E4 regions.
The titer of the recombinant adenovirus prepared by the 293TD37 cell line packaging method is higher.
Based on the principle, the invention can greatly improve the capacity of the vaccine of the adenovirus vector, and enhances the specific immune response to the African swine fever virus by using a mode of simultaneously expressing four independent antigens of the African swine fever virus on one adenovirus vector, so that the domestic pigs can obtain better immune protection.
Drawings
FIG. 1 is a schematic diagram of the Ad5-E4-up-gRNA cleavage site and the PAM site of example 2
FIG. 2 is a schematic diagram of the Ad5-E4-down-gRNA cleavage site and the PAM site of example 2
FIG. 3 shows the results of the "double restriction" detection of plasmids by the vectors Ad5-E4-up-gRNA, Ad5-E4-down-gRNA, and cas9 in example 2, wherein lane 1 shows Ad5-E4-up-gRNA, Ad5-E4-down-gRNA, and cas9, and M shows Marker
FIG. 4 shows the result of the amplified electrophoresis of the fiber and ITR fragments containing partial knockdown in example 2, wherein lane 1 shows the amplified result of the fiber partial fragment, lane 2 shows the amplified result of the ITR partial fragment, and M shows Marker
FIG. 5 shows the results of electrophoretic detection of the Fiber-ITR fusion fragment of example 2, in which lane 1 is the Fiber-ITR fusion fragment, and M is Marker
FIG. 6 shows the results of the PCR-verified electrophoresis of the colonies of example 2, wherein lanes 1-24 are colonies, M is Marker
FIG. 7 shows the results of the electrophoretic tests of the plasmid clones of the positive clones of FIG. 6, which were verified by digestion with BamHI and XhoI in example 2, wherein 1-5 is digestion with BamHI, 6-10 is digestion with XhoI, 1, 10 are pAd5 control (for sure E4 gene), and M is Marker
FIG. 8 is a schematic diagram of the 100k-gRNA cleavage site and PAM site of example 3
FIG. 9 is a schematic diagram of the protease-gRNA cleavage site and PAM site in example 3
FIG. 10 shows the results of the "double digestion" of 100k-gRNA, protease-gRNA and cas9 in example 3, lane 1 shows the results of the "double digestion" of 100k-gRNA, protease-gRNA and cas9, and M shows Marker
FIG. 11 shows the results of PCR amplification and electrophoresis of 100k, E4ORF6/7 expression cassette and protease of example 3, wherein lane 1 is E4ORF6/7 expression cassette, lane 2 is 100k, and M is Marker
FIG. 12 shows the results of the fusion PCR electrophoresis of the 100k, E4ORF6/7 expression cassette and the Protease fragment of example 3, wherein lane 1 shows the fragment 100k, E4ORF6/7 expression cassette and the Protease fusion PCR product, and M shows Marker
FIG. 13 shows the results of the PCR-verified electrophoresis of the colonies of example 3, in which lanes 1-24 are colonies, M is Marker
FIG. 14 shows the results of the XhoI cleavage of the colonies 9, 18, 21 and 24 positive clones selected from FIG. 13 in example 3, wherein lane 1 shows XhoI cleavage of the positive clone 9, lane 2 shows XhoI cleavage of the positive clone 18, lane 3 shows XhoI cleavage of the positive clone 21, lane 4 shows XhoI cleavage of the positive clone 24, lane 5 shows XhoI cleavage of the control plasmid pAd5LCL3, and M shows Marker
FIG. 15 shows the results of the amplification electrophoresis of CMV-MCS and SV40 earlyployA fragments of example 4, wherein lane 1 is CMV-MCS fragment, lane 2 is SV40 earlyployA fragment, and M is 2000Marker
FIG. 16 shows the results of the amplification electrophoresis of CMV-MCS-SV40 earlylylA, PUC, Ad5 right arm, Ad5 left arm in example 4, wherein lane 1 is CMV-MCS-SV40 earlylylA fusion fragment, lane 2 is PUC, lane 3 is Ad5 right arm, lane 4 is Ad5 left arm, and M is 2000Marker
FIG. 17 shows the results of PCR-verified electrophoresis of colonies of competent cells transformed with the ligation products of the four fragments of pS5E1 backbone, Ad5 left arm, Ad5 right arm and CMV-MCS-SV40 earlyplolyA in example 4, wherein lanes 1-6 are colonies, and M is Marker
FIG. 18 is the result of restriction enzyme examination of the selected colony Nos. 1 to 6 in FIG. 17 of example 4, in which the left 1 to 6 are single restriction enzymes of plasmid pS5E1NcoI, the right 1 to 6 are single restriction enzymes of plasmid pS5E1 PacI, and M is 15000bp Marker
FIG. 19 shows the results of PCR amplification and electrophoresis detection of IRES fragment of example 4, wherein lanes 1 and 2 are the PCR amplification products of IRES fragment, and M is 15000bp Marker
FIG. 20 shows the results of restriction electrophoresis of the fragment IRES of example 4 and pS5E1 vector, wherein lane 1 shows the restriction of the fragment IRES EcoRV and NotI, lane 2 shows the restriction of pS5E1 EcoRV and NotI, and M shows a 15000bp Marker
FIG. 21 shows the results of PCR-verified electrophoresis of the colonies of the competent cells transformed with the ligation product of pS5E1 vector and IRES fragment in example 4, wherein the numbers 1 to 9 are colonies, and M is Marker
FIG. 22 shows restriction enzyme electrophoresis detection and verification of pS5E1-IRES plasmid NotI and EcoRV of example 4, wherein 2 and 6 of FIG. 21 are selected for plasmid extraction and restriction enzyme verification, wherein lane 1 is plasmid NotI and EcoRV restriction enzyme identification, lane 2 is plasmid NotI and EcoRV restriction enzyme identification
FIG. 23 shows the results of electrophoretic detection of the cleavage of I215L and pS5E1-IRES vector in example 4, wherein the carrier of the lane is pS5E1-IRES, the cleavage of NotI and XhoI is performed in two steps, the fragment I215L of the lane I215L is performed in two steps, the cleavage of NotI and XhoI is performed in two steps, and M is 15000bp and 2000bp Marker
FIG. 24 shows the results of PCR-verified electrophoresis of colonies of transformation competent cells with ligation products of I215L and pS5E1-IRES in example 4, wherein the numbers 1 to 11 are colonies, and M is 2000bp Marker
FIG. 25 shows the restriction enzyme electrophoresis detection of pS5E1-IRES-I215L plasmid in example 4, wherein the colonies 5,6,7 and 8 shown in FIG. 24 are selected for plasmid extraction and restriction enzyme verification, wherein Lane 2 is restriction enzyme verification of plasmid No.2, Lane 9 is restriction enzyme verification of plasmid No.9, Lane 11 is restriction enzyme verification of plasmid No.11, and M is Marker
FIG. 26 shows the results of electrophoresis detection of L8 Lubiqiutin fragments obtained by fusing L8L and ubiqiutin in example 4 and purified by a gel recovery and purification kit, wherein the L8 Lubiqiutin fragment is shown in lane 1, and M is Marker
FIG. 27 shows the electrophoresis detection results of the cleavage products of the fragment L8Lubiqutin and pS5E1-IRES-I215L vector of example 4, wherein the lane 1 is the pS5E1-IRES-I215L plasmid; lane 2 is pS5E1-IRES-I215L plasmid EcoRV and BamHI cut; lane 3 shows the L8Lubiqutin fragments cut with EcoRV and BamHI, and M shows 15000bp Marker
FIG. 28 shows the results of PCR-verified electrophoresis of the colonies of the pS5E1-IRES-I215L vector and L8Lubiqutin ligation product transformation-competent cells of example 4, wherein the numbers 1 to 24 are colonies, and M is a 2000bp Marker
FIG. 29 shows the restriction electrophoresis detection and verification of pS5E1-L8Lubiqutin-IRES-I215L plasmid of example 4, wherein lanes 4, 6, 9, 14, 17 and 18 are selected from the colony plasmids BamHI and EcoRV of 4, 6, 9, 14, 17 and 18 in FIG. 27, and M is 15000bp Marker
FIG. 30 shows the results of the amplification electrophoresis of the left arm of the shuttle plasmid pS5E4-EGFP, the right arm of the shuttle plasmid pS5E4-EGFP, EF1 α -EGFP-HBV, and the shuttle plasmid skeleton pS5E4-EGFP in example 5, wherein lane 1 shows the left arm of the shuttle plasmid pS5E4-EGFP, lane 2 shows the right arm of the shuttle plasmid pS5E4-EGFP, lane 3 shows the shuttle plasmid EF1 α -EGFP-HBV, lane 4 shows the shuttle plasmid skeleton pS5E4-EGFP, and M shows 2000Marker
FIG. 31 shows the results of PCR-verified electrophoretic measurements of colonies of competent cells transformed with the four fragment ligation products of the backbone of the shuttle plasmids pS5E4-EGFP, pS5E4-EGFP, EF1 α -EGFP-HBV, and pS5E4-EGFP in example 5, wherein lanes 1-20 are colonies, and M is Marker
FIG. 32 shows the results of electrophoresis in example 5, which were verified by selecting the restriction enzyme digestion of the colonies Nos. 3,4,5, and 6 shown in FIG. 30, wherein the numbers 1-4 are the positive clones No.3, 4,5, and 6, the numbers 5-8 are the positive clones No.3, 4,5, and 6, the HindIII single restriction enzyme digestion is performed, the numbers M1 and M3 are 15000bp markers, and the numbers M2 are 2000bp markers
FIG. 33 shows the results of electrophoretic detection of the fusion PCR amplification of I73Rhbsag and 2A-E146L fragments in example 5, where lane 1 is the I73Rhbsag fragment, lane 1 is the 2A-E146L fragment, and M is 2000bp Marker
FIG. 34 shows the results of restriction electrophoresis of the vector for the fragment pS5E4-EGFP in example 5, wherein lane 1 shows the recovery of the fragment pS5E4-EGFP, BamHI and XhoI double-enzyme gel, and M shows a 15000bp Marker
FIG. 35 shows the results of PCR-verified electrophoresis of the colonies of the transformed competent cells, in which the plasmid 1-12 is a colony and M is 15000bp Marker, obtained by seamlessly cloning and connecting the recovered vector pS5E4-EGFP gel of example 5 with an I73Rhbsag fragment and 2A-E146L
FIG. 36 shows the results of electrophoresis of BamHI and XhoI double digestion verification of the extracted plasmid of the positive clones No.1, 2 and 3 of FIG. 35 selected in example 5, wherein the BamHI and XhoI double digestion verification of the positive clones No.1, 2 and 3 in lanes 1,2 and 3 are performed, respectively, and M is 15000bp Marker
FIG. 37 shows the results of agarose gel electrophoresis test of pAd5LCL3 and pS5E1-L8Lubiqutin-IRES-I215L in example 6, wherein pAd5LCL3 is shown in lane 1, and pS5E1-L8Lubiqutin-IRES-I215L is shown in lane 2
FIG. 38 shows the results of electrophoresis of plasmid pAd5LCL3-L8Lubiqutin-IRES-I215L obtained by homologous recombination of shuttle plasmid pS5E1-L8Lubiqutin-IRES-I215L and adenovirus vector plasmid pAd5LCL3 of example 6, wherein lanes 1-7 represent clones pAd5LCL3-L8Lubiqutin-IRES-I215L, and M represents 15000bp Marker
FIG. 39 shows the results of restriction enzyme digestion verification and detection of plasmid extracted from example 6 by selecting the positive plasmid No.6 from FIG. 38, wherein the plasmid No.1 is pAd5LCL3-P72-IRES-B602L plasmid XhoI restriction enzyme digestion, and M is 15000bp Marker
FIG. 40 shows the results of the agarose gel-verified electrophoretic detection of shuttle plasmid pS5E4-I73Rhbsag-2A-E146L and adenovirus vector plasmid pAd5LCL3-L8Lubiqutin-IRES-I215L in example 6, wherein lane 1 is pS5E4-I73Rhbsag-2A-E146L, lane 2 is pAd5LCL3-L8Lubiqutin-IRES-I215, and M is 15000bp Marker 215L
FIG. 41 shows the results of electrophoresis of plasmid pS5E4-I73Rhbsag-2A-E146L and plasmid pAd5LCL3-L8Lubiqutin-IRES-I215L of the recombinant adenovirus vector pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L obtained by homologous recombination in example 6, wherein lanes 1-8 are plasmids and M is 15000bp Marker
FIG. 42 is the result of the enzyme digestion verification test of example 6, which includes selecting the positive plasmid No.2 of FIG. 41, transforming the plasmid into competent cells, extracting the plasmid, wherein the lane No.2 is pAd5LCL3-L8Lubiqutin-I215L-I73HbsAg-E146L plasmid XhoI enzyme digestion, and M is 15000bp Marker
FIG. 43 is a photograph of 293TD37 cells induced by TP0 of example 7
FIG. 44 is a photograph of 293TD37 cells induced by TP1 of example 7
FIG. 45 is a photograph of 293TD37 cells induced by TP2 of example 7
FIG. 46 is a photograph of 293TD37 cells induced by TP3 of example 7
FIG. 47 is a photograph of 293TD37 cytopathic effect caused by TP4 of example 7
FIG. 48 is a graph showing the results of Western Blot for detecting L8Lubiqutin and I215L proteins in African swine fever multiple antigen recombinant adenovirus vaccine pAd5LCL3-L8Lubiqutin-I215L-I73HbsAg-E146L in example 11, wherein lane 1 is 293 blank cells, lanes 2 and 3 are samples of 293TD37 cells infected with pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L, and M is Marker
FIG. 49 is a vector map of pAd5LCL3
FIG. 50 is a vector map of pS5E1
FIG. 51 is a vector map of pS5E1-L8Lubiqutin-IRES-I215L
FIG. 52 is a vector map of pS5E4-EGFP
FIG. 53 is a vector map of pS5E4-I73Rhbsag-2A-E146L
FIG. 54 is a vector map of pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L
FIG. 55 is a graphical representation of the results of the CD8+ T cell response induced by pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L of example 12
FIG. 56 is a graph showing the results of the CD4+ T cell response induced by pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L of example 12
FIG. 57 is a representation of the cellular immune response following intramuscular injection of pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L of example 12
FIG. 58 is a representation of blank control immune responses in example 12
Detailed Description
In the following, preferred embodiments of the present invention will be described in further detail with reference to the accompanying drawings, it being noted that the following embodiments are intended to facilitate understanding of the present invention without any limitation thereto.
EXAMPLE 1 construction of adenovirus vector plasmid lacking E1 and E3 genes
In A549 cells
Figure BDA0003150437770000101
Amplifying wild type human adenovirus type 5: (
Figure BDA0003150437770000102
VR-1516, gene sequence AC _000008.1), collecting and concentrating virus liquid, extracting adenovirus genome by a HirtVireal DNA Extract method, constructing linear hAD5 genome into circular supercos-Ad5 carrier plasmid by a cosmid method, excising hAD5 adenovirus E1 region by CRISPR/cas9, and designing gRNA as follows:
hAd5-E1 upstream gRNA:
GGCGGGAAAACUGAAUAAGGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCUUUU
hAd5-E1 downstream gRNA:
GAGAUGAUCCAGUCGUAGCGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCUUUU
designing gRNA sites at the upstream and downstream of an hAD 5E1 region, recovering a large fragment vector after cutting, designing a primer, respectively inserting ITR and PIX sequences into the upstream and downstream by fusion PCR, introducing a SwaI enzyme cutting site, then carrying out seamless cloning on the fused fragment and the vector to obtain an E1 knockout supercos-Ad5 delta E1 adenovirus vector, and then carrying out excision of an E3 region on the supercos-Ad5 delta E1 plasmid to design gRNAs as follows:
hAd5-E3 upstream gRNA:
GCGGGACAUUUCAGAUCGGGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCUUUU
hAd5-E3 downstream gRNA:
GUAAGGGUACUGCUAUCGGGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCUUUU
designing gRNA sites at the upstream and downstream of an hAD 5E 3 region, recovering a large fragment vector after cutting, designing primers, carrying out fusion PCR on Fiber excessively cut at the upstream and downstream of E3 and a pVIII sequence, connecting in a seamless cloning mode to obtain an adenovirus vector plasmid pAd5 with deletion of E1 and E3 genes, and introducing a SwaI enzyme cutting site.
Example 2 construction of E1, E3 and E4 Gene deleted adenovirus vector plasmid pAd5 Δ E4
The E4 gene knockout can be further realized by using the vector plasmid pAd5 obtained in example 1 and in which the E1 and E3 genes are knocked out, so that the capacity of an adenovirus vector can be improved, the immunogenicity of the adenovirus vector can be reduced, a part of fiber is amplified by using a PCR method, an NdeI single enzyme cutting site is introduced, a Gibson seamless cloning method is used, an excessively cut fragment is connected to the vector, and the vector plasmid pAd5 delta E4 with E1, E3 and E4 genes deleted and SwaI and I-sciI enzyme cutting sites introduced is obtained.
1. Selection of target sequence of target gene E4 CRISPR
1) Selection of CRISPR target sequence of fiber gene upstream of E4 gene
Using the Saimer fly GeneArtTMThe CRISPR Search and Design tool (thermolasher. com/crisprdesign) software, which imports the first 400 bases of the fiber gene, automatically analyzes the 400 base sequence, provides 6 potential CRISPR target sequences. In consideration of the length of an E4 gene knockout sequence and the requirement of constructing a live vector, GCTACTAAACAATTCCTTCC is selected as a targeting sequence, the finally obtained gRNA is named Ad5-E4-up-gRNA, and the cleavage site and the PAM site are shown in FIG. 1.
2) Selection of non-coding sequence CRISPR target sequence downstream of E4
Using the Saimer fly GeneArtTMCRISPR Search and Design tool (thermofisher. com/CRISPR Design) software, 300 bases downstream of E4 were input, the software was automatically analyzed, 6 potential CRISPR target sequences were provided, AGGTTCGCGTGCGGTTTTCT was selected as the targeting sequence, the finally obtained gRNA was named Ad5-E4-down-gRNA, and the cleavage site and PAM site are shown in fig. 2.
2. DNA amplification of Ad5-E4-up-gRNA and Ad5-E4-down-gRNA
1) DNA template design of Ad5-E4-up-gRNA
5’-TAATACGACTCACTATAGTACTAAACAATTCCTTCCGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCC GTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT-3’
2) DNA template design of Ad5-E4-down-gRNA
5’-TAATACGACTCACTATAGGTTCGCGTGCGGTTTTCTGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCC GTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT-3’
3. Upstream and downstream primers for designing DNA templates for amplifying Ad5-E4-up-gRNA and Ad5-E4-down-gRNA
Designing the upstream and downstream primers to perform PCR amplification of a DNA template for Ad5-E4-up-gRNA and a DNA template for Ad5-E4-down-gRNA, respectively, using GeneArtTMPrecision gRNA Synthesis Kit for amplification.
Designing a primer:
Ad5-E4-up-gRNA-Forward:TAATACGACTCACTATAGTACTAAACAATTCCT
Ad5-E4-up-gRNA-Reverse:TTCTAGCTCTAAAACGGAAGGAATTGTTTAGTA
Ad5-E4-down-gRNA-Forward:TAATACGACTCACTATAGGTTCGCGTGCGGTTT
Ad5-E4-down-gRNA-Reverse:TTCTAGCTCTAAAACAGAAAACCGCACGCGAAC
4. DNA template for amplifying Ad5-E4-up-gRNA and Ad5-E4-down-gRNA
1) A0.3. mu.M mixed working solution of Ad5-E4-up-gRNA-Forward/Reverse primer was prepared
10 μ M Ad5-E4-up-gRNA-Forward primer 3ul, 10 μ M Ad5-E4-up-gRNA-Reverse primer 3ul, water was supplemented to 100 ul.
2) A0.3. mu.M mixed working solution of Ad5-E4-down-gRNA-Forward/Reverse primer was prepared
10 μ M Ad5-E4-down-gRNA-Forward primer 3ul, 10 μ M Ad5-E4-down-gRNA-Reverse primer 3ul, water was supplemented to 100 ul.
3) PCR reaction system
The PCR reaction system for the DNA template amplification of Ad5-E4-up-gRNA is as follows: phusionTMHigh-Fidelity PCR Master Mix (2X) 12.5ul, Tracr Fragment + T7 Primer Mix 1ul, 0.3. mu.M Ad5-E4-up-gRNA-Forward/Reverse Primer Mix 1ul, water to 25 ul.
The PCR reaction system for the DNA template amplification of Ad5-E4-down-gRNA is as follows: phusionTMHigh-Fidelity PCR Master Mix (2X) 12.5ul, Tracr Fragment + T7 Primer Mix 1ul, 0.3. mu.M Ad5-E4-down-gRNA-Forward/Reverse Primer Mix 1ul, water supplement to 25 ul.
4) PCR procedure
Initial denaturation at 98 ℃,10 sec, 1 cycle; denaturation at 98 ℃ for 5 sec; annealing at 55 ℃, 15sec, and 32 cycles; extending for 72 ℃, 1min, and 1 cycle; the temperature was maintained at 4 ℃.
5. Obtaining Ad5-E4-up-gRNA and Ad5-E4-down-gRNA through in vitro transcription
Using TranscriptAIdTMThe Enzyme Mix carries out in vitro transcription on the template DNA to obtain Ad5-E4-up-gRNA and Ad 5-E4-down-gRNA.
The reaction system for obtaining Ad5-E4-up-gRNA through in vitro transcription is as follows: NTP mix 8ul, E1A-gRNA DNA template 6ul, 5 × TranscriptAIdTM Reaction Buffer 4ul,TranscriptAidTMEnzyme Mix 2 ul. After 4 hours incubation at 37 ℃ 1ul of DNase I was added and incubated for 15 minutes at 37 ℃.
The reaction system for obtaining Ad5-E4-down-gRNA by in vitro transcription is as follows: NTP mix 8ul, E1B-gRNA DNA template 6ul, 5 × TranscriptAIdTM Reaction Buffer 4ul,TranscriptAidTMEnzyme Mix 2 ul. After 4 hours incubation at 37 ℃ 1ul of DNase I was added and incubated for 15 minutes at 37 ℃.
In vitro transcription to obtain Ad5-E4-up-gRNA and Ad 5-E4-down-gRNA.
6. Purification of in vitro transcription products
1) Supplementing the transcribed reaction system to 200ul by nuclease-free water;
2) adding 100ul Binding buffer, and mixing well;
3) adding 300ul ethanol (> 96%), and mixing well;
4) transferring the mixture to the Gene JETTMIn RNA Purification Micro Column, 14000 Xg is centrifuged for 30-60 seconds, and the solution is discarded;
5) 700ul of Wash Buffer1 (13 mL of ethanol was added), 14000 Xg was centrifuged for 30-60 seconds, and the solution was discarded;
6) adding 700ul of Wash Buffer2 (adding 30mL of ethanol), centrifuging for 30-60 seconds at 14000 Xg, discarding the solution, and repeating the steps once;
7)14000 Xg empty for 60 seconds, completely removing all eluent, and placing the empty tube in a collection tube of 1.5 mL;
8) 10ul of nuclease-free water was added to the center of the column, and the gRNA was collected by centrifugation at 14000 Xg for 60 seconds.
Wherein, both the Wash Buffer1 and the Wash Buffer2 are TranscriptAIDTMThe RNA sequences of the reagents in the Enzyme Mix kit, the Ad5-E4-up-gRNA and the Ad5-E4-down-gRNA obtained by transcription are shown as follows:
Ad5-E4-up-gRNA:GUACUAAACAAUUCCUUCCGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCC GUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCUUUU
Ad5-E4-down-gRNA:GGUUCGCGUGCGGUUUUCUGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCC GUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCUUUU
7. CRISPR/Cas9 enzyme digestion "
The vector plasmid obtained in example 1 was digested with Ad5-E4-up-gRNA, Ad5-E4-down-gRNA and Cas9 in a double digestion manner, and the reaction systems were Cas9 protein 3. mu.g, Ad5-E4-up-gRNA 6. mu.g, Ad5-E4-down-gRNA 6. mu.g, pAd5-REBP vector plasmid 3. mu.g, NEB buffer 3.15 ul, and water was added to 50 ul.
The cleavage reaction was incubated at 37 ℃ overnight. 3ul samples were taken for agarose gel validation and the electrophoretic pattern of the experiment is shown in FIG. 3. Lane 1 shows the results of Ad5-E4-up-gRNA, Ad5-E4-down-gRNA, and cas9 "double digestion" pAd5 vector plasmids, which show that the target size is 2500bp-5000bp, and the digestion result is correct. The vector was purified using the Axygen gel recovery kit.
8. Obtaining a fragment containing a part of knocked-out fiber and an ITR (internal transcribed spacer) and introducing an I-SceI enzyme cutting site, knocking out a primer containing the knocked-out part of fiber, amplifying the fiber fragment and introducing the I-SceI enzyme cutting site
1) Amplification of fragment fiber
An amplification primer:
Fiber-RH-F:GAGTGCTACTAAACAATTCCTTCCTGGACCCAGAATATTGG
Fiber-ISceI-ITR-R:TGGTGTTATTACCCTGTTATCCCTAGCAATTGAAAAATAAACACGTTG
the amplification sequence is as follows:
TGGTGTTATTACCCTGTTATCCCTAGCAATTGAAAAATAAACACGTTGAAACATAACACAAACGATTCTTTATTCTTGGGCAATGTATGAAAAAGTGTAAGAGGATGTGGCAAATATTTCATTAATGTAGTTGTGGCCAGACCAGTCCCATGAAAATGACATAGAGTATGCACTTGGAGTTGTGTCTCCTGTTTCCTGTGTACCGTTTAGTGTAATGGTTAGTGTTACAGGTTTAGTTTTGTCTCCGTTTAAGTAAACTTGACTGACAATGTTACTTTTGGCAGTTTTACCGTGAGATTTTGGATAAGCTGATAGGTTAGGCATAAATCCAACAGCGTTTGTATAGGCTGTGCCTTCAGTAAGATCTCCATTTCTAAAGTTCCAATATTCTGGGTCCAGGAAGGAATTGTTTAGTAGCACTC
the amplification system is as follows: 10 μ M Fiber-RH-F primer 1 ul; 10 μ M Fiber-ISceI-ITR-R primer 1 ul; template pAd5(100ng/ul)0.5 ul; q5 high fidelity enzyme 25 ul; water is added to 50 ul.
The PCR procedure was: initial denaturation at 98 ℃,10 sec, 1 cycle; denaturation at 98 ℃ for 5 sec; annealing at 60 ℃ for 30 sec; extension 72 ℃,10 sec, 35 cycles; extension at 72 deg.C for 5min, and 1 cycle; the temperature was maintained at 4 ℃. The electrophoresis chart of the amplification result is shown in FIG. 4, wherein lane 1 shows the amplification result of the fiber partial fragment, M is 2000Marker, and the amplification result is correct, and the fragment is purified by using the Axygen gel recovery kit.
2) Amplification of ITR fragments
An amplification primer:
ISceI-ITR-F:TAGGGATAACAGGGTAATAACACCACTCGACACGGCAC
ITR-RH-R:GGCGTAGGTTCGCGTGCGGTTTTCTGGGTGTTTTTTGTGGACTT
the amplification sequence is as follows:
GGCGTAGGTTCGCGTGCGGTTTTCTGGGTGTTTTTTGTGGACTTTAACCGTTACGTCATTTTTTAGTCCTATATATACTCGCTCTGCACTTGGCCCTTTTTTACACTGTGACTGATTGAGCTGGTGCCGTGTCGAGTGGTGTTATTACCCTGTTATCCCTA
the amplification system is as follows: 10 μ M ISceI-ITR-F primer 1 ul; 10uM ITR-RH-R primer 1 ul; template pAd5(100ng/ul)0.5 ul; q5 high fidelity enzyme 25 ul; water is added to 50 ul.
The PCR procedure was: initial denaturation at 98 ℃,10 sec, 1 cycle; denaturation at 98 ℃ for 5 sec; annealing at 60 ℃ for 30 sec; extension 72 ℃,10 sec, 35 cycles; extension at 72 deg.C for 5min, and 1 cycle; the temperature was maintained at 4 ℃. The amplification result is shown in FIG. 4, lane 2 shows the result of ITR partial fragment amplification, M is 2000Marker, which shows that the amplification result is correct, and the fragment is purified by using Axygen gel recovery kit.
3) Fusion PCR to obtain Fiber-ITR fusion fragment
The amplification system is as follows: 10 μ M Fiber-RH-F primer 1ul, 10 μ M Fiber-ISceI-ITR-R primer 1ul, template pAd5(100ng/ul)0.5ul, Q5 Hi-Fi enzyme 25ul, water to 50 ul.
The PCR procedure was: initial denaturation at 98 ℃,10 sec, 1 cycle; denaturation at 98 ℃ for 5 sec; annealing at 60 ℃ for 30 sec; extension 72 ℃, 20sec, 35 cycles; extension at 72 deg.C for 5min, and 1 cycle; the temperature was maintained at 4 ℃. The amplification result is shown in FIG. 5, lane 1 shows the fusion fragment of Fiber-ITR, and M shows 2000Marker, which indicates that the fusion result is correct. The fragments were purified using the Axygen gel recovery kit.
9. Carrier attachment
The Fiber-ITR fragment was ligated to the E4 knockout vector plasmid using Gibson of NEB, as follows: 100ng of plasmid fragment of the product vector is recovered by glue, 50ng of fiber-ITR fragment of the product is recovered by glue, 10ul of Gibson premix is obtained, and water is supplemented to 20 ul. Incubate at 50 ℃ for 40 minutes.
10. Transformation of
Taking out the kanamycin-resistant culture medium plate, putting the prepared NEB 10 beta competent cells on ice for melting, adding 10ul of ligation products, slightly sucking the ligation products evenly by a pipette, and placing the ligation products on the ice for 30 minutes; the centrifuge tubes were placed in a 42 ℃ water bath and heat-shocked for 90 seconds to select transformants using kanamycin resistance.
11. Colony PCR for transformant screening
Colony PCR validation was performed on the transformants using PCR amplification.
Design of downstream primer for colony PCR
E4-cexu-F:AGTGACGATTTGAGGAAGTTG
E4-cexu-R:TCAATTGCAGAAAATTTCAAGTC
The reaction system is as follows: 10 mu M E4-cexu-F primer 1ul, 10 mu M E4-cexu-R primer 1ul, Q5 high fidelity enzyme 10ul, replenishing water to 20ul, and picking up a monoclonal colony in a reaction system. The PCR procedure was: initial denaturation at 98 ℃,10 sec, 1 cycle; denaturation at 98 ℃ for 5 sec; annealing at 60 ℃ for 30 sec; extension 72 ℃, 20sec, 35 cycles; extension at 72 deg.C for 5min, and 1 cycle; the temperature was maintained at 4 ℃. Agarose gel electrophoresis was performed, and as shown in FIG. 6, positive bands were observed in most colonies except for the colonies No.2, 8, 11, and 17.
12. Plasmid restriction enzyme verification
4 positive clone colonies are picked, plasmids are extracted, digestion verification is carried out on BamHI and XhoI, digestion results are shown in figure 7, and as can be seen from figure 7, digestion results of plasmids No. 2-5 BamHI and XhoI are both correct, and a sequencing result is correct, so that adenovirus vector plasmids pAd5 delta E4 with deletion of E1, E3 and E4 genes are obtained.
Example 3 construction of adenovirus vector plasmid pAd5LCL3 deleted for E1, E3, E4 and E2a genes
1. Selection of target sequence of target gene E2a CRISPR
1) Selection of CRISPR target sequence of 100k gene on upstream of E2a gene
Using the Saimer fly GeneArtTMThe CRISPR Search and Design tool (thermofisher. com/crispdesign) software imports the first 400 bases of the 100k gene and the software automatically analyzes the 400 bases sequence, providing 6 potential CRISPR target sequences. Considering the length of E2a gene knockout sequence and the requirement of constructing a live vector, ATAGGTGGCGTTCGTAGGCA was selected as the targeting sequence, and the final gRNA was named 100k-gRNA, cleavage site and PAM site asAs shown in fig. 8.
2) Selection of non-coding sequence CRISPR target sequence downstream of E2a
Using the Saimer fly GeneArtTMCRISPR Search and Design tool (thermofisher. com/CRISPR Design) software, 300 bases downstream of E4 were input, the software was automatically analyzed to provide 6 potential CRISPR target sequences, TACCCCGGTAATAAGGTTCA was selected as a targeting sequence, the finally obtained gRNA was named protease-gRNA, cleavage site and PAM site are shown in fig. 9.
2. DNA amplification of 100k-gRNA and protease-gRNA
1) DNA template design for 100k-gRNA
5’-TAATACGACTCACTATAGAGGTGGCGTTCGTAGGCAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCC GTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT-3’
2) DNA template design of protease-gRNA
5’-TAATACGACTCACTATAGCCCCGGTAATAAGGTTCAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCC GTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT-3’
3. Designing upstream and downstream primers of DNA template for amplifying 100k-gRNA and protease-gRNA
An upstream primer and a downstream primer were designed to perform PCR amplification of a 100k-gRNA DNA template and a protease-gRNA DNA template, respectively, using GeneArtTMPrecision gRNA Synthesis Kit for amplification.
1) Primer design
100k-gRNA-Foward:TAATACGACTCACTATAG AGGTGGCGTTCGTAG
100k-gRNA-Reverse:TTCTAGCTCTAAAAC TGCCTACGAACGCCACCT
protease-gRNA-Foward:TAATACGACTCACTATAG CCCCGGTAATAAGGT
protease-gRNA-Reverse:TTCTAGCTCTAAAAC TGAACCTTATTACCGGGG
2) DNA template for amplifying 100k-gRNA and protease-gRNA
Firstly, preparing 0.3 mu M100 k-gRNA-Forward/Reverse primer mixed working solution, comprising 10 mu M100 k-gRNA-Forward primer 3ul, 10 mu M100 k-gRNA-Reverse primer 3ul, and supplementing water to 100 ul.
Preparing 0.3 mu M of Aprotease-gRNA-Forward/Reverse primer mixed working solution, including 3ul of 10 mu M of protease-gRNA-Forward primer, 3ul of 10 mu M of protease-gRNA-Reverse primer, and supplementing water to 100 ul.
PCR reaction system
The PCR reaction system for DNA template amplification of 100k-gRNA is as follows: phusionTMHigh-Fidelity PCR Master Mix (2X) 12.5ul, Tracr Fragment + T7 Primer Mix 1ul, 0.3. mu.M 100k-gRNA-Forward/Reverse Primer Mix 1ul, water make-up to 25 ul.
The PCR reaction system for the DNA template amplification of the protease-gRNA is as follows: phusionTMHigh-Fidelity PCR Master Mix (2X) 12.5ul, Tracr Fragment + T7 Primer Mix 1ul, 0.3. mu.M protease-gRNA-Forward/Reverse Primer Mix 1ul, water supplement to 25 ul.
(iv) PCR procedure
Initial denaturation at 98 ℃,10 sec, 1 cycle; denaturation at 98 ℃ for 5 sec; annealing at 55 ℃, 15sec, and 32 cycles; extending for 72 ℃, 1min, and 1 cycle; the temperature was maintained at 4 ℃.
3. Obtaining 100k-gRNA and protease-gRNA through in vitro transcription
Using TranscriptAIdTMThe Enzyme Mix carries out in vitro transcription on the template DNA to obtain 100k-gRNA and protease-gRNA.
1) Obtaining 100k-gRNA and protease-gRNA through in vitro transcription
The reaction system for obtaining 100k-gRNA by in vitro transcription is as follows: NTP mix 8ul, 100k-gRNA DNA template 6ul, 5 × TranscriptAIdTM Reaction Buffer 4ul,TranscriptAidTMEnzyme Mix 2 ul. After 4 hours incubation at 37 ℃ 1ul of DNase I was added and incubated for 15 minutes at 37 ℃.
The reaction system for obtaining the protease-gRNA through in vitro transcription is as follows: NTP mix 8ul, protease-gRNA DNA template 6ul, 5 × TranscriptAIDTM Reaction Buffer 4ul,TranscriptAidTMEnzyme Mix 2 ul. After 4 hours incubation at 37 ℃ 1ul of DNase I was added and incubated for 15 minutes at 37 ℃.
2) Purification of in vitro transcription products
Supplementing the reaction system after transcription with nuclease-free water200ul, adding 100ul Binding buffer, mixing, adding 300ul ethanol (ethanol)>96%), mixing well, transferring the mixture to the Gene JETTMIn RNA Purification Micro Column, 14000 Xg is centrifuged for 30-60 seconds, and the solution is discarded; 700ul of Wash Buffer1 (13 mL of ethanol was added), 14000 Xg was centrifuged for 30-60 seconds, and the solution was discarded; 700ul of Wash Buffer2 (30 mL of ethanol added) was added, the mixture was centrifuged at 14000 Xg for 30-60 seconds, and the solution was discarded, and the above procedure was repeated once. 14000 Xg was left empty for 60 seconds, all the eluate was completely removed, the empty tube was placed in a 1.5mL collection tube, 10ul of nuclease-free water was added to the center of the column, and the gRNA was collected by centrifugation at 14000 Xg for 60 seconds.
Wherein, both the Wash Buffer1 and the Wash Buffer2 are TranscriptAIDTMThe RNA sequences of 100k-gRNA and protease-gRNA obtained by transcription of the reagents in the Enzyme Mix kit are shown below:
100k-gRNA:GAGGUGGCGUUCGUAGGCAGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCUUUU
protease-gRNA:GCCCCGGUAAUAAGGUUCAGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCUUUU
4. CRISPR/Cas9 enzyme digestion "
The adenovirus vector plasmid which is obtained in the example 2 and lacks E1, E3 and E4 genes is subjected to double enzyme digestion by using 100k-gRNA, protease-gRNA and Cas9, and the reaction system is 3 mu g of Cas9 protein; 6 mu g of 100 k-gRNA; 6 mu g of protease-gRNA; 3. mu.g of the vector plasmid obtained in example 2; NEB buffer 3.15 ul; water was replenished to 50 ul.
The above digestion reactions were incubated overnight at 37 ℃. 3ul samples were taken for agarose gel validation and the results are shown in FIG. 10. Lane 1 shows the results of "double digestion" of vector plasmids by 100k-gRNA, protease-gRNA and cas9, and fragments with the target size of 1000 and 2500bp appeared, which indicates that the digestion results are correct. The vector was purified using the Axygen gel recovery kit.
5. Obtaining a 100k, E4ORF6/7 expression cassette and a Protease fragment containing partial knockout
1) Amplification of partially knocked-out 100k, E4ORF6/7 expression cassette, Protease fragment
Part knocked-out 100k amplification primers:
100k-F:TGAGAATAGGTGGCGTTCGTAGGCAAGGCTGACATCCGCTATGG
100k-ORF6/7-R:TACAATTCCCAACACATACAAGTTTCCTTCTCCTATAGGCAGAA
the amplification system is as follows: 10 μ M100 k-F primer 1 ul; 10 μ M100 k-ORF6/7-R primer 1 ul; template pAd 5. delta.E 4(100ng/ul)0.5 ul; q5 high fidelity enzyme 25 ul; water is added to 50 ul.
The PCR procedure was: initial denaturation at 98 ℃,10 sec, 1 cycle; denaturation at 98 ℃ for 5 sec; annealing at 60 ℃ for 30 sec; extension 72 ℃, 20sec, 35 cycles; extension at 72 deg.C for 5min, and 1 cycle; the temperature was maintained at 4 ℃.
E4ORF6/7 expression cassette amplification primer:
ORF6/7-F:ACTTGTATGTGTTGGGAATTGTA
ORF6/7-R:ATCGTTTGTGTTATGTTTCAACG
the amplification system is as follows: ORF6/7-F primer 1 ul; 10 μ M ORF6/7-R primer 1 ul; 0.5ul of template ORF6/7 expression cassette gene (100 ng/ul); q5 high fidelity enzyme 25 ul; water is added to 50 ul.
The PCR procedure was: initial denaturation at 98 ℃,10 sec, 1 cycle; denaturation at 98 ℃ for 5 sec; annealing at 60 ℃ for 30 sec; extension 72 ℃,10 sec, 35 cycles; extension at 72 deg.C for 5min, and 1 cycle; the temperature was maintained at 4 ℃.
Amplification of partially knocked-out Protease fragment
ORF6/7-Protease-F:CCCACCCTTGCCGTCTGCGCCGTATCGTTTGTGTTATGTTTCAACG
Protease-R:ATGGATCACAACCCCACCATGAACCTTATTACCGGGGTACCCA
The amplification system is as follows: 10 μ M ORF6/7-Protease-F primer 1 ul; 10 μ M of Protease-R primer 1 ul; template pAd 5. delta.E 4(100ng/ul)0.5 ul; q5 high fidelity enzyme 25 ul; water is added to 50 ul.
The PCR procedure was: initial denaturation at 98 ℃,10 sec, 1 cycle; denaturation at 98 ℃ for 5 sec; annealing at 60 ℃ for 30 sec; extension 72 ℃,10 sec, 35 cycles; extension at 72 deg.C for 5min, and 1 cycle; the temperature was maintained at 4 ℃.
(100 k), E4ORF6/7 expression cassette, and the results of protease PCR amplification are shown in FIG. 11, wherein lane 1 is E4ORF6/7 expression cassette, lane 2 is 100k, and M is 15000bpMarker
The amplification result is correct, and the fragments are respectively recovered and purified by using an Axygen gel recovery kit.
6. Obtaining a fusion fragment of 100k, E4ORF6/7 expression frame and Protease fragment by fusion PCR
The amplification system is as follows: 10 μ M100 k-F primer 1 ul; 10 μ M of Protease-R primer 1 ul; the template 100k glue recovery product (50ng/ul)1ul template E4ORF6/7 expression frame glue recovery product (50ng/ul)1ul template E4ORF6/7 expression frame glue recovery product (50ng/ul)1 ul; q5 high fidelity enzyme 25 ul; water is added to 50 ul.
The PCR procedure was: initial denaturation at 98 ℃,10 sec, 1 cycle; denaturation at 98 ℃ for 5 sec; annealing at 60 ℃ for 30 sec; extension 72 ℃, 50sec, 35 cycles; extension at 72 deg.C for 5min, and 1 cycle; the temperature was maintained at 4 ℃. The amplification results are shown in FIG. 12, in which lane 1 shows the fragment 100k, the E4ORF6/7 expression cassette, and the protease fusion PCR product, and the amplification results are correct. The fragments were purified using the Axygen gel recovery kit.
7. Carrier attachment
The 100k, E4ORF6/7 expression cassette, protease fusion PCR gel recovery product was ligated to the E2a knockout vector of step 4 using Gibson from NEB as follows: 100ng of vector fragment after E2a knockout of gel recovery product, 100k of gel recovery product, 50ng of E4ORF6/7 expression frame, 50ng of protease fusion PCR fragment, 10ul of Gibson premix and 20ul of water supplement. Incubate at 50 ℃ for 40 minutes.
8. Transformation of
Taking out the kanamycin-resistant culture medium plate, putting the prepared NEB 10 beta competent cells on ice for melting, adding 10ul of ligation products, slightly sucking the ligation products evenly by a pipette, and placing the ligation products on the ice for 30 minutes; the centrifuge tubes were placed in a 42 ℃ water bath and heat-shocked for 90 seconds to select transformants using kanamycin resistance.
9. Colony PCR for transformant screening
Colony PCR validation was performed on the transformants using PCR amplification.
Design of downstream primer for colony PCR
DBP-upsteam-F:GTTGGGCTCGCATGTGCCG
DBP-downsteam-R:ACTCCCATGGATCACAACCC
The reaction system is as follows: 10 mu M DBP-uptecam-F primer 1ul, 10 mu M DBP-downecam-R primer 1ul, Q5 high fidelity enzyme 10ul, moisturizing to 20ul, and picking the single colony in the reaction system. The PCR procedure was: initial denaturation at 98 ℃,10 sec, 1 cycle; denaturation at 98 ℃ for 5 sec; annealing at 60 ℃ for 30 sec; extension 72 ℃, 20sec, 35 cycles; extension at 72 deg.C for 5min, and 1 cycle; the temperature was maintained at 4 ℃. Agarose gel electrophoresis was performed and positive bands appeared at 9, 18, 21, and 24 as shown in FIG. 13.
10. Plasmid restriction enzyme verification
The colonies of 4 positive clones 9, 18, 21 and 24 were picked, plasmids were extracted, and the restriction enzyme digestion was verified by XhoI, and the restriction enzyme digestion results are shown in FIG. 14, wherein lane 1 is the restriction enzyme digestion of positive clone XhoI of number 9, lane 2 is the restriction enzyme digestion of positive clone XhoI of number 18, lane 3 is the restriction enzyme digestion of positive clone XhoI of number 21, lane 4 is the restriction enzyme digestion of positive clone XhoI of number 24, and lane 5 is the restriction enzyme digestion of XhoI of control plasmid pAd5LCL 3. As can be seen from FIG. 14, the restriction enzyme cutting results of plasmid XhoI are all correct, and the sequencing results are correct, that is, plasmid pAd5LCL3 with E2a region sequence position deleted, in which E1, E3, E4 and E2a genes are deleted, and ORF6/7 expression cassette of E4 region is placed, is obtained, and the vector map is shown in FIG. 49.
Example 4 construction of African Swine fever adenovirus type 5 vector E1 region shuttle plasmid pS5E1-L8Lubiqutin-IRES-I215L
1. Construction of shuttle plasmid in E1 region of human adenovirus type 5 vector
The backbone of the shuttle plasmid pS5E1 used basic elements (2796bp) such as puc origin and amp (pS5E1 backbone synthesized by Beijing Bomeide Gene technology, Inc.), ITR partial sequence (355bp) of Ad5 left arm, PIX partial sequence (2100bp) of right arm and PIVa2 partial sequence (2100bp), and CMV-MCS (Seq ID No.14) (944bp) SV40 early polyA (Seq ID No.15) (160 bp).
1) Primer design
puc-Ad5-right arm-F:TAATGCAGCTGGCTTATCGAAACGTGGAATGCGAGACCGTCT
Ad5-right arm-CMV-R:ACACACAAGCAGGGAGCAGATACAAGGGTGGGAAAGAATATATAAG
CMV-F:GTATCTGCTCCCTGCTTGTG
CMV-SV40-R:TAAACAAGTTGGGGTGGGCGAAGTGATCAGCGGGTTTAAACGGG
SV40-F:CTTCGCCCACCCCAACTTGT
SV40-R:AGAGGTCGACGGTATACAGAC
SV40-Ad5-left arm-F:TGTCTGTATACCGTCGACCTCTCCGAAAAACACCTGGGCGAGTCTCC
Ad5-left arm-puc-R:ACACTATAGAATACACGGAATTCTTAATTAAATCATCAATAATATACCTTATTTTG
puc-F:GAATTCCGTGTATTCTATAGTGT
puc-R:TTTCGATAAGCCAGCTGCATTA
2) Amplification of fragments of interest
Amplifying a CMV promoter MCS fragment of a pS5E1 shuttle plasmid by taking pCDNA3.1(+) as a template (the plasmid is purchased from Saimer fly company) and CMV-F and CMV-SV40-R as primers; an amplification system: 50ng of pCDNA3.1(+) plasmid, 1ul of 10uM CMV-F primer, 1ul of 10uM CMV-SV40-R primer and 20ul of Q5 high fidelity enzyme; supplementing water to 40 ul; the PCR procedure was: 10s at 98 ℃; at 98 deg.C, 5s, 60 deg.C, 30s, 72 deg.C, 1min, 35 cycles; 72 ℃ for 5 min.
② an SV 40-earlyplo A fragment of the pS5E1 shuttle plasmid is amplified by taking pCDNA3.1(+) as a template (the plasmid is purchased from Saimer Fei company) and SV40-F and SV40-R as primers; an amplification system: 50ng of pCDNA3.1(+) plasmid, 1ul of 10uM SV40-F primer, 1ul of 10uM SV40-R primer and 20ul of Q5 high-fidelity enzyme; supplementing water to 40 ul; the PCR procedure was: 10s at 98 ℃; 35 cycles of 98 deg.C, 5s, 60 deg.C, 30s, 72 deg.C, 10 sec; 72 ℃ for 5 min.
The amplification product agarose validation is shown in FIG. 15, in which lane 1 is CMV-MCS fragment, lane 2 is SV40 earlylylA fragment, and M is 2000 Marker. As can be seen from FIG. 15, the amplification results were correct.
③ purifying by using an Axygen gel recovery kit.
Fourthly, PCR amplification is carried out on the pS5E1 shuttle plasmid skeleton by taking pS5E1 skeleton plasmid synthesized by Bomeide company as a template and puc-F and puc-R as primers, and an amplification system is as follows: pS5E1 backbone plasmid 50ng, 10uM puc-F primer 1ul, 10uM puc-R primer 1ul, Q5 Hi-Fi enzyme 20 ul; supplementing water to 40 ul; the PCR procedure was: 10s at 98 ℃; 35 cycles of 98 deg.C, 5s, 60 deg.C, 30s, 72 deg.C, 1min, 20 sec; 72 ℃ for 5 min.
Fifthly, amplifying the left arm of the shuttle plasmid pS5E1 by taking pAd5LCL3 plasmid as a template and SV40-Ad5-left arm-F and Ad5-left arm-puc-R as primers, and obtaining an amplification system: 50ng of pAd5LCL3 plasmid, 1ul of 10uM SV40-Ad5-left arm-F primer, 1ul of 10uM Ad5-left arm-puc-R primer, 20ul of Q5 high fidelity enzyme and water supplementation to 40 ul. The PCR procedure was: 10s at 98 ℃; at 98 deg.C, 5s, 60 deg.C, 30s, 72 deg.C, 20s, 35 cycles; 72 ℃ for 5 min.
Sixthly, amplifying the right arm of the shuttle plasmid pS5E1 by taking pAd5LCL3 plasmid as a template and puc-Ad5-right arm-F and Ad5-right arm-CMV-R as primers, wherein the amplification system comprises the following steps: pAd5LCL3 plasmid 50ng, 10uM puc-Ad5-right arm-F primer 1ul, 10uM Ad5-right arm-CMV-R primer 1ul, Q5 Hi-Fi enzyme 20ul, water make up to 40 ul. The PCR procedure was: 10s at 98 ℃; at 98 deg.C, 5s, 60 deg.C, 30s, 72 deg.C, 15s, 35 cycles; 72 ℃ for 5 min.
Seventhly, amplifying the CMV-MCS-SV40 earlylyLYA fragment of the pS5E1 shuttle plasmid by taking the CMV-MCS of the glue recovery product as a template and CMV-F and SV40-R as primers, and obtaining an amplification system: 50ng of pAd5LCL3 plasmid, 1ul of 10uM CMV-F primer, 1ul of 10uM SV40-R primer, 20ul of Q5 high-fidelity enzyme and water supplement to 40 ul. The PCR procedure was: 10s at 98 ℃; 35 cycles of 98 deg.C, 5s, 60 deg.C, 30s, 72 deg.C, 40 s; 72 ℃ for 5 min.
The amplification product was verified on agarose as shown in FIG. 16, wherein lane 1 is CMV-MCS-SV40 earlyplolyA fusion fragment, lane 2 is PUC, lane 3 is Ad5 right arm, and lane 4 is Ad5 left arm.
3) Ligation transformation of fragments
The fragments were purified using Axygen gel recovery kit, and then four fragments of pS5E1 backbone, Ad5 left arm, Ad5 right arm, CMV-MCS-SV40 earlylylylA were ligated using a seamless Cloning kit from Bomeide, with linker systems of 2 × Smaless Cloning Mix 10ul, pS5E1 backbone 50ng, Ad5 left arm 50ng, Ad5 right arm 50ng, CMV-MCS-SV40 polyA 50ng, supplemented with water to 20ul, and incubated at 50 ℃ for 40 minutes to obtain the ligation product plasmid pS5E 1. The ligation products were transformed into DH 5. alpha. competent cells, plated on plates containing ampicillin, and cultured at 37 ℃ for 12 to 16 hours.
4) Verification of plasmids
Bacterial colony PCR verification
Colonies were picked and checked on agarose gel, and a positive band was observed as shown in FIG. 17.
② enzyme digestion verification
And (3) selecting positive clones, placing the positive clones in 5mL of LB liquid culture medium containing ampicillin resistance, culturing for 12-15 hours, extracting plasmids, performing enzyme digestion verification, and obtaining electrophoresis results shown in figure 18, wherein the left 1-6 is single enzyme digestion of the plasmid pS5E1NcoI, the right 1-6 is single enzyme digestion of the plasmid pS5E1 PacI, the M is 15000bp Marker, the enzyme digestion results are correct, and successfully constructing a shuttle plasmid pS5E1 in the E1 region of the human adenovirus 5 type vector, and the vector map of the shuttle plasmid is shown in figure 50.
2. Construction of African swine fever adenovirus type 5 vector shuttle plasmid pS5E1-L8Lubiqutin-IRES-I215L
1) Ligation of pS5E1 with IRES fragment
Firstly, primer synthesis
IRES-EcoRV-F:ccg GATATC TGTCGTCATCATCCTTATAGTCC
IRES-NotI-R:aaatat GCGGCCGC GGTTGTGGCCATTATCATCGTG
Amplification of IRES fragment
An amplification system: 25ul of Q5 enzyme, 10uM primer IRES-EcoRV-F1 ul, 10uM primer IRES-NotI-R1 ul, 2ul of template IRES template and water supplementing to 50 ul; the PCR procedure was: 10s at 98 ℃; at 98 deg.C, 5s, 60 deg.C, 30s, 72 deg.C, 20s, 35 cycles; 72 ℃ for 5 min. The electrophoresis detection of the amplification result is shown in FIG. 19, wherein lanes 1 and 2 are IRES fragment PCR amplification products, M is 15000bp Marker, and the amplification result is correct.
③ purification of the IRES fragment using Axygen PCR purification kit.
Cutting target fragment IRES with pS5E1 carrier enzyme
An enzyme digestion reaction system: vector pS5E1, IRES fragment ~ 2ug, EcoRV and NotI each 1 ul; 10 Xcutmarstat buffer 5 ul; adding water to 50 ul; reaction conditions are as follows: 30min at 37 ℃; inactivating at 65 deg.C for 20 min; and (5) recovering and purifying the glue. The electrophoretic detection of the cleavage products is shown in FIG. 20, wherein the fragment IRES EcoRV and NotI is cleaved in lane 1, the fragment pS5E1 EcoRV and NotI is cleaved in lane 2, and M is 15000bp Marker.
Connecting pS5E1 vector with IRES fragment
A connection system: pS5E1(100 ng); IRES fragment (vector: fragment 1:5, molar ratio); t4 DNA ligase 1 ul; 10 Xligase buffer1 ul; water is added to 10 ul. Reaction conditions are as follows: room temperature, 30 min. The ligation products were transformed into DH 5. alpha. competent cells, plated on plates containing ampicillin, and cultured at 37 ℃ for 12 to 16 hours.
Sixth colony PCR verification
An amplification system: q5 enzyme 10ul, 10uM primer IRES-EcoRV-F1 ul, 10uM primer IRES-NotI-R1 ul, water supplement to 20 ul; the PCR procedure was: 10s at 98 ℃; at 98 deg.C, 5s, 60 deg.C, 30s, 72 deg.C, 20s, 35 cycles; 72 ℃ for 5 min. Electrophoresis was performed, as shown in FIG. 21, in which colonies Nos. 1 to 9 and M were Marker, as seen from FIG. 21, and positive bands appeared in Nos. 2 and 6.
And enzyme cutting verification of the plasmids NotI and EcoRV, selecting 2 and 6 for plasmid extraction, enzyme cutting verification, and obtaining the result shown in FIG. 22, wherein the enzyme cutting identification of the plasmid No.2 NotI and EcoRV, the enzyme cutting identification of the plasmid No.6 NotI and EcoRV, and the enzyme cutting result is correct.
2) Ligation of pS5E1-IRES to I215L fragment
Firstly, primer synthesis
I215L-NotI-F:aaggaaaaaaGCGGCCGCgccaccATGGTGAGCAGGTTTCTGATC
I215L-XhoI-R:catgCTCGAG TCAGGCGTAATCGGGCACAT
② PCR amplification of I215L fragment
An amplification system: 25ul of Q5 enzyme, 10uM primer I215L-NotI-F1 ul, 10uM primer I215L-XhoI-R1 ul, template I215L 1ul, and water is supplemented to 50 ul; the PCR procedure was: 10s at 98 ℃; 35 cycles of 98 deg.C, 5s, 60 deg.C, 30s, 72 deg.C, 40 s; 72 ℃ for 5 min.
③ purification of the I215L fragment using the Axygen PCR purification kit.
Fourthly, the target fragment I215L is enzyme-digested with pS5E1-IRES vector
An enzyme digestion reaction system: vector pS5E1-IRES, I215L fragment ~ 2ug, NotI and XhoI each 1 ul; 10 Xcutmarstat buffer 5 ul; water is added to 50 ul. Reaction conditions are as follows: 30min at 37 ℃; inactivating at 65 deg.C for 20 min. And (5) recovering and purifying the glue. The electrophoretic detection of the cleaved products is shown in FIG. 23, wherein the lane vector is double cleaved with pS5E1-IRES NotI and XhoI, the lane I215L is double cleaved with fragment I215L NotI and XhoI, and M is 15000bp and 2000bp Marker.
Fifth, the target fragment I215L is connected with pS5E1-IRES
A connection system: pS5E1-IRES (100 ng); I215L fragment (carrier: fragment 1: 3 molar ratio); t4 DNA ligase 1 ul; 10 Xligase buffer1 ul; water is added to 10 ul. Reaction conditions are as follows: room temperature, 30 min. The ligation products were transformed into DH 5. alpha. competent cells, plated on plates containing ampicillin, and cultured at 37 ℃ for 12 to 16 hours.
Sixth colony PCR verification
An amplification system: q5 enzyme 10ul, 10uM universal primer CMV-F1 ul, 10uM primer I215L-XhoI-R1 ul, and supplementing water to 20 ul; the PCR procedure was: 10s at 98 ℃; at 98 deg.C, 5s, 60 deg.C, 30s, 72 deg.C, 30s, 35 cycles; 72 ℃ for 5 min. Electrophoresis was performed, as shown in FIG. 24, in which the numbers 1 to 11 were colonies and M was 2000bp Marker. As can be seen in FIG. 24, 1,2, 5,6,7, 8, 11 are positive colonies.
And seventhly, carrying out plasmid enzyme digestion verification (NotI and XhoI), selecting colonies of 5,6,7 and 8, carrying out plasmid extraction, and carrying out enzyme digestion verification. The results are shown in FIG. 25, which are all positive plasmids.
3) Ligation of pS5E1-IRES-MGF5L6L with fragment L8Lubiqutin
Firstly, primer synthesis
L8L-BamHI-F:cgcGATCCgccaccATGGGCAACAGACTGATCAAG
L8L-ubiqutin-R:AAGGGTTTTCACGAAAATCTGCATGGCGTAGTCGGGCACGTCGT
ubiqutin-F:ATGCAGATTTTCGTGAAAACCC
ubiqutin-EcoRV-R:ccgGATATC TTACTTGTCTTCTGGTTTGTTGA
② PCR amplification of L8Lubiqutin fragment
Amplification of L8L fragment
An amplification system: 25ul of Q5 enzyme, L8L-BamHI-F1 ul of primer, L8L-ubiqutin-R1 ul of primer, L8L 2ul of template, and supplementing water to 50 ul; reaction conditions are as follows: 30S at 98 ℃; 10s at 98 ℃, 30s at 68 ℃, 15s at 72 ℃ and 35 cycles; 5min at 72 ℃.
Amplification of ubiqutin fragments
An amplification system: 25ul of Q5 enzyme, 1ul of a primer ubiqutin-F, 1ul of a primer ubiqutin-EcoRV-R, 2ul of a template ubiqutin, and 50ul of water; reaction conditions are as follows: 30S at 98 ℃; 10s at 98 ℃, 30s at 68 ℃, 15s at 72 ℃ and 35 cycles; 5min at 72 ℃.
Purifying the L8L and ubiqutin fragments by using an Axygen gel recovery and purification kit;
fusion PCR amplification of L8Lubiqutin fragment
An amplification system: 25ul of Q5 enzyme, 25ul of upstream primer L8L-BamHI-F, 50ng of downstream primer ubiqutin-EcoRV-R template fragment L8L and fragment ubiqutin respectively, and water is supplemented to 50 ul; reaction conditions are as follows: 98 deg.C; 5s at 98 ℃, 30s at 68 ℃, 30s at 72 ℃ and 35 cycles; 7min at 72 ℃.
③ purifying the L8Lubiqutin fragment by using an Axygen PCR purification kit, wherein the fused L8Lubiqutin fragment is shown in FIG. 26.
Fourthly, enzyme digestion of target fragment L8Lubiqutin and pS5E1-IRES-I215L carrier
An enzyme digestion reaction system: vector pS5E1-IRES-I215L, L8Lubiqutin fragment-2 ug, EcoRV and BamHI each 1 ul; 10 Xcutmarstat buffer 5 ul; water is added to 50 ul. Reaction conditions are as follows: 30min at 37 ℃; inactivating at 65 deg.C for 20 min. And (5) recovering and purifying the glue. The restriction products were detected by electrophoresis as shown in FIG. 27, in which lane 1 is pS5E1-IRES-I215L plasmid; lane 2 is pS5E1-IRES-I215L plasmid EcoRV and BamHI cut; lane 3 shows the L8Lubiqutin fragments EcoRV and BamHI cut, M15000 bp Marker.
Connecting pS5E1-IRES-I215L vector with L8Lubiqutin fragment
A connection system: pS5E1-IRES-I215L 100 ng; 50ng of L8Lubiqutin fragment; t4 DNA ligase 1 ul; 10 Xligase buffer1 ul; water is added to 10 ul. Reaction conditions are as follows: room temperature, 30 min. The ligation products were transformed into DH 5. alpha. competent cells, plated on plates containing ampicillin, and cultured at 37 ℃ for 12 to 16 hours.
Sixth colony PCR verification
An amplification system: q5 enzyme 10ul, 10uM universal primer CMV-F1 ul, 10uM primer ubiqutin-EcoRV-R1 ul, and water is supplemented to 20 ul; the PCR procedure was: 10s at 98 ℃; 35 cycles of 98 deg.C, 5s, 60 deg.C, 30s, 72 deg.C, 40 s; 72 ℃ for 5 min; electrophoresis was performed, as shown in FIG. 28, in which the numbers 1 to 24 were colonies and M was 2000bp Marker.
Seventhly, carrying out enzyme digestion verification on the plasmids BamHI and EcoRV, selecting colonies of 4, 6, 9, 14, 17 and 18 for plasmid extraction, carrying out enzyme digestion verification, wherein the results are shown in figure 29, the enzyme digestion verification is carried out on the BamHI and EcoRV, and M is 15000bp Marker. As can be seen from FIG. 29, the restriction enzyme digestion result is correct, the shuttle plasmid pS5E1-L8Lubiqutin-IRES-I215L plasmid of the E1 region of the African swine fever adenovirus type 5 vector is successfully constructed, and the vector map is shown in FIG. 51.
Example 5 construction of African Swine fever adenovirus type 5 vector E4 region shuttle plasmid pS5E4-I73Rhbsag-2A-E146L
1. Construction of shuttle plasmid in E4 region of human adenovirus type 5 vector
The skeleton of the shuttle plasmid pS5E4 adopts puc origin, amp and other basic elements, the left arm ITR sequence (370bp) of Ad5E4 region, the right arm fiber gene sequence (1746bp) and EF1 alpha-EGFP-HBV polyA gene.
1) Gene synthesis
EF1 alpha-EGFP-HBV polyA gene was synthesized by Bomeide.
2) Primer design
puc-Ad5E4-left arm-F:
AGGTGACACTATAGAATACACGTTAATTAAATCATCAATAATATACCTTATTTTG
Ad5E4-left arm-EF1α-R:caatccccccttttcttttaaaaAACACCACTCGACACGGCAC
EF1α-F:ttttaaaagaaaaggggggattg
EF1α-R:TAGAGCCCCAGCTGGTTCTTT
EF1α-Ad5E4-right arm-F:GGAAAGAACCAGCTGGGGCTCTAGCAATTGAAAAATAAACACGTTGA
Ad5E4-right arm-puc-R:TAATACGACTCACTATAGGGAGACCCAAAATGTAACCACTGTGAG
puc-F:TCTCCCTATAGTGAGTCGTATT
puc-R:CGTGTATTCTATAGTGTCACCT
ORF6/7-Protease-F:CGTTGAAACATAACACAAACGATACGGCGCAGACGGCAAGGGTGGG
3) Amplification of fragments of interest
Amplifying an EF1 alpha-EGFP-HBV polyA fragment of a pS5E4-EGFP shuttle plasmid by taking an EF1 alpha-EGFP-HBV gene synthetic fragment as a template and EF1 alpha-F and EF1 alpha-R as primers; an amplification system: EF1 alpha-EGFP-HBV gene synthetic fragment 50ng, 10uM EF1 alpha-F primer 1ul, 10uM EF1 alpha-R primer 1ul, Q5 Hi-Fi enzyme 20 ul; supplementing water to 40 ul. The PCR procedure was: 98 ℃ for 10 sec; 35 cycles of 98 deg.C, 5sec, 60 deg.C, 30sec, 72 deg.C, 40 sec; 72 ℃ for 5 min.
② the left arm segment of the pS5E1 shuttle plasmid is amplified by taking pAd5LCL3 as a template and puc-Ad5E4-left arm-F and Ad5E4-left arm-EF1 alpha-R as primers. An amplification system: 50ng of pAd5LCL3 plasmid, 1ul of 10uM puc-Ad5E4-left arm-F primer, 1ul of 10uM Ad5E4-left arm-EF1 alpha-R primer, and 20ul of Q5 Hi-Fi enzyme; supplementing water to 40 ul. The PCR procedure was: 10s at 98 ℃; 35 cycles of 98 deg.C, 5s, 60 deg.C, 30s, 72 deg.C, 10 sec; 72 ℃ for 5 min.
Thirdly, amplifying the right arm segment of the pS5E4-EGFP shuttle plasmid by taking pAd5LCL3 as a template and EF1 alpha-Ad 5E4-right arm-F and Ad5E4-right arm-puc-R as primers; an amplification system: pAd5LCL3 plasmid 50ng, 10uM EF1 α -Ad5E4-right arm-F primer 1ul, 10uM Ad5E4-right arm-puc-R primer 1ul, Q5 Hi Enzyme 20 ul; supplementing water to 40 ul.
The PCR procedure was: 10s at 98 ℃; 35 cycles of 98 deg.C, 5s, 60 deg.C, 30s, 72 deg.C, 40 sec; 72 ℃ for 5 min.
Fourthly, PCR amplification is carried out on the pS5E4-EGFP shuttle plasmid skeleton by taking the pS5E1 plasmid as a template and puc-F and puc-R as primers; an amplification system: pS5E1 backbone plasmid 50ng, 10uM puc-F primer 1ul, 10uM puc-R primer 1ul, Q5 Hi-Fi enzyme 20 ul; supplementing water to 40 ul. The PCR procedure was: 10s at 98 ℃; 35 cycles of 98 deg.C, 5s, 60 deg.C, 30s, 72 deg.C, 1min, 20 sec; 72 ℃ for 5 min. The agarose validation of the amplification products is shown in FIG. 30, wherein lane 1 is the left arm of pS5E4-EGFP shuttle plasmid, lane 2 is the right arm of pS5E4-EGFP shuttle plasmid, lane 3 is EF1 α -EGFP-HBV, lane 4 is the backbone of pS5E4-EGFP shuttle plasmid, and M is 2000 Marker. As can be seen from FIG. 30, the amplification results were correct.
4) The desired fragment was purified using the Axygen gel recovery kit.
5) Ligation transformation of fragments
Connecting the four fragments of the left arm of the pS5E4-EGFP shuttle plasmid, the right arm of the pS5E4-EGFP shuttle plasmid, EF1 alpha-EGFP-HBV and pS5E4-EGFP shuttle plasmid skeleton by using a seamless Cloning kit of Bomeide company, wherein the connecting system is 2 multiplied by Smaless Cloning Mix 10ul, 50ng of the left arm fragment of the pS5E4-EGFP shuttle plasmid, 50ng of the right arm fragment of the pS5E4-EGFP shuttle plasmid, 50ng of the EF1 alpha-EGFP-HBV fragment, 50ng of the shuttle plasmid skeleton fragment of pS5E4-EGFP, replenishing water to 20ul, and preserving the temperature for 40 minutes at 50 ℃; the ligation products were transformed into DH 5. alpha. competent cells, plated on plates containing ampicillin, and cultured at 37 ℃ for 12 to 16 hours.
6) Verification of plasmids
Bacterial colony PCR verification
The objective fragment was PCR-amplified by colony using the primer puc-Ad5E4-left arm-F/EF1 alpha-R as a primer, and the result of agarose gel validation shows that a positive band appears as shown in FIG. 31.
② enzyme digestion verification
Selecting No.3, 4,5 and 6 positive clones, culturing in 5mL LB liquid medium containing ampicillin resistance for 12-15 hours, extracting plasmids for enzyme digestion verification, wherein electrophoresis results are shown in figure 32, wherein 1-4 is No.3, 4,5 and 6 positive clones PacI single enzyme digestion, 5-8 is No.3, 4,5 and 6 positive clones HindIII single enzyme digestion, M1 and M3: 15000bp Marker; m2: 2000bp Marker; the enzyme digestion result is correct, and the sequencing is correct; the shuttle plasmid pS5E4-EGFP in the E4 region of the human adenovirus type 5 vector was successfully constructed, and the vector map thereof is shown in FIG. 52.
2. Construction of shuttle plasmid pS5E4-I73Rhbsag-2A-E146L in E4 region of African swine fever adenovirus type 5 vector
1) Primer design
pS5E4-I73R-BamHI-F:ccaagctgtgaccggcgcctacGGATCCgccaccATGGAGACACAGAAG
I73R-hbsag-R:AGCCGCTGGTGGTGTTCTCCATGGCGTAGTCAGGCACATCGTA
hbsag-F:ATGGAGAACACCACCAGCGGC
hbsag-2A-R:TGAAGTTAGTAGCTCCGCTTCCGATGTACACCCAGAGGCAGAA
2A-F:GGAAGCGGAGCTACTAACTTC
2A-E146L-R:ACAAAGTCTGTTGTTCCGCCCATAGGTCCAGGGTTCTCCTCCA
E146L-F:ATGGGCGGAACAACAGACTTT
E146L-pS5E4-XhoI-R:CGGGTTTAAACGGGCCCTCTAGACTCGAGTTAGATGATTCTCTGC
2) Amplification of fragments of interest I73R, hbsag, 2A, E146L
Amplifying an I73R fragment by taking an I73R gene synthetic fragment as a template and pS5E4-I73R-BamHI-F and I73-hbsag-R as primers; an amplification system: 50ng of I73 gene synthetic fragment, 1ul of 10uM pS5E4-I73R-BamHI-F primer, 1ul of 10uM I73-hbsag-R primer and 20ul of Q5 Hi-Fi enzyme; supplementing water to 40 ul; the PCR procedure was: 98 ℃ for 10 sec; 35 cycles of 98 deg.C, 5sec, 60 deg.C, 30sec, 72 deg.C, 20 sec; 72 ℃ for 5 min.
Amplifying the hbsag fragment by using the hbsag gene synthetic fragment as a template and using hbsag-F and hbsag-2A-R as primers; an amplification system: 50ng of the hbsag gene synthetic fragment, 1ul of 10uM hbsag-F primer, 1ul of 10uM hbsag-2A-R primer and 20ul of Q5 high fidelity enzyme; supplementing water to 40 ul; the PCR procedure was: 98 ℃ for 10 sec; 35 cycles of 98 deg.C, 5sec, 60 deg.C, 30sec, 72 deg.C, 20 sec; 72 ℃ for 5 min.
Thirdly, amplifying the 2A fragment by taking the 2A gene synthesized fragment as a template and taking 2A-F and 2A-E146L-R as primers; an amplification system: 50ng of 2A gene synthetic fragment, 1ul of 10uM 2A-F primer, 1ul of 10uM 2A-E146L-R primer and 20ul of Q5 high fidelity enzyme; supplementing water to 40 ul; the PCR procedure was: 98 ℃ for 10 sec; 35 cycles of 98 deg.C, 5sec, 60 deg.C, 30sec, 72 deg.C, 20 sec; 72 ℃ for 5 min.
Fourthly, amplifying the E146L fragment by taking the E146L gene synthetic fragment as a template and taking E146L-F and E146L-pS5E4-XhoI-R as primers; an amplification system: 50ng of E146L gene synthetic fragment, 1ul of 10uM E146L-F primer, 1ul of 10uM E146L-pS5E4-XhoI-R primer and 20ul of Q5 Hi-Fi enzyme; supplementing water to 40 ul; the PCR procedure was: 98 ℃ for 10 sec; at 98 deg.C, 5sec, 60 deg.C, 30sec, 72 deg.C, 30sec, 35 cycles; 72 ℃ for 5 min.
The desired fragment was purified using the Axygen gel recovery kit.
4) Fusion PCR amplification of I73Rhbsag fragment
An amplification system: 50ng of I73R gel recovery fragment, 50ng of hbsag gel recovery fragment, 1ul of 10uM pS5E4-I73R-HamHI-F primer, 1ul of 10uM hbsag-2A-R primer and 25ul of Q5 Hi-Fi enzyme; adding water to 50 ul; the PCR procedure was: 98 ℃ for 10 sec; 35 cycles of 98 deg.C, 5sec, 60 deg.C, 30sec, 72 deg.C, 20 sec; 72 ℃ for 5 min.
5) Fusion PCR amplification of 2A-E146L fragment
An amplification system: 50ng of a 2A gel recovery fragment, 50ng of an E146L gel recovery fragment, 1ul of a10 uM 2A-F primer, 1ul of a10 uM E146L-pS5E4-XhoI-R primer and 25ul of Q5 Hi-Fi enzyme; adding water to 50 ul; the PCR procedure was: 98 ℃ for 10 sec; at 98 deg.C, 5sec, 60 deg.C, 30sec, 72 deg.C, 30sec, 35 cycles; 72 ℃ for 5 min. The fusion results are shown in FIG. 33, in which lane 1 is the I73Rhbsag fragment, lane 1 is the 2A-E146L fragment, and M is 2000bp Marker.
6) pS5E4-EGFP vector restriction enzyme
An enzyme digestion reaction system: vector pS5E4-EGFP 2ug, BamHI and XhoI each 1 ul; 10 Xcutmarstat buffer 5 ul; water is added to 50 ul. Reaction conditions are as follows: 30min at 37 ℃; inactivating at 65 deg.C for 20 min. And recovering and purifying the Axygen kit gel.
7) Purifying the vector fragment by using an Axygen gel recovery kit;
the gel recovery results are shown in FIG. 34, in which lane 1 shows the recovery of the fragment pS5E 4-EGFPdamI, XhoI double-enzyme gel, M is 15000bp Marker.
8) pS5E4-EGFP glue recovery vector, I73Rhbsag fragment and 2A-E146L seamless cloning connection and transformation
A connection system: the pS5E4-EGFP gel recovered product (100ng), I73Rhbsag fragment (50ng), 2A-E146L fragment (50ng), 2 × Smaless Cloning Mix 5ul, supplemented with water to 10 ul. Reaction conditions are as follows: 50 ℃ for 40 min. The ligation products were transformed into DH 5. alpha. competent cells, plated on plates containing ampicillin, and cultured at 37 ℃ for 12 to 16 hours.
9) Verification of plasmids
Bacterial colony PCR verification
The target fragment was amplified by colony PCR using EF1 α 2(jd) -F, HBV (jd) -R as primers, and the results of agarose gel assay are shown in FIG. 35, in which the numbers 1-12 are colonies, M is 15000bp Marker, and all are positive bands.
② enzyme digestion verification
Selecting No.1, No.2 and No.3 positive clones, culturing in 5mL LB liquid culture medium containing ampicillin resistance for 12-15 hours, extracting plasmids, and performing BmHI and XhoI double enzyme digestion verification; the cleavage results are shown in FIG. 36, wherein lanes 1,2 and 3 are positive clones BamHI and XhoI, and M is 15000bp Marker. The restriction enzyme cutting result is correct, the sequencing is correct, the shuttle plasmid pS5E4-I73Rhbsag-2A-E146L of the E4 region of the African swine fever adenovirus type 5 vector is successfully constructed, and the vector map is shown in FIG. 53.
Example 6 recombination of shuttle plasmids pS5E1-L8Lubiqutin-IRES-I215L, pS5E4-I73Rhbsag-2A-E146L and pAd5LCL3 constructs pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L plasmid
1. Homologous recombination of shuttle plasmid pS5E1-L8Lubiqutin-IRES-I215L and adenovirus vector plasmid pAd5LCL3
1) PacI and SwaI carry out enzyme digestion on the shuttle plasmid pS5E1-L8Lubiqutin-IRES-I215L and the adenovirus vector plasmid pAd5LCL3, and the enzyme digestion reaction system is as follows:
A. shuttle plasmid pS5E1-L8Lubiqutin-IRES-I215L 3 μ g; PacI 2 ul; buffer cutmarst 4 ul; supplementing water to 40 ul.
B. Adenovirus vector plasmid pAd5LCL 33 ug; SwaI 2 ul; buffer 3.14 ul; supplementing water to 40 ul.
The reaction conditions are 37 ℃ and 1 h; inactivating at 65 deg.C for 20 min.
2ul agarose gel was used for verification, and the result is shown in FIG. 37, wherein lane 1 is pAd5LCL3, and lane 2 is pS5E1-L8 Lubiqutin-IRES-I215L.
2) Dephosphorylation of enzyme digestion products
Reaction system: 37.5ul of enzyme digestion reaction liquid; dephosphorylating enzyme 1 ul; dephosphorylating buffer 5 ul; water is added to 50 ul. The reaction conditions are 37 ℃ and 1 h; inactivating at 65 deg.C for 5 min.
3) Gel recovery of the vector and fragment was performed using the OMEGA Ultra-Sep Gel Extraction Kit.
4) And co-transforming BJ5183 competent cells by using 100ng of purified shuttle plasmids and 100ng of purified adenovirus vectors, coating the transformed products on an LB plate containing Kan, and culturing at 37 ℃ for 12-16 h.
5) Selecting colonies in 5mL LB liquid medium containing Kan, carrying out shake culture at 37 ℃ for 12-16 h, and extracting plasmids for XhoI enzyme digestion verification; the results are shown in FIG. 38, where lanes 1-7 are pAd5LCL3-L8Lubiqutin-IRES-I215L clone, M: 15000bp Marker, as can be seen from FIG. 38, clones No.6 and No.7 were cleaved correctly.
6) The No.6 positive plasmid is transformed to DH5a competence, a colony is selected to be placed in 5mL LB liquid culture medium containing Kan, shaking culture is carried out at 37 ℃ for 12-16 h, plasmid extraction is carried out again, XhoI enzyme digestion verification is carried out, the enzyme digestion result is shown in figure 39, wherein a No.1 lane is pAd5LCL3-L8Lubiqutin-IRES-I215L plasmid XhoI enzyme digestion, M is 15000bp Marker, as can be seen from figure 39, the enzyme digestion result is correct, and adenovirus vector plasmid pAd5LCL3-L8Lubiqutin-IRES-I215L is successfully constructed.
2. The shuttle plasmid pS5E4-I73Rhbsag-2A-E146L and the adenovirus vector plasmid pAd5LCL3-L8Lubiqutin-IRES-I215L are subjected to homologous recombination to obtain pAd5LCL3-L8Lubiqutin-I215L-I73HbsAg-E146L
1) The shuttle plasmid pS5E4-I73Rhbsag-2A-E146L and the adenovirus vector plasmid pAd5LCL3-L8Lubiqutin-IRES-I215L are subjected to enzyme digestion by PacI and I-sceI, and the enzyme digestion reaction system is as follows:
A. shuttle plasmid pS5E4-I73Rhbsag-2A-E146L 3. mu.g; PacI 2 ul; 10 Xcutmarstat buffer 4 ul; supplementing water to 40 ul.
B. Adenovirus vector plasmid pAd5LCL3-L8Lubiqutin-IRES-I215L 3 ug; I-sciI 2 ul; buffer cutmarst 4 ul; supplementing water to 40 ul.
The reaction conditions are 37 ℃ and 1 h; inactivating at 65 deg.C for 20 min.
2ul agarose gel was used for verification, and the results are shown in FIG. 40, wherein lane 1 is pS5E4-I73Rhbsag-2A-E146L, and lane 2 is pAd5LCL3-L8 Lubiqutin-IRES-I215L.
2) Dephosphorylation of enzyme digestion products
Reaction system: 37.5ul of enzyme digestion reaction liquid; dephosphorylating enzyme 1 ul; dephosphorylating buffer 5 ul; water is added to 50 ul. The reaction conditions are 37 ℃ and 1 h; inactivating at 65 deg.C for 5 min.
3) Gel recovery of the vector and fragment was performed using the OMEGAUultra-Sep Gel Extraction Kit.
4) And co-transforming BJ5183 competent cells by using 100ng of purified shuttle plasmids and 100ng of purified adenovirus vectors, coating the transformed products on an LB plate containing Kan, and culturing at 37 ℃ for 12-16 h.
5) 6 colonies were picked and shake-cultured in 5mL LB liquid medium containing Kan at 37 ℃ for 12-16 h, and plasmids were extracted for XhoI restriction enzyme validation, the results are shown in FIG. 41, where lanes 1-8 are plasmids, M is 15000bp Marker, and it can be seen that 1-8 plasmids are all correct.
6) Transforming the positive plasmid No.2 to DH5a competent; selecting a colony in 5mL LB liquid medium containing Kan, carrying out shake culture at 37 ℃ for 12-16 h, extracting plasmids, and carrying out XhoI enzyme digestion verification again; the digestion result is shown in FIG. 42, the lane No.2 is pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L plasmid XhoI digestion, M is 15000Marker, and as can be seen from FIG. 42, pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L is successfully constructed, the digestion result is correct, and the vector map is shown in FIG. 54.
EXAMPLE 7 packaging of recombinant adenovirus
The pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L plasmid was packaged using 293TD37 cells, and the procedure was as follows:
preparation of 293TD37 cells: the day before transfection, cells were prepared, and 293TD37 cells to be transfected were seeded into 6-well plates at 0.5X 106Pore, 5% CO at 37 ℃2The cells were cultured for 24 hours at rest, and the cells had a confluency of 40-50% on the day of transfection.
Plasmid pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L linearization: the plasmid to be transfected was digested with PacI, incubated at 37 ℃ for 40min and then inactivated at 65 ℃ for 20 min.
Transfection: the linearized 2. mu.g plasmid and PEI were diluted separately with 100ul serum-free medium; and adding the plasmid diluent into the PEI diluent, repeatedly sucking for 5 times or vortexing for 10 seconds, uniformly mixing, and incubating for 10 minutes at room temperature to form a transfection complex. During incubation, cell culture was gently aspirated from the plate, 2mL of fresh growth medium was added, and 10 minutes later the transfection complex was added to the cells that had been replaced with fresh medium.
Cell culture: transfected 293TD37 cells at 37 ℃ in 5% CO2Standing and culturing for 72-96 hours in an incubator; after the viral plasmid is transfected for 72-96 hours, 6-well plate cell suspension is collected in a 1.5ml centrifuge tube, namely TP 0.
Continuous inoculation: freezing and thawing the collected cell suspension at-80 deg.C for 3 times, centrifuging at 4 deg.C and 2000g for 10min, collecting supernatant 500ul, infecting 293TD37 cells (293TD37 cells need to be prepared one day earlier), and culturing at 37 deg.C and 5% CO2Incubate for 60 min, supplement 2mL FBS medium, 37 ℃, 5% CO2Culturing for 72 hours, and collecting cell suspension TP 1; the previous steps were repeated and the cell suspension, i.e., TP2, was collected. The virus inoculation is continued until the cells show lesions.
Cytopathic effect: after 293TD37 cells were cultured from TP0 to TP4, the cells were progressively diseased until 293TD37 cells were completely diseased at TP 4. The cytopathic effects of TP0 to TP4 are shown in FIGS. 43-47, respectively.
Example 8 detection of titer of African Swine fever Multi-antigen recombinant adenovirus vaccine
293TD37 cells were prepared, well-grown cells were collected from T75 flasks, supernatant was discarded, cells were washed with PBS, digested with 0.25% trypsin, digested with 10mL of fresh DMEM medium containing 10% fetal bovine serum, aspirated and mixed, and seeded into 6-well plates (5X 10)5Viable cells/mL, 2mL per well), 5% CO at 37 deg.C2And (5) standing and culturing in a carbon dioxide incubator. After 24 hours, after the cells grow into monolayer cells in an adherent way, the culture medium is discarded, and serum-free DMEM maintenance liquid is used for 10 times of recombinant adenovirus-3~10-6The dilutions were performed in duplicate, and each dilution was inoculated into 2 wells at 250uL per well, and after 1 hour of infection, the supernatant was discarded, supplemented with complete medium, and then subjected to static culture in a 5% carbon dioxide incubator at 37 ℃. After 24h, the supernatant was discarded, cells were washed with PBS 1mL per well, PBS was discarded, 1mL of cold formaldehyde was added per well for fixation, room temperature 10min, formaldehyde was discarded, cells were washed with PBS 1mL per well, adenovirus antibody-FITC was added 1mL per well, after 1h at room temperature, cells were washed with PBS 1mL per well, 1mL PBS was added per well after two passes, and counting was performed under a fluorescent microscope (200 x, 10 sequential fields). And (3) calculating: viral titer (FFU/mL) mean × 1013 × 4 × 10(-n). FFU of pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L virusIs 2.2X 108FFU/mL, higher titer.
Example 9 detection of stability of African Swine fever multiple antigen recombinant adenovirus vaccine pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L
Preparing 293TD37 cells, collecting well-grown cells from T75 culture flask, discarding supernatant, washing cells with PBS, digesting with 0.25% trypsin, adding 10mL of DMEM fresh medium containing 10% fetal calf serum to stop digestion, mixing, seeding 293TD37 cells into 6-well plate (5 × 10)5cells/mL, 2 mL/well), incubating for 1 hour at room temperature to adhere, and observing the adherence degree under a microscope after incubation. Infection was performed with pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L virus particles, with a titer of 5 MOI/well. After the 293TD37 cells are diseased 48 hours later, the cells are collected, freeze thawing is carried out repeatedly for 3 times, then centrifugation is carried out at 2000g, the supernatant is collected, the collected supernatant is used for detecting FFU, and then new 293TD37 cells are infected again until 30 generations. The virus liquid collected from the 5 th, 10 th, 15 th, 20 th, 25 th and 30 th generations is detected, and the genome of the virus is still complete, which indicates that the replication-defective pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L virus can be stably packaged in 293TD37 cells.
Example 10 detection of African Swine fever multiple antigen recombinant adenovirus vaccine pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L recovery mutation (RCA)
The pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L virus RCA detection method comprises the following steps:
1. pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L virus solution is prepared, the virus titer is measured, the virus particle concentration is measured, 1% of Universal nucleic acid (Universal nucleic acid 7.5-15 units/mL virus solution) is added into the virus solution to digest the DNA of the host cell, and the mixture is subjected to water bath at 37 ℃ for 40 min. The virus particles are collected by using an ultrafiltration centrifugal tube with 300Kd, centrifuging for 30min by 1000g and eluting by 1 XPBS, and the A260 is measured, and the concentration of the particles is A260 x 1.1 x 10 x 12 VP/mL.
2. Viral infection, 6-well plates of A549 cells were prepared, 2.5X 10 cells per well5Per well, discard medium, wash with PBS once, and place adenovirus at 1X 109vP/well inoculation of virus, infection of A549 cells, wild type adenovirus type 5 as control, 37℃,5%CO2After 1h, abandoning the virus liquid, supplementing 5% of complete culture medium, 37 ℃ and 5% of CO2Culturing for 48 h.
3. Immunostaining, discarding cell supernatant, washing cells on the surface of PBS, fixing with glacial formaldehyde, standing at-20 deg.C for 20min, washing with 1 × PBS for three times, each time for 5min, adding 2ml of 1% BSA-PBS solution into each well, placing on a shaker, and incubating for 1 h. The supernatant was discarded, adenovirus type 5 fluorescent antibody (1:500 dilution) was added, incubated for 1h, and washed three times with 1 XPBS for 5min each time.
Observing with 10-fold fluorescence microscope, and calculating RCA by using formula
RCA=(average positive cell field)×(374field/well)×(dilution factor))/Total VPs in 0.5ml viral sample
The judgment criterion was that RCA level was <1 RCA/3X 1010vp. The level of RCA of pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L is less than 1RCA/3 multiplied by 1010vp, which shows that the replication-defective pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L virus prepared by the invention can be stably packaged in 293TD37 cells, and the probability of conversion into wild type is low or not.
Example 11 African swine fever multiple antigen recombinant adenovirus vaccine pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L protein expression test
Preparing 293TD37 cells one day in advance, placing the 293TD37 cells in a 12-hole cell culture plate, infecting 293TD37 cells by using African swine fever multi-antigen recombinant adenovirus vaccine pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L virus, enabling the cells to be diseased after 48 hours, collecting all 1ml of cells, washing the cells by using PBS, preparing samples and using the samples for Western Blot detection; the target protein was detected using antibodies to HA, purchased from Abcam. Wherein the L8Lubiquitin fusion protein, I215L protein HAs HA tag, and the protein size is 32kda and 26 kda. The experimental results are shown in FIG. 48, wherein lane 1 is 293 blank cells, and lanes 2 and 3 are samples of 293TD37 cells infected with pAd5LCL3-L8Lubiqutin-I215L-I73 Rhbsag-E146L; it can be clearly seen that the L8Lubiquitin fusion protein and the I215L protein have normal expression, and thus the pAd5LCL3-L8 Lubiquitin-I215L-I73 Rhbsag-E146L vaccine can normally express the target protein in 293 cells.
Example 12 immunological evaluation on African Swine fever multiple antigen recombinant adenovirus vaccine pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L mouse model
Vaccine cellular immune response detection
10 SPF-rated mice (6-8 weeks old) were randomized into 2 groups of 5 mice each. Mice were immunized with pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L according to the grouping shown in Table 1. The injection mode is as follows: intramuscular injection of the inner thigh; the injection dose is as follows: 100 ul.
Table 1: vaccine immunoassay for grouping of mice
Figure BDA0003150437770000271
Mice were sacrificed 14 days after immunization, splenic lymphocytes were isolated, and cultured for 6 hours with stimulation of PK15 cells transfected with shuttle plasmids pS5E1-L8Lubiqutin-I215L and pS5E4-I73Rhbsag-E146L, while blocking cytokine secretion by addition of a protein secretion blocking agent. After 6 hours, Fc receptors were blocked, dead cells and cell surface molecular markers were stained, and intracellular cytokines were stained after fixation and perforation of the cells. Cell surface markers include CD4, CD8, and intracellular cytokines include IFN γ, IL 2. The levels of IFN γ and IL2 expression of CD4+ T cells and CD8+ T cells after stimulation with the protein of interest were analyzed using a flow cytometer (CyExpert).
CD8+ T cell and CD4+ T cell immune responses induced by pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L are shown in FIGS. 55 and 56, and representative results are shown in FIGS. 57-58, wherein FIG. 57 is a representation of cellular immune responses after intramuscular injection of pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L, and FIG. 58 is a representation of blank control immune responses. The results show that: 14 days after mice are immunized, after spleen cells are stimulated by target protein, the levels of IFN gamma, TNF alpha and IL2 expressed by CD8+ T cells are all obviously higher than that of Ad5 vector Control group (Control) (P < 0.05). After CD4+ T cells are stimulated, the expression levels of IFN gamma, TNF alpha and IL2 are all obviously higher than those of an Ad5 vector Control group (Control) (P < 0.05). The result of cellular immune response detection shows that the adenovirus vector vaccine immunized by intramuscular injection with 1 x 10^7FFU can induce the immunized mice to generate specific cellular immune response.
Although the present invention is disclosed above, the present invention is not limited thereto. Various changes and modifications may be effected therein by one skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
Sequence listing
<110> Jiaxing Anyu Biotechnology Ltd
<120> recombinant adenovirus vaccine for African swine fever and construction method thereof
<150> 2020106427557
<151> 2020-07-06
<160> 15
<170> SIPOSequenceListing 1.0
<210> 1
<211> 336
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
atgggcaaca gactgatcaa gaaggatctg aagaagtgtg agtactacta cggcgagcag 60
cagaacctga agcagatctg gagactgctg tttaatgagc ctctgggcac ctacgtggtg 120
tccagcttcc tgaagaagaa ctacgtggtg atctccttct cctgtcctac aaacacaaga 180
atcatgcacc tgagaatcaa catctgctac gatctgtact gtatcaacgg cgagtactac 240
gagaagatcg acgattttat caggctgtac ccccacatct tctacaggcc tctgtacagg 300
tacaagagct acccttacga cgtgcccgac tacgcc 336
<210> 2
<211> 471
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
atgcagattt tcgtgaaaac ccttacgggg aagaccatca ccctcgaggt tgaaccctcg 60
gatacgatag aaaatgtaaa ggccaagatc caggataagg aaggaattcc tcctgatcag 120
cagagactga tctttgctgg caagcagctg gaagatggac gtactttgtc tgactacaat 180
attcaaaagg agtctactct tcatcttgtg ttgagacttc gtggtggtgc taagaaaagg 240
aagaagaagt cttacaccac tcccaagaag aataagcaca agagaaagaa ggttaagctg 300
gctgtcctga aatattataa ggtggatgag aatggcaaaa ttagtcgcct tcgtcgagag 360
tgcccttctg atgaatgtgg tgctggggtg tttatggcaa gtcactttga cagacattat 420
tgtggcaaat gttgtctgac ttactgtttc aacaaaccag aagacaagta a 471
<210> 3
<211> 666
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
atggtgagca ggtttctgat cgccgagtac aggcacctga tcgagaaccc ctccgagaac 60
tttaagatct ccgtgaacga gaaggatatg acagagtggg atgtgatcct gagaggcccc 120
cctgacacct tttacgaggg cggcctgttt aaggccaaga tcgcctttcc tcccgagtac 180
ccttacgccc cccccaggct gacatttaca agcgagatgt ggcaccccaa catctacagc 240
gatggcaagc tgtgtatctc catcctgcac ggcgacaatg ccgaggagca gggcatgaca 300
tggagccctg cccagaagat cgacaccatc ctgctgagcg tgatctccct gctgaacgag 360
cctaaccctg actcccccgc caacgtggat gccgccaaga gctacaggaa gctgctgtac 420
aaggaggacc tggagtccta ccccatggag gtgaagagga ccgtgaagaa gtccctggat 480
gagtgctccc ccgaggacat cgagtacttt aagaacgccg ccagcaatgt gcctcctatc 540
ccttccgacg cctacgagga tgagtgcgag gagatggagg atgacaccta catcctgacc 600
tacgacgatg aggacgagga ggaggaggat gacgagtacc cctacgatgt gcccgattac 660
gcctga 666
<210> 4
<211> 243
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
atggagacac agaagctgat ctccatggtg aaggaggccc tggagaagta ccagtaccct 60
ctgaccgcca agaatatcaa ggtggtgatc cagaaggagc acaacgtggt gctgcctacc 120
ggctccatca attccatcct gtactccaac agcgagctgt tcgagaagat cgacaagacc 180
aacaccatct accctcctct gtggatcagg aagaactacc cctacgatgt gcctgactac 240
gcc 243
<210> 5
<211> 678
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
atggagaaca ccaccagcgg cttcctgggc cccctgctgg tgctgcaggc cggattcttc 60
ctgctgaccc gcatcctgac catcccccag agcctggaca gctggtggac ctccctgaac 120
tttctgggcg gggcccccac ctgccccgga cagaactctc agagccccac ctccaaccac 180
agccccacca gctgcccccc catctgccca ggatatagat ggatgtgcct ccgccgcttc 240
atcatcttcc tgttcatcct gctcctgtgc ctcatcttcc tcctcgtgct cctggactac 300
cagggcatgc tccccgtctg ccccctcctg cctggcacat ccaccacctc caccggcccc 360
tgcaagacct gcaccatccc cgcccagggc acctccatgt tcccctcctg ctgctgcacc 420
aaaccctccg acggcaactg cacctgcatc cccatcccca gcagctgggc cttcgccagg 480
ttcctgtggg aatgggccag cgtcaggttc agctggctct ccctcctcgt gcccttcgtg 540
cagtggtttg tgggcctgag ccccaccgtc tggctcagcg tgatctggat gatgtggtat 600
tgggggcccc gcctgtacaa catcctctcc cctttcctcc ccctgctgcc catcttcttc 660
tgcctctggg tgtacatc 678
<210> 6
<211> 441
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
atgggcggaa caacagactt tgtgctgagc atcacaatcg tgctggtgat cctgatcatc 60
atcgccttca tctggtacaa ttttaccggc tggtccccct ttaagtacag caagggcaac 120
accgtgacat ttaagacccc tgacgagagc agcatcgcct acatgagatt taggaactgt 180
gtgttcacat tcaccgaccc caagggcagc ctgcacagca tcgacgtgac agaggtgctg 240
aacaacatgg ccaagggctt tagggatgcc cagaatcccc ctagctcctt cacactgggc 300
ggccactgcc aggcccccct gaatgctttt tcctttgtgc tgcctggcgt gaacgacaga 360
gccacagtgg ccaccgccga cgaggccaag aagtgggaga actgcgacgc caccctgacc 420
ggcctgcaga gaatcatcta a 441
<210> 7
<211> 32619
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
agcttttgcc attctcaccg gattcagtcg tcactcatgg tgatttctca cttgataacc 60
ttatttttga cgaggggaaa ttaataggtt gtattgatgt tggacgagtc ggaatcgcag 120
accgatacca ggatcttgcc atcctatgga actgcctcgg tgagttttct ccttcattac 180
agaaacggct ttttcaaaaa tatggtattg ataatcctga tatgaataaa ttgcagtttc 240
atttgatgct cgatgagttt ttctaatcag aattggttaa ttggttgtaa cactggcaga 300
gcattacgct gacttgacgg gacggcggct ttgttgaata aatcgaactt ttgctgagtt 360
gaaggatcag atcacgcatc ttcccgacaa cgcagaccgt tccgtggcaa agcaaaagtt 420
caaaatcacc aactggtcca cctacaacaa agctctcatc aaccgtggct ccctcacttt 480
ctggctggat gatggggcga ttcaggcctg gtatgagtca gcaacacctt cttcacgagg 540
cagacctcag cgctcaaaga tgcaggggta aaagctaacc gcatctttac cgacaaggca 600
tccggcagtt caacagatcg ggaagggctg gatttgctga ggatgaaggt ggaggaaggt 660
gatgtcattc tggtgaagaa gctcgaccgt cttggccgcg acacgccgac atgatccaac 720
tgataaaaga gtttgatgct cagggtgtag cggttcggtt tattgacgac gggatcagta 780
ccgacggtga tatggggcaa atggtggtca ccatcctgtc ggctgtggca caggctgaac 840
gccggaggat cctagagcgc acgaatgagg gccgacagga agcaaagctg aaaggaatca 900
aatttggccg caggcgtacc gtggacagga gcgtcgattt ttgtgatgct cgtcaggggg 960
gcggagccta tggaaaaacg ccagcaacgc ggccttttta cggttcctgg ccttttgctg 1020
gccttttgct cacatgttct ttcctgcgtt atcccctgat tctgtggata accgtattac 1080
cgcctttgag tgagctgata ccgctcgccg cagccgaacg accgagcgca gcgagtcagt 1140
gagcgaggaa gcggaagagc gcccaatacg caaaccgcct ctccccgcgc gttggccgat 1200
tcattaatgc agctggcacg acaggtttcc cgactggaaa gcgggcagtg agcgcaacgc 1260
aattaatgtg agttagctca ctcattaggc accccaggct ttacacttta tgcttccggc 1320
tcgtatgttg tgtggaattg tgagcggata acaatttcac acaggaaaca gctatgacca 1380
tgattacgcc aagcttgcat gcctgcaggt cgatcgatta attaacgacc catcatcaat 1440
aatatacctt attttggatt gaagccaata tgataatgag ggggtggagt ttgtgacgtg 1500
gcgcggggcg tgggaacggg gcgggtgacg taggttttag ggcggagtaa cttgtatgtg 1560
ttgggaattg tagttttctt aaaatgggaa gttacgtaac gtgggaaaac ggaagtgacg 1620
atttgaggaa gttgtgggtt ttttggcttt cgtttctggg cgtaggttcg cgtgcggttt 1680
tctgggtgtt ttttgtggac tttaaccgtt acgtcatttt ttagtcctat atatactcgc 1740
tctgcacttg gccctttttt acactgtgac tgattgagct ggtgccgtgt cgagtggtgt 1800
tattaccctg ttatccctag caattgaaaa ataaacacgt tgaaacataa cacaaacgat 1860
tctttattct tgggcaatgt atgaaaaagt gtaagaggat gtggcaaata tttcattaat 1920
gtagttgtgg ccagaccagt cccatgaaaa tgacatagag tatgcacttg gagttgtgtc 1980
tcctgtttcc tgtgtaccgt ttagtgtaat ggttagtgtt acaggtttag ttttgtctcc 2040
gtttaagtaa acttgactga caatgttact tttggcagtt ttaccgtgag attttggata 2100
agctgatagg ttaggcataa atccaacagc gtttgtatag gctgtgcctt cagtaagatc 2160
tccatttcta aagttccaat attctgggtc caggaaggaa ttgtttagta gcactccatt 2220
ttcgtcaaat cttataataa gatgagcact ttgaactgtt ccagatattg gagccaaact 2280
gcctttaaca gccaaaactg aaactgtagc aagtatttga ctgccacatt ttgttaagac 2340
caaagtgagt ttagcatctt tctctgcatt tagtctacag ttaggagatg gagctggtgt 2400
ggtccacaaa gttagcttat cattattttt gtttcctact gtaatggcac ctgtgctgtc 2460
aaaactaagg ccagttccta gtttaggaac catagccttg tttgaatcaa attctaggcc 2520
atggccaatt tttgttttga ggggatttgt gtttggtgca ttaggtgaac caaattcaag 2580
cccatctcct gcattaatgg ctatggctgt agcgtcaaac atcaacccct tggcagtgct 2640
taggttaacc tcaagctttt tggaattgtt tgaagctgta aacaagtaaa ggcctttgtt 2700
gtagttaata tccaagttgt gggctgagtt tataaaaaga gggccctgtc ctagtcttag 2760
atttagttgg ttttgagcat caaacggata actaacatca agtataaggc gtctgttttg 2820
agaatcaatc cttagtcctc ctgctacatt aagttgcata ttgccttgtg aatcaaaacc 2880
caaggctcca gtaactttag tttgcaagga agtattatta atagtcacac ctggaccagt 2940
tgctacggtc aaagtgttta ggtcgtctgt tacatgcaaa ggagccccgt actttagtcc 3000
tagttttcca ttttgtgtat aaatgggctc tttcaagtca atgcccaagc taccagtggc 3060
agtagttaga gggggtgagg cagtgatagt aagggtactg ctatcggtgg tggtgagggg 3120
gcctgatgtt tgcagggcta gctttccttc tgacactgtg aggggtcctt gggtggcaat 3180
gctaagtttg gagtcgtgca cggttagcgg ggcctgtgat tgcatggtga gtgtgttgcc 3240
cgcgaccatt agaggtgcgg cggcagccac agttagggct tctgaggtaa ctgtgagggg 3300
tgcagatatt tccaggttta tgtttgactt ggtttttttg agaggtgggc tcacagtggt 3360
tacattttgg gaggtaaggt tgccggcctc gtccagagag aggccgttgc ccattttgag 3420
cgcaagcatg ccattggagg taactagagg ttcggatagg cgcaaagaga gtaccccagg 3480
gggactctct tgaaacccat tgggggatac aaagggagga gtaagaaaag gcacagttgg 3540
aggaccggtt tccgtgtcat atggatacac ggggttgaag gtatcttcag acggtcttgc 3600
gcgcttcatc tgcaacaaca tgaagatagt gggtgcggat ggacaggaac aggaggaaac 3660
tgacattcca tttagattgt ggagaaagtt tgcagccagg aggaagctgc aataccagag 3720
ctgggaggag ggcaaggagg tgctgctgaa taaactggac agaaatttgc taactgattt 3780
taagtaagtg atgctttatt attttttttt attagttaaa gggaataaga tctttgagac 3840
cgcacagggt cttaataagg gtgcagagat cctcaggtcc ttgacaaggt gagtgaatgc 3900
agccttcggt ttctaccgag tgctgagtta tggtaatggg cttttctccc accatgacca 3960
ccaatttctg acgcttggtt ggcaacttgt agctaaggcg gtgtccggtg gtattactgt 4020
cgtaggtgac tttggcctgc tttaccagac aaaagatacc ccttttgcac tggtgcaagt 4080
taaccatgtc ttggagctct tgattcatgc gctgttgctc ggccgctgcc ctgcgtcttt 4140
ctagcaggcg ctgctctgta ataattccgt ccatttctag ctagagaaac ctgaattaga 4200
atagcccgta gagttgcttg aattgttcat aaaccccaca gtagctgcgc ctttggccta 4260
ataccctaag ggttttctaa gctcacctcc tgttctggta aacagagtta ttgaggtctg 4320
tccggaaaaa gtctggttta cggtcaggcg gtaggtgtgg tgcagcggcc ggtgacgcac 4380
tcgtacgttc ccggcaggta aggagggtgg tgttttttct gatggagtag ctgagctcgg 4440
agaggttctc tcgtagactc actccgtctg ggttgaaact gttgtaaatc acagagggag 4500
agatgttaaa agtaccaggt aaggttcgcc ttggtttgct tgggcgggtg aagacggtgg 4560
cgtttacagg atggcgatag gagccccagt atattttaat ttctgtattt attatactca 4620
gcacagagat ggcaacaaag atcttgatgt aatccagggt taggacagtt gcaaatcaca 4680
gtgagaacac agggtcccct gtcccgctca actagcaggg ggcgctgggt aaactcccga 4740
atcaggctac gggcaagctc tccctgggcg gtaagccgga cgccgtgcgc cgggccctcg 4800
atatgatcct cgggcaattc aaagtagcaa aactcaccgg agtcgcgggc aaagcacttg 4860
tggcggcgac agtggaccag gtgtttcagg cgcagttgct ctgcctctcc acttaacatt 4920
cagtcgtagc cgtccgccga gtcctttacc gcgtcaaagt taggaataaa ttgatccgga 4980
tagtggccgg gaggtcccga gaaggggtta aagtagaccg atggcacaaa ctcctcaata 5040
aattgcagag ttccaatgcc tccagagcgc ggctcagagg acgaggtctg cagagttagg 5100
attgcctgac gaggcgtgaa tgaagagcgg ccggcgccgc cgatctgaaa tgtcccgtcc 5160
ggacggagac caagcgagga gctcaccgac tcgtcgttga gctgaatacc tcgccctctg 5220
attgtcaggt gagttatacc ctgcccgggc gaccgcaccc tgtgacgaaa gccgcccgca 5280
agctgcgccc ctgagttagt catctgaact tcggcctggg cgtctctggg aagtaccaca 5340
gtggtgggag cgggactttc ctggtacacc agggcagcgg gccaactacg gggattaagg 5400
ttattacgag gtgtggtggt aatagccgcc tgttccagga gaattcggtt tcggtgggcg 5460
cgtattccgt tgacccggga tatcatgtgg ggtcccgcgc tcatgtagtt tattcgggtt 5520
gagtagtctt gggcagctcc agccgcaagt cccatttgtg gctggtaact ccacatgtag 5580
ggcgtgggaa tttccttgct cataatggcg ctgacaacag gtgctggcgc cgggtgtggc 5640
cgctggagat gacgtagttt tcgcgcttaa atttgagaaa gggcgcgaaa ctagtcctta 5700
agagtcagcg cgcagtattt actgaagaga gcctccgcgt cttccagcgt gcgccgaagc 5760
tgatcttcgc ttttgtgata caggcagctg cgggtgaggg atcgcagaga cctgtttttt 5820
attttcagct cttgttcttg gcccctgctc tgttgaaata tagcatacag agtgggaaaa 5880
atcctgtttc taagctcgcg ggtcgatacg ggttcgttgg gcgccagacg cagcgctcct 5940
cctcctgctg ctgccgccgc tgtggatttc ttgggctttg tcagagtctt gctatccggt 6000
cgcctttgct tctgtgtggc cgctgctgtt gctgccgctg ccgccggtgc agtatgggct 6060
gtagagatga cggtagtaat gcaggatgtt acgggggaag gccacgccgt gatggtagag 6120
aagaaagcgg cgggcgaagg agatgttgcc cccacagtct tgcaagcaag caactatggc 6180
gttcttgtgc ccgcgccatg agcggtagcc ttggcgctgt tgttgctctt gggctaacgg 6240
cggcggctgc ttggacttac cggccctggt tccagtggtg tcccatctac ggttgggtcg 6300
gcgaacgggc agtgccggcg gcgcctgagg agcggaggtt gtagccatgc tggaaccggt 6360
tgccgatttc tggggcgccg gcgaggggaa tgcgaccgag ggtgacggtg tttcgtctga 6420
cacctcttcg acctcggaag cttcctcgtc taggctctcc cagtcttcca tcatgtcctc 6480
ctcctcctcg tccaaaacct cctctgcctg actgtcccag tattcctcct cgtccgtggg 6540
tggcggcggc agctgcagct tctttttggg tgccatcctg ggaagcaagg gcccgcggct 6600
gctgctgata gggctgcggc ggcgggggga ttgggttgag ctcctcgccg gactgggggt 6660
ccaagtaaac cccccgtccc tttcgtagca gaaactcttg gcgggctttg ttgatggctt 6720
gcaattggcc aagaatgtgg ccctgggtaa tgacgcaggc ggtaagctcc gcattaggcg 6780
ggcgggattg gtcttcgtag aacctaatct cgtgggcgtg gtagtcctca ggtacaaatt 6840
tgcgaaggta agccgacgtc cacagccccg gagtgagttt caaccccgga gccgcggact 6900
tttcgtcagg cgagggaccc tgcagctcaa aggtaccgat aatttgactt tcgttaagca 6960
gctgcgaatt gcaaaccagg gagcggtgcg gggtgcatag gttgcagcga cagtgacact 7020
ccagtagacc gtcaccgctc acgtcttcca ttatgtcaga gtggtaggca aggtagttgg 7080
ctagctgcag aaggtagcag tggccccaaa gcggcggagg gcattcgcgg tacttaatgg 7140
gcacaaagtc gctaggaagt gcacagcagg tggcgggcaa gattcctgag cgctctagga 7200
taaagttcct aaagttctgc aacatgcttt gactggtgaa gtctggcaga ccctgttgca 7260
gggttttaag caggcgttcg gggaaaatga tgtccgccag gtgcgcggcc acggagcgct 7320
cgttgaaggc cgtccatagg tccttcaagt tttgctttag cagtttctgc agctccttga 7380
ggttgcactc ctccaagcac tgctgccaaa cgcccatggc cgtctgccag gtgtagcata 7440
gaaataagta aacgcagtcg cggacgtagt cgcggcgcgc ctcgcccttg agcgtggaat 7500
gaagcacgtt ttgcccaagg cggttttcgt gcaaaattcc aaggtaggag accaggttgc 7560
agagctccac gttggagatc ttgcaggcct ggcgtacgta gccctgtcga aaggtgtagt 7620
gcaatgtttc ctctagcttg cgctgcatct ccgggtcagc aaagaaccgc tgcatgcact 7680
caagctccac ggtaacgagc actgcggcca tcattagttt gcgtcgctcc tccaagtcgg 7740
caggctcgcg cgtttgaagc cagcgcgcta gctgctcgtc gccaactgcg ggtaggccct 7800
cctctgtttg ttcttgcaaa tttgcatccc tctccagggg ctgcgcacgg cgcacgatca 7860
gctcactcat gactgtgctc atgaccttgg ggggtaggtt aagtgccggg taggcaaagt 7920
gggtgacctc gatgctgcgt tttagtacgg ctaggcgcgc gttgtcaccc tcgagttcca 7980
ccaacactcc agagtgactt tcattttcgc tgttttcctg ttgcagagcg tttgccgcgc 8040
gcttctcgtc gcgtccaaga ccctcaaaga tttttggcac ttcgttgagc gaggcgatat 8100
caggtatgac agcgccctgc cgcaaggcca gctgcttgtc cgctcggctg cggttggcac 8160
ggcaggatag gggtatcttg cagttttgga aaaagatgtg ataggtggca agcacctctg 8220
gcacggcaaa tacggggtag aagttgaggc gcgggttggg ctcgcatgtg ccgttttctt 8280
ggcgtttggg gggtacgcgc ggtgagaata ggtggcgttc gtaggcaagg ctgacatccg 8340
ctatggcgag gggcacatcg ctgcgctctt gcaacgcgtc gcagataatg gcgcactggc 8400
gctgcagatg cttcaacagc acgtcgtctc ccacatctag gtagtcgcca tgcctttcgt 8460
ccccccgccc gacttgttcc tcgtttgcct ctgcgttgtc ctggtcttgc tttttatcct 8520
ctgttggtac tgagcggtcc tcgtcgtctt cgcttacaaa acctgggtcc tgctcgataa 8580
tcacttcctc ctcctcaagc gggggtgcct cgacggggaa ggtggtaggc gcgttggcgg 8640
catcggtgga ggcggtggtg gcgaactcag agggggcggt taggctgtcc ttcttctcga 8700
ctgactccat gatctttttc tgcctatagg agaaggaaac ttgtatgtgt tgggaattgt 8760
agttttctta aaatgggaag ttacgtaacg tgggaaaacg gaagtgacga tttgaggaag 8820
ttgtgggttt tttggctttc gtttctgggc gtaggttcgc gtgcggtttt ctgggtgttt 8880
tttgtggact ttaaccgtta cgtcattttt tagtcctata tatactcgct ctgcacttgg 8940
ccctttttta cactgtgact gattgagctg gtgccgtgtc gagtggtgtt tttttaatag 9000
gttttctttt ttactggtaa ggctgactgt tatgactacg tccggcgttc catttggcat 9060
gacactacga ccaacacgat ctcggttgtc tcggcgcact ccgtacagta gggatcgtct 9120
acctcctttt gagacagaaa cccgcgctac catactggag gatcatccgc tgctgcccga 9180
atgtaacact ttgacaatgc acaacgtgag ttacgtgcga ggtcttccct gcagtgtggg 9240
atttacgctg attcaggaat gggttgttcc ctgggatatg gttctaacgc gggaggagct 9300
tgtaatcctg aggaagtgta tgcacgtgtg cctgtgttgt gccaacattg atatcatgac 9360
gagcatgatg atccatggtt acgagtcctg ggctctccac tgtcattgtt ccagtcccgg 9420
ttccctgcag tgtatagccg gcgggcaggt tttggccagc tggtttagga tggtggtgga 9480
tggcgccatg tttaatcaga ggtttatatg gtaccgggag gtggtgaatt acaacatgcc 9540
aaaagaggta atgtttatgt ccagcgtgtt tatgaggggt cgccacttaa tctacctgcg 9600
cttgtggtat gatggccacg tgggttctgt ggtccccgcc atgagctttg gatacagcgc 9660
cttgcactgt gggattttga acaatattgt ggtgctgtgc tgcagttact gtgctgattt 9720
aagtgagatc agggtgcgct gctgtgcccg gaggacaagg cgccttatgc tgcgggcggt 9780
gcgaatcatc gctgaggaga ccactgccat gttgtattcc tgcaggacgg agcggcggcg 9840
gcagcagttt attcgcgcgc tgctgcagca ccaccgccct atcctgatgc acgattatga 9900
ctctaccccc atgtagacta gggttctgtg agtttgatta aggtacggtg atctgtataa 9960
gctatgtggt ggtggggcta tactactgaa tgaaaaatga cttgaaattt tctgcaattg 10020
aaaaataaac acgttgaaac ataacacaaa cgatacggcg cagacggcaa gggtgggggt 10080
aaataatcac ccgagagtgt acaaataaaa gcatttgcct ttattgaaag tgtctctagt 10140
acattatttt tacatgtttt tcaagtgaca aaaagaagtg gcgctcctaa tctgcgcact 10200
gtggctgcgg aagtagggcg agtggcgctc caggaagctg tagagctgtt cctggttgcg 10260
acgcagggtg ggctgtacct ggggactgtt gagcatggag ttgggtaccc cggtaataag 10320
gttcatggtg gggttgtgat ccatgggagt ttggggccag ttggcaaagg cgtggagaaa 10380
catgcagcag aatagtccac aggcggccga gttgggcccc tgtacgcttt gggtggactt 10440
ttccagcgtt atacagcggt cgggggaaga agcaatggcg ctacggcgca ggagtgactc 10500
gtactcaaac tggtaaacct gcttgagtcg ctggtcagaa aagccaaagg gctcaaagag 10560
gtagcatgtt tttgagtgcg ggttccaggc aaaggccatc cagtgtacgc ccccagtctc 10620
gcgaccggcc gtattgacta tggcgcaggc gagcttgtgt ggagaaacaa agcctggaaa 10680
gcgcttgtca taggtgccca aaaaatatgg cccacaacca agatctttga caatggcttt 10740
cagttcctgc tcactggagc ccatggcggc agctgttgtt gatgttgctt gcttctttat 10800
gttgtggcgt tgccggccga gaagggcgtg cgcaggtaca cggtttcgat gacgccgcgg 10860
tgcggctggt gcacacggac cacgtcaaag acttcaaaca aaacataaag aagggtgggc 10920
tcgtccatgg gatccacctc aaaagtcatg tctagcgcgt gggcggagtt ggcgtagaga 10980
aggttttggc ccaggtctgt gagtgcgccc atggacataa agttactgga gaatgggatg 11040
cgccaaaggg tgcgatcgca aagaaacttt ttctgggtaa tgctgtcaac tgcggtcttg 11100
cctataagcg gataggggaa gttagcaggg taggcctgtc cttcgcgcat ggtgggggca 11160
aggtagccaa caaatccaga gttgttgtgt tggtgtagga tgcccacctg ttggtagtcc 11220
ttgtatttag tatcatccac cacctgacgg ctcatgggct ggaagtttct aaagaaggag 11280
tacatgcggt ccttgtagct ctctgggata tagaagccct ggtagccaat gttatagtta 11340
gctagcattt gtaccaggaa ccagtctttg gtcatgttac actgggcaac gttgtaaccc 11400
tccccgtcaa ctgagcgctt aatttcaaac tcgttggggg taagcaggcg gtcattgcca 11460
ggccagctga cagaagagtc aaaggtaatg gccaccttct taaaggtgtg gttgaggtaa 11520
aaggttccat ctaggtaggg tatagagcca gagtaggtgt aataagggtc gtagcccgag 11580
cccagtgatg gggtttcctt agtcttaagg cgcgtgaagg cccagccgcg gaaagccgcc 11640
cagttgcggg aggggatgga tatgggcacg ttggtagcgt tggcgggtat agggtagagc 11700
atgttggcgg cggagagata gtcgttaaag gactggtcgt tggtgtcgtt tctaagcatg 11760
gcctcaagcg tggaggcggt gttgtgggcc atggggaaga aggtggcgta aaggcaaatg 11820
ctatcaaact taatgctggc tccgtcaacc cttaggtcat ttcctaggga gctctgcaga 11880
accatgttaa catccttcct gaagttccac tcgtaggtgt atgagcccgg caggagaagg 11940
aggtttttaa tggcaaagaa cttctgaggc acctggatgt ggaagggcac atagcgacca 12000
ttgcccagca acattgagcg gtagcgcagg ccagcattgc ggtggtggtt aaatgggttg 12060
acgttgtcca tatagtcaag ggaccagcgt gctccaaggt taatgtagca gtccactagc 12120
ccgggagcca ccactcgctt gttcatgtag tcgtaggtgt ttgggttatc agaaattttt 12180
acgttggaag gactgtactt tagcttgtcg ggcaaataca gcgctatgtt ggagtacagg 12240
aaatttctcc acaggttggc atttagattg atttccatgg caaaattatt tccaactctt 12300
atttcatttt tatctgaaaa ttctgtagca tctttttccc atccattttc ctgacctgtt 12360
ttaggtttta ccttggtaag agtctctgta ttaatcacac ctcccagtgg aaagcagtaa 12420
tttggaagtt catcttcagt tccatgattt tcaataattc taacatctgg atcatagctg 12480
tcaacagcct gattccacat agaaaagtac ctggttctat caccaatgga atcaagcaaa 12540
agctggtatg aaagctctgt gtttctgtct tgcaaatcta caacagcatt caactgcgat 12600
gcttggcccg ccagaacacc catattaccc gtgctgttgt aatacattag accaataaaa 12660
ttgtccctaa aagcaatgta attaggcctg ttgggcatag attgttggcc cattagttct 12720
cgtgagttac cttccttaat agtgggcatg taagaaatat gagtgtctgg ggtttctata 12780
tctacatctt cactgtacaa taccacttta ggagtcaagt tatcaccatt gcctgcggct 12840
gcctcagtag ttgagaaaaa ttgcatttcc acttgacttt ctagctttcc attttgttgc 12900
tttacaagaa tgccttgccc tccattttca tttgtgggtt ttgcatatga accgtaacat 12960
ggtttcattg gggtagtctt ttttaggact ctcccagctg catgattaat ttctgtttcg 13020
taccactgag attctcctat ttgaggttca ggttgaaatg ttttatcggc atatttaggt 13080
gtttgacctt cgacacctat ttgaataccc tcctttgtaa tatttatacc agaataaggc 13140
gcctgcccaa atacgtgagt tttttgctgc tcagcttgct cgtctacttc gtcttcgttg 13200
tcatcgtcct cttcttctag gtttatttca agagcagtag cagcttcatc ccattcgcaa 13260
ggatttgggg cacccttggg agccagggcg ttgtaggcag tgccagagta gggcttaaaa 13320
gtagggcccc tgtccagcac gccgcggatg tcaaagtacg tggaagccat gtccagcaca 13380
cggttatcac ccacagctag ggtgaaccgc gccttgtacg agtacgcagt atcctcacgg 13440
tccacaggga tgaaccgcag cgtcaaacgc tgggaccggt ctgtggtcac gtcgtgcgta 13500
ggcgccaccg tggggtttct aaacttgtta ttcaggctga agtacgtctc ggtggcgcgg 13560
gcaaactgca ccagcccggg gctcaggtac tccgaggcgt cctggcccga gatgtgcatg 13620
taagaccact gcggcatcat cgaaggggta gccatcttgg aaagcgggcg cgcggcggct 13680
cagcagctcc tctggcggcg acatggacgc atacatgaca cacatacgac acgttagcta 13740
tcagaagcat cgtcggcgct tcagggattg cacccccaga cccacgatgc tgttcagtgt 13800
gctttgccag ttgccactgg ctacgggccg caacgatcgc ggaccgctgg cggcgcggcg 13860
cagggacgcg cggctaggac gggttacaac aacggcggtc gggcctggca gcacaggttt 13920
ctgctgggtg tcggcggggg gaggcaggtc cagcgttacg ggtgtgtgct ggcccagcac 13980
tccggtagcc atgggcgcga tgggacgggt ggtgggcagg ccttgcttta gtgcctcctc 14040
gtacgaggga ggctcgtcta tttgcgtcac cagagtttct tccctgtcgg ggcgcggacg 14100
cttttcgcca cgcccctctg gagacactgt ctccacggcc ggtggaggct cctctacggg 14160
agggcgggga tcaagcttac tgttaatctt attttgcact gcctggttgg ccaggtccac 14220
caccccgcta atgccagagg ccaggccatc taccaccttt tgttggaaat tttgctcttt 14280
caacttatcc ctcagcatct ggcctgtgct gctgttccag gccttgctgc catagttctt 14340
aacggtggaa ccgaaatttt taatgccgct ccacagcgag ccccagctga aggcgccacc 14400
gctcatattg ctggtgccga tatcttgcca gtttcccatg aacgggcgcg agccgtgtcg 14460
cggggccaga gacgcaaagt tgatgtcttc cattctacaa aatagttaca ggaccaagcg 14520
agcgtgagag tccagacttt ttattttgat ttttccacat gcaacttgtt tttaatcagt 14580
gtctctgcgc ctgcaaggcc acggatgcaa ttccgggcac ggcgccaatc gccgcggcga 14640
tcagtggaat aaggaggggc aggataccgc cgcgcatgcg acggtgcgac gcgcgccgcc 14700
gccggtggtg cgcacgacgc atgccgcccg tcaggccgtg gccggccatg cccctcctac 14760
ggtgcattct tcctcggaat cccggcaccg ggaaacggag gcggcaggtg agggccatat 14820
ctgcaagaac cacaaagacc ggcttttaaa cgatgctggg gtggtagcgc gctgttggca 14880
gcaccagggt cctgcctcct tcgcgagcca ccctgcgcac ggaaatcggg gccagcacgg 14940
gctggcgacg gcgacggcgg cggcgggttc cagtggtggt tcggcgtcgg gtagttgctc 15000
gtcttctggg gcggtaggtg tagccacgat agccgggggt aggcgcaatg gaaggatgta 15060
gggcatattc gggcagtagc gcgctggcgg cgccgtactt cctcgaacgg cgcgggcgcc 15120
ggggggctga aacgcgaaac atccacgggt ccgtttgcac ctccgtagag gtcttggacg 15180
cggccgcagc gaccgcctgc accgcggcat ccgccaccgc tgaggcaacc ggggacgttt 15240
gtgtctccat gccctctgtg gcggtggcaa tactggtgct actggtagtg ggtatctgaa 15300
cgtccacggt ctgcacgccc agtcccggcg ccacctgctt gattggccgc acgcggacct 15360
cgggctccag cccaggttcc acggtcattt tttccaagac atcttccagt cgctggcgct 15420
tgggtaccat cagctgcacg gtgggtgcca agtcaccaga ctcgcgcttt aggccgcgct 15480
tttcttcgga cggtgcaagc gcgggcagca cctgctgcag tgttacgggc tttaggctag 15540
gtgttgggtt gccctcgtcc agcggcaacg ccagcatgtc cttatgccgc tttccgtagg 15600
caaactcccc gaggcgctcg ttggcctgct caagcaggtc ctcgtcgccg tacacctcat 15660
catacacgcg cttgtaggtg cgggtggagc gctcaccggg cgtaaagact acggtggtgc 15720
cgggtcgcaa aacacgtttt acgcgtcgac ctttccactg tacccgtcgc ctgggcgcgg 15780
tagcgtgcag cagttccacc tcgtcgtcaa gttcatcatc atcatctttc tttttctttt 15840
tgacccgctt tagctttcgg ggcttgtaat cctgctcttc cttcttcggg gggccataga 15900
tctccggcgc gatgacctgg agcatctctt ctttgatttt gcgcttggac atagcttcgt 15960
tgcgcgccgc cgccgctgga tacatacaac agtacgagtc taagtagttt tttcttgcaa 16020
tctagttgcg cggggggcgg gtgcgcacgg gcacgcgcag gccgctaacc gagtcgcgca 16080
cccaatacac gttgcccctg cgaccctgag tcatagcact aatggccgcg gctgctgcgg 16140
cggccgctcg tcgcctggac ctggggggca cagtgacaat acccgcggcc agccttcgag 16200
cggcccgcat ggccgcccgt cggccggtgc gacgtgcgcg gttaagcagg gccgccgccg 16260
cgcgttgggc ggcagtgccg ggtcggcggc ggtggcgacg tgctacgcgc ctccgccgtc 16320
tcttcatttt agcatagcgc cgggctccgc gcaccacggt ctgaatggcc gcgtccactg 16380
tggacactgg tggcggcgtg ggcgtgtagt tgcgcgcctc ctccaccacc gcgtcgatgg 16440
cgtcatcgac ggtggtgcgc ccagtgcggc cgcgtttgtg cgcgccccag ggcgcgcggt 16500
agtgcccgcg cacgcgcact gggtgttggt cggagcgctt cttggccccg ccaaacatct 16560
tgcttgggaa gcgcaggccc cagcctgtgt tattgctggg cgatataagg atggacatgc 16620
ttgctcaaaa agtgcggctc gataggacgc gcggcgagac tatgcccagg gccttgtaaa 16680
cgtaggggca ggtgcggcgt ctggcgtcag taatggtcac tcgctggact cctccgatgc 16740
tgttgcgcag cggtagcgtc ccgtgatctg tgagagcagg aacgttttca ctgacggtgg 16800
tgatggtggg ggctggcggg cgcgccaaaa tctggttctc gggaaagcga ttgaacacgt 16860
gggtcagaga ggtaaactgg cggatgagtt gggagtagac ggcctggtcg ttgtagaagc 16920
tcttggagtg cacgggcaac agctcggcgc ccaccaccgg aaagttgctg atctggcgcg 16980
tggagcggaa ggtcacgggg tcttgcatca tgtctggcaa cgaccagtag acctgctccg 17040
agccgcaggt tacgtcagga gtgcaaagca gggtccatga gcggattccg gtctgagggt 17100
cgccgtagtt gtatgcaagg taccagctgc ggtactgggt gaaggtgctg tcattgctta 17160
ttaggttgta actgcgtttc ttgctgtcct ctgtcagggg tttgatcacc ggtttcttct 17220
gaggcttctc gacctcgggt tgcgcagcgg gggcggcagc ttcggccgct gcttcggcct 17280
cagcgcgctt ctcctcagcc cgtgtggcaa aggtgtcgcc gcgaatggca tgatcgttca 17340
tgtcctccac cggctgcatt gccgcggctg ccgcgttgga gttctcttcc gcgccgctgc 17400
cactgctgtt gctgccgcct gcgccacccc cgccctgttc ggtgtcatct ttcaagctcg 17460
cctggtaggc gtccacatcc aacagtgcgg gaatgttacc accctccaga tcatcgtagg 17520
tgatcctaaa gccctcctgg aagggttgcc gcttgcggat gcccaacaag ttgctcaggc 17580
ggctgtgggt gaagtccacc ccgcatcctg gcagcaaaat gatgtctgga tggaaggctt 17640
cgtttgtata taccccaggc atgacaagac cagtgacggg gtcaaacccc agtctgaagt 17700
tgcgggtgtc aaactttacc ccgatgtcgc tttccagaac cccgttctgt ctgcccactt 17760
tcaagtagtg ctccacgatc gcgttgttca taaggtctat ggtcatggtc tcggagtagt 17820
tgccctcggg cagcgtgaac tccacccact cgtatttcag ctccacctga ttgtccttag 17880
taggcaagcg cgacaccatc acccgcgcct taaacttatt ggtaaacatg aactcgttca 17940
catttggcat gttggtatgc aggatggttt tcaggtcgcc gccccagtgc gaccggtcgt 18000
caagattgat ggtctgtgtg cttgcctccc ccgggctgta gtcattgttt tgaatgaccg 18060
tggtcagaaa gttgctgtgg tcgttctggt agttcaggga tgccacatcc gttgacttgt 18120
tgtccaccag gtacacacgg gtggtgtcga ataggggtgc caactcagag taacggatgc 18180
tgtttctccc cccggtaggc cgcaggtacc gcggaggcac aaacggcggg tccaggggag 18240
catcgaaggg agaacccagc gccgccgcca ctggcgccgc gctcaccaca ctctcgtagg 18300
agggaggagg accttcctca tacatcgccg cgcgccgcat actaagggga atacaagaaa 18360
accaacgctc ggtgccatgg ccttggtgag ttttttattt tgcatcatgc tttttttttt 18420
tttaaaacat tctccccagc ctggggcgaa ggtgcgcaaa cgggttgcca ctccctccca 18480
aatccaggac gctgctgtcg tctgccgagt catcgtcctc ccacaccaga ccccgctgac 18540
ggtcgtgcct ttgacgacgg gtgggcgggc gcgggcctgg cacgtccctg tgctcctgcg 18600
cgtacgtctt ccatctactc atcttgtcca ctaggctctc tatcccgttg ttgggaaatg 18660
ccggaggcag gtttttttcg cgctgcggct gcagcagcga gttgtttagg tactcctcct 18720
cgcccagcag gcgcgggcgg gtggtgcgag tgctggtaag agaccctatc aagcttggaa 18780
atgggctact agcatctgac cgcggggccg cagcgcctag atcggacaag ctgcttggcc 18840
tgcggaagct ttcctttcgc agcgccgcct ctgcctgctc gcgctgttgc aactctagca 18900
gggtctgcgg ttgcggggaa aacacgctgt cgtctatgtc gtcccagagg aatccatcgt 18960
taccctcggg cacctcgaat cccccggtgt agaaaccagg gggcggtagc cagtgcgggt 19020
tcaagatggc attggtgaaa tactcggggt tcacggcggc cgcgcgatgc aagtagtcca 19080
ttaggcggtt gataaacggc cggtttgagg catacatgcc cggttccatg ttgcgcgcgg 19140
tcatgtccag cgccacgctg ggcgttaccc cgtcgcgcat caggttaagg ctcacgctct 19200
gctgcacgta gcgcaaaatg cgctcctcct cgctgtttaa actgtgcaac gaggggatct 19260
tctgccgccg gttggtcagc aggtagttta gggttgcctc caggctgccc gtgtcctcct 19320
gccccagcgc gcggctgaca cttgtaatct cctggaaagt atgctcgtcc acatgcgcct 19380
gacctatggc ctcgcggtac agtgtcagca agtgacctag gtatgtgtcc cgggacacgc 19440
tgccactgtc cgtgaagggc gctattagca gcagcaacag gcgcgagttg ggcgtcagca 19500
agctagacac ggtcgcgcgg tcgcctgtgg gagcccgcac cccccacagc ccctgcaagt 19560
ttttgaaagc ctggctcagg tttacggtct gcaggccttg tctactggtc tggaaaaaat 19620
agtctggccc agactggtac acctcacttt gcggtgtctc agtcaccatt agccgcagtg 19680
cgctcacaaa gttggtgtag tcctcctgtc cccgcggcac gttggcgggc tgtgtactca 19740
ggaaggcgtt tagtgcaacc atggagccca ggttgccctg ctgctgcgcg cgctcacgct 19800
gcgccacggc ctcgcgcaca tcccccacca gccggtccag gttggtctgc acgttgccgc 19860
tgttgtaacg agccacgcgc tgaagcagcg cgtcgtagac caggccggcc tcgtcgggcc 19920
ggatggccct gttttcggcc agcgcgttta cgatcgccag caccttctcg tgcgtggggt 19980
ttgcgcgcgc cgggaccacc gcttccagaa ttgcggagag ccggttggcc tgcggctgct 20040
gccggaacgc gtcaggattg cgcgcagtca gcgacatgat gcggtccatg acctggcgcc 20100
agtcgtccgt ggagttaagg ccggacggct ggctctgcag cgccgcccgc accgccgggt 20160
ccgttgcgtc ttgcatcatc tgatcagaaa catcaccgct tagtactcgc cgtcctctgg 20220
ctcgtactca tcgtcctcgt catattcctc cacgccgccg acgttgccag cgcgcgcggg 20280
tgccaccgcc agcccaggtc cggccccagc tgcctccagg gcgcgtcggc ttggggccca 20340
gcgcaggtca gcgcccgcgt caaagtagga ctcggcctct ctatcgccgc tgcccgtgcc 20400
agccagggcc ctttgcaggc tgtgcatcag ctcgcggtcg ctgagctcgc gccgccggct 20460
cacgctcacg gccttgtgga tgcgctcgtt gcgataaacg cccaggtcgt cgctcaaggt 20520
aagcaccttc agcgccatgc gcatgtagaa cccctcgatc tttacctcct tgtctatggg 20580
aacgtaaggg gtatggtata tcttgcgggc gtaaaacttg cccaggctaa gcatggaata 20640
gttgatggcg gccaccttgt cagccaggct caagctgcgc tcctgcacca ctatgctctg 20700
caggatgttt atcaaatcga gcagccagcg gccctcgggc tctactatgt ttagcagcgc 20760
atccctgaat gcctcgttgt ccctgctgtg ctgcactata aggaacagct gcgccatgag 20820
cggcttgcta tttgggtttt gctccagcgc gcttacaaag tcccacagat gcatcagtcc 20880
tatagccacc tcctcgcgcg ccacaagcgt acgcacgtgg ttgttaaagc ttttttgaaa 20940
gttaatctcc tggttcaccg tctgctcgta tgcggttacc aggtcggcgg ccgccacgtg 21000
tgcgcgcgcg ggactaatcc cggttcgcgc gtcgggctca aagtcctcct cgcgcagcaa 21060
ccgctcgcga ttcaggccat gccgcagctc gcgccctgcg tggaactttc gatcccgcat 21120
ctcctcgggc tcctctccct cgcggtcgcg aaacaggttc tgccgcggca cgtacgcctc 21180
acgcgtatca cgcttcagct gcacccttgg gtgccgctca ggagagggcg ctcctagccg 21240
cgccaggccc tcgccctcct ccaagtccag gtagtgccgg gcccggcgcc gcgggggttc 21300
gtaatcacca tctgctgccg cgtcaaccgc ggatgtcgcc cctcctgacg cggtaggagg 21360
aggggagggt gccctgcatg tctgccgctg ctcttgctct tgccgctgct gaggaggggg 21420
gcgcatctgc cgcagcaccg gatgcatctg ggaaaagcaa aaaaggggct cgtccctgtt 21480
tccggaggaa tttgcaagcg gggtcttgca tgacggggag gcaaaccccc gttcgccgca 21540
gtccggccgg tccgagactc gaaccggggg tcccgcgact caacccttgg aaaataaccc 21600
tccggctaca gggagcgagc cacttaatgc tttcgctttc cagcctaacc gcttacgctg 21660
cgcgcggcca gtggccaaaa aagctagcgc agcagccgcc gcgcctggaa ggaagccaaa 21720
aggagcactc ccccgttgtc tgacgtcgca cacctgggtt cgacacgcgg gcggtaaccg 21780
catggatcac ggcggacggc cggatacggg gctcgaaccc cggtcgtccg ccatgatacc 21840
cttgcgaatt tatccaccag accacggaag agtgcccgct tacaggctct ccttttgcac 21900
gctagagcgt caacgattgc gcgcgcctga ccggccagag cgtcccgacc atggagcact 21960
ttttgccgct gcgcaacatc tggaaccgcg tccgcgactt tccgcgcgcc tccaccaccg 22020
ccgccggcat cacctggatg tccaggtaca tctacggata tcatcgcctt atgttggaag 22080
atctcgcccc cggagccccg gccaccctac gctggcccct ctaccgccag ccgccgccgc 22140
actttttggt gggataccag tacctggtgc ggacttgcaa cgactacgta tttgactcga 22200
gggcttactc gcgtctcagg tacaccgagc tctcgcagcc gggtcaccag accgttaact 22260
ggtccgttat ggccaactgc acttacacca tcaacacggg cgcataccac cgctttgtgg 22320
acatggatga cttccagtct accctcacgc aggtgcagca ggccatatta gccgagcgcg 22380
ttgtcgccga cctagccctg cttcagccga tgaggggctt cggggtcaca cgcatgggag 22440
gaagagggcg ccacctacgg ccaaactccg ccgccgccgc agcgatagat gcaagagatg 22500
caggacaaga ggaaggagaa gaagaagtgc cggtagaaag gctcatgcaa gactactaca 22560
aagacctgcg ccgatgtcaa aacgaagcct ggggcatggc cgaccgcctg cgcattcagc 22620
aggccggacc caaggacatg gtgcttctgt cgaccatccg ccgtctcaag accgcctact 22680
ttaattacat catcagcagc acctccgcca gaaacaaccc cgaccgccgc ccgctgccgc 22740
ccgccacggt gctcagccta ccttgcgact gtgactggtt agacgccttt ctcgagaggt 22800
tttccgatcc ggtcgatgcg gactcgctca ggtccctcgg cggcggagta cctacacaac 22860
aattgttgag atgcatcgtt agcgccgtat ccctgccgca tggcagcccc ccgccaaccc 22920
ataaccggga catgacgggc ggcgtcttcc aactgcgccc ccgcgagaac ggccgcgccg 22980
tcaccgagac catgcgccgt cgccgcgggg agatgatcga gcgctttgtc gaccgcctcc 23040
cggtgcgccg tcgtcgccgc cgtgtccccc ctcccccacc gccgccagaa gaagaagaag 23100
gggaggccct tatggaagag gagattgaag aagaagaaga ggcccctgta gcctttgagc 23160
gcgaggtgcg cgacactgtc gccgagctca tccgtcttct ggaggaggag ttaaccgtgt 23220
cggcgcgcaa ctcccagttt ttcaacttcg ccgtggactt ctacgaggcc atggagcgcc 23280
ttgaggcctt gggggatatc aacgaatcca cgttgcgacg ctgggttatg tacttcttcg 23340
tggcagaaca caccgccacc accctcaact acctctttca gcgcctgcga aactacgccg 23400
tcttcgcccg gcacgtggag ctcaatctcg cgcaggtggt catgcgcgcc cgcgatgccg 23460
aagggggcgt ggtctacagc cgcgtctgga acgagggagg cctcaacgcc ttctcgcagc 23520
tcatggcccg catttccaac gacctcgccg ccaccgtgga gcgagccgga cgcggagatc 23580
tccaggagga agagatcgag cagttcatgg ccgagatcgc ctatcaagac aactcaggag 23640
acgtgcagga gattttgcgc caggccgccg tcaacgacac cgaaattgat tctgtcgaac 23700
tctctttcag gttcaagctc accgggcccg tcgtcttcac gcagaggcgc cagattcagg 23760
agatcaaccg ccgcgtcgtc gcgttcgcca gcaacctacg cgcgcagcac cagctcctgc 23820
ccgcgcgcgg cgccgacgtg cccctgcccc ctctcccggc gggtccggag ccccccctac 23880
ctccgggggc tcgcccgcgt caccgctttt agatgcatca tccaaggaca cccccgcggc 23940
ccaccgcccg ccgcgcggta ccgtagtcgc gccgcgggga tgcggcctct tgcaagccat 24000
cgacgccgcc accaaccagc ccctggaaat taggtatcac ctggatctag cccgcgccct 24060
gacccgtcta tgcgaggtaa acctgcagga gctcccgcct gacctgacgc cgcgggagct 24120
ccagaccatg gacagctccc atctgcgcga tgttgtcatc aagctccgac cgccgcgcgc 24180
ggacatctgg actttgggct cgcgcggcgt ggtggtccga tccaccgtaa ctcccctcga 24240
gcagccagac ggtcaaggac aagcagccga agtagaagac caccagccaa acccgccagg 24300
cgaggggctc aaattcccac tctgcttcct tgtgcgcggt cgtcaggtca acctcgtgca 24360
ggatgtacag cccgtgcacc gctgccagta ctgcgcacgt ttttacaaaa gccagcacga 24420
gtgttcggcc cgtcgcaggg acttctactt tcaccacatc aatagccact cctccaattg 24480
gtggcgggag atccagttct tcccgatcgg ctcgcatcct cgcaccgagc gtctctttgt 24540
cacctacgat gtagagacct atacttggat gggggccttt gggaagcagc tcgtgccctt 24600
catgctggtc atgaagttcg gcggagatga gcctctagtg actgccgcgc gagacctagc 24660
cgcgaacctt ggatgggacc gctgggaaca agacccgctt accttctact gcatcacccc 24720
agaaaaaatg gccataggtc gccagtttag gacctttcgc gaccacctgc aaatgctaat 24780
ggcccgtgac ctgtggagct cattcgtcgc ttccaaccct catcttgcag actgggccct 24840
ttcagagcac gggctcagct cccctgaaga gctcacctac gaggaactta aaaaattgcc 24900
ttccatcaag ggcatcccgc gcttcttgga actttacatt gtgggccaca acatcaacgg 24960
ctttgacgag atcgtgctcg ccgcccaggt aattaacaac cgttccgagg tgccgggacc 25020
cttccgcatc acacgcaact ttatgcctcg cgcgggaaag atactcttca acgatgtcac 25080
cttcgccctg ccaaatccgc gttccaaaaa gcgcacggac tttttgctct gggagcaggg 25140
cggatgcgac gacactgact tcaaatacca gtacctcaaa gtcatggtca gggacacctt 25200
tgcgctcacc cacacctcgc tccggaaggc cgcgcaggca tacgcgctac ccgtagaaaa 25260
gggatgctgc gcctaccagg ccgtcaacca gttctacatg ctaggctctt accgttcgga 25320
ggccgacggg tttccgatcc aagagtactg gaaagaccgc gaagagtttg tcctcaaccg 25380
cgagctgtgg aaaaaaaagg gacaggataa gtatgacatc atcaaggaaa ccctggacta 25440
ctgcgcccta gacgtgcagg tcaccgccga gctggtcaac aagctgcgcg actcctacgc 25500
ctccttcgtg cgtgacgcgg taggtctcac agacgccagc ttcaacgtct tccagcgtcc 25560
aaccatatca tccaactcac atgccatctt caggcagata gtcttccgag cagagcagcc 25620
cgcccgtagc aacctcggtc ccgacctcct cgctccctcg cacgaactat acgattacgt 25680
gcgcgccagc atccgcggtg gaagatgcta ccctacatat cttggaatac tcagagagcc 25740
cctctacgtt tacgacattt gcggcatgta cgcctccgcg ctcacccacc ccatgccatg 25800
gggtccccca ctcaacccat acgagcgcgc gcttgccgcc cgcgcatggc agcaggcgct 25860
agacttgcaa ggatgcaaga tagactactt cgacgcgcgc ctgctgcccg gggtctttac 25920
cgtggacgca gaccccccgg acgagacgca gctagacccc ctaccgccat tctgctcgcg 25980
caagggcggc cgcctctgct ggaccaacga gcgcctacgc ggagaggtag ccaccagcgt 26040
tgaccttgtc accctgcaca accgcggttg gcgcgtgcac ctggtgcccg acgagcgcac 26100
caccgtcttt cccgaatggc ggtgcgttgc gcgcgaatac gtgcagctaa acatcgcggc 26160
caaggagcgc gccgatcgcg acaaaaacca aaccctgcgc tccatcgcca agttgctgtc 26220
caacgccctc tacgggtcgt ttgccaccaa gcttgacaac aaaaagattg tcttttctga 26280
ccagatggat gcggccaccc tcaaaggcat caccgcgggc caggtgaata tcaaatcctc 26340
ctcgtttttg gaaactgaca atcttagcgc agaagtcatg cccgcttttc agagggagta 26400
ctcaccccaa cagctggccc tcgcagacag cgatgcggaa gagagtgagg acgaacgcgc 26460
ccccaccccc ttttatagcc ccccttcagg aacacccggt cacgtggcct acacctacaa 26520
accaatcacc ttccttgatg ccgaagaggg cgacatgtgt cttcacaccc tggagcgagt 26580
ggacccccta gtggacaacg accgctaccc ctcccactta gcctccttcg tgctggcctg 26640
gacgcgagcc tttgtctcag agtggtccga gtttctatac gaggaggacc gcggaacacc 26700
gctcgaggac aggcctctca agtctgtata cggggacacg gacagccttt tcgtcaccga 26760
gcgtggacac cggctcatgg aaaccagagg taagaaacgc atcaaaaagc atgggggaaa 26820
cctggttttt gaccccgaac ggccagagct cacctggctc gtggaatgcg agaccgtctg 26880
cggggcctgc ggcgcggatg cctactcccc ggaatcggta tttctcgcgc ccaagctcta 26940
cgccctcaaa agtctgcact gcccctcgtg cggcgcctcc tccaagggca agctgcgcgc 27000
caagggccac gccgcggagg ggctggacta tgacaccatg gtcaaatgct acctggccga 27060
cgcgcagggc gaagaccggc agcgcttcag caccagcagg accagcctca agcgcaccct 27120
ggccagcgcg cagcccggag cgcacccctt caccgtgacc cagactacgc tgacgaggac 27180
cctgcgcccg tggaaagaca tgaccctggc ccgtctggac gagcaccgac tactgccgta 27240
cagcgaaagc cgccccaacc cgcgaaacga ggagatatgc tggatcgaga tgccgtagag 27300
caggtgaccg agctgtggga ccgcctggaa ctgcttggtc aaacgctcaa aagcatgcct 27360
acggcggacg gtctcaaacc gttgaaaaac tttgcttcct tgcaagaact gctatcgctg 27420
ggcggcgagc gccttctggc ggatttggtc agggaaaaca tgcgagtcag ggacatgctt 27480
aacgaagtgg cccccctgct cagggatgac ggcagctgca gctctcttaa ctaccagttg 27540
cagccggtaa taggtgtgat ttacgggccc accggctgcg gtaagtcgca gctgctcagg 27600
aacctgcttt cttcccagct gatctcccct accccggaaa ccgttttctt catcgccccg 27660
caggtagaca tgatcccccc atctgaactc aaagcgtggg aaatgcaaat ctgtgagggt 27720
aactacgccc ctgggccgga tggaaccatt ataccgcagt ctggcaccct ccgcccgcgc 27780
tttgtaaaaa tggcctatga cgatctcatc ctggaacaca actatgacgt tagtgatccc 27840
agaaatatct tcgcccaggc cgccgcccgt gggcccattg ccatcattat ggacgaatgc 27900
atggaaaatc ttggaggtca caagggcgtc tccaagttct tccacgcatt tccttctaag 27960
ctacatgaca aatttcccaa gtgcaccgga tacactgtgc tggtggttct gcacaacatg 28020
aatccccgga gggatatggc tgggaacata gccaacctaa aaatacagtc caagatgcat 28080
ctcatatccc cacgtatgca cccatcccag cttaaccgct ttgtaaacac ttacaccaag 28140
ggcctgcccc tggcaatcag cttgctactg aaagacattt ttaggcacca cgcccagcgc 28200
tcctgctacg actggatcat ctacaacacc accccgcagc atgaagctct gcagtggtgc 28260
tacctccacc ccagagacgg gcttatgccc atgtatctga acatccagag tcacctttac 28320
cacgtcctgg aaaaaataca caggaccctc aacgaccgag accgctggtc ccgggcctac 28380
cgcgcgcgca aaacccctaa ataaagacag caagacactt gcttgatcca aatccaaaca 28440
gagtctggtt ttttatttat gttttaaacc gcattgggag gggaggaagc cttcagggca 28500
gaaacctgct ggcgcagatc caacagctgc tgagaaacga cattaagttc ccgggtcaaa 28560
gaatttaaat tctactcgct ggcactcaag agtggcctct tgaggaactc accgggtata 28620
aatacactac acgtcagctg actataataa taaaacgcca actttgaccc ggaacgcgga 28680
aaacacctga gaaaaacacc tgggcgagtc tccacgtaaa cggtcaaagt ccccgcggcc 28740
ctagacaaat attacgcgct atgagtaaca caaaattatt cagatttcac ttcctcttat 28800
tcagttttcc cgcgaaaatg gccaaatctt actcggttac gcccaaattt actacaacat 28860
ccgcctaaaa ccgcgcgaaa attgtcactt cctgtgtaca ccggcgcaca ccaaaaacgt 28920
cacttttgcc acatccgtcg cttacatgtg ttccgccaca cttgcaacat cacacttccg 28980
ccacactact acgtcacccg ccccgttccc acgccccgcg ccacgtcaca aactccaccc 29040
cctcattatc atattggctt caatccaaaa taaggtatat tattgatgat gataagctat 29100
caaacatgag aattcggcgc gccattatca tttgcgggtc ctttccggcg atccgccttg 29160
ttacggggcg gcgacctcgc gggttttcgc tatttatgaa aattttccgg tttaaggcgt 29220
ttccgttctt cttcgtcata acttaatgtt tttatttaaa ataccctctg aaaagaaagg 29280
aaacgacagg tgctgaaagc gagctttttg gcctctgtcg tttcctttct ctgtttttgt 29340
ccgtggaatg aacaacgcgc ctcactgccc gctttccagt cgggaaacct gtcgtgccag 29400
ctgcattaat gaatcggcca acgcgcgggg agaggcggtt tgcgtattgg gcgccagggt 29460
ggtttttctt ttcaccagtg agacgggcaa cagctgattg cccttcaccg cctggccctg 29520
agagagttgc agcaagcggt ccacgctggt ttgccccagc aggcgaaaat cctgtttgat 29580
ggtggttgac ggcgggatat aacatgagct gtcttcggta tcgtcgtatc ccactaccga 29640
gatatccgca ccaacgcgca gcccggactc ggtaatggcg cgcattgcgc ccagcgccat 29700
ctgatcgttg gcaaccagca tcgcagtggg aacgatgccc tcattcagca tttgcatggt 29760
ttgttgaaaa ccggacatgg cactccagtc gccttcccgt tccgctatcg gctgaatttg 29820
attgcgagtg agatatttat gccagccagc cagacgcaga cgcgccgaga cagaacttaa 29880
tgggcccgct aacagcgcga tttgctggtg acccaatgcg accagatgct ccacgcccag 29940
tcgcgtaccg tcttcatggg agaaaataat actgttgatg ggtgtctggt cagagacatc 30000
aagaaataac gccggaacat tagtgcaggc agcttccaca gcaatggcat cctggtcatc 30060
cagcggatag ttaatgatca gcccactgac gcgttgcgcg agaagattgt gcaccgccgc 30120
tttacaggct tcgacgccgc ttcgttctac catcgacacc accacgctgg cacccagttg 30180
atcggcgcga gatttaatcg ccgcgacaat ttgcgacggc gcgtgcaggg ccagactgga 30240
ggtggcaacg ccaatcagca acgactgttt gcccgccagt tgttgtgcca cgcggttggg 30300
aatgtaattc agctccgcca tcgccgcttc cactttttcc cgcgttttcg cagaaacgtg 30360
gctggcctgg ttcaccacgc gggaaacggt ctgataagag acaccggcat actctgcgac 30420
atcgtataac gttactggtt tcacattcac caccctgaat tgactctctt ccgggcgcta 30480
tcatgccata ccgcgaaagg ttttgcacca ttcacctgca caccgcgcct taattaagaa 30540
ttccgtgtat tctatagtgt cacctaaatc gtatgtgtat gatacataag gttatgtatt 30600
aattgtagcc gcgttctaac gacaatatgt acaagcctaa ttgtgtagca tctggcttac 30660
tgaagcagac cctatcatct ctctcgtaaa ctgccgtcag agtcggtttg gttggacgaa 30720
ccttctgagt ttctggtaac gccgttccgc accccggaaa tggtcagcga accaatcagc 30780
agggtcatcg ctagccagat cctctacgcc ggacgcatcg tggccaaaag gatctaggtg 30840
aagatccttt ttgataatct catgaccaaa atcccttaac gtgagttttc gttccactga 30900
gcgtcagacc ccttaataag atgatcttct tgagatcgtt ttggtctgcg cgtaatctct 30960
tgctctgaaa acgaaaaaac cgccttgcag ggcggttttt cgaaggttct ctgagctacc 31020
aactctttga accgaggtaa ctggcttgga ggagcgcagt caccaaaact tgtcctttca 31080
gtttagcctt aaccggcgca tgacttcaag actaactcct ctaaatcaat taccagtggc 31140
tgctgccagt ggtgcttttg catgtctttc cgggttggac tcaagacgat agttaccgga 31200
taaggcgcag cggtcggact gaacgggggg ttcgtgcata cagtccagct tggagcgaac 31260
tgcctacccg gaactgagtg tcaggcgtgg aatgagacaa acgcggccat aacagcggaa 31320
tgacaccggt aaaccgaaag gcaggaacag gagagcgcac gagggagccg ccagggggaa 31380
acgcctggta tctttatagt cctgtcgggt ttcgccacca ctgatttgag cgtcagattt 31440
cgtgatgctt gtcagggggg cggagcctat ggaaaaacgg ctttgccgcg gccctctcac 31500
ttccctgtta agtatcttcc tggcatcttc caggaaatct ccgccccgtt cgtaagccat 31560
ttccgctcgc cgcagtcgaa cgaccgagcg tagcgagtca gtgagcgagg aagcggaata 31620
tatcctgtat cacatattct gctgacgcac cggtgcagcc ttttttctcc tgccacatga 31680
agcacttcac tgacaccctc atcagtgcca acatagtaag ccagtataca ctccgctagc 31740
gctgaggtct gcctcgtgaa gaaggtgttg ctgactcata ccaggcctga atcgccccat 31800
catccagcca gaaagtgagg gagccacggt tgatgagagc tttgttgtag gtggaccagt 31860
tggtgatttt gaacttttgc tttgccacgg aacggtctgc gttgtcggga agatgcgtga 31920
tctgatcctt caactcagca aaagttcgat ttattcaaca aagccacgtt gtgtctcaaa 31980
atctctgatg ttacattgca caagataaaa atatatcatc atgaacaata aaactgtctg 32040
cttacataaa cagtaataca aggggtgtta tgagccatat tcaacgggaa acgtcttgct 32100
cgaggccgcg attaaattcc aacatggatg ctgatttata tgggtataaa tgggctcgcg 32160
ataatgtcgg gcaatcaggt gcgacaatct atcgattgta tgggaagccc gatgcgccag 32220
agttgtttct gaaacatggc aaaggtagcg ttgccaatga tgttacagat gagatggtca 32280
gactaaactg gctgacggaa tttatgcctc ttccgaccat caagcatttt atccgtactc 32340
ctgatgatgc atggttactc accactgcga tccccgggaa aacagcattc caggtattag 32400
aagaatatcc tgattcaggt gaaaatattg ctgatgcgct ggcagtgttc ctgcgccggt 32460
tgcattcgat tcctgtttgt aattgtcctt ttaacagcga tcgcgtattt cgtctcgctc 32520
aggcgcaatc acgaatgaat aacggtttgg ttgatgcgag tgattttgat gacgagcgta 32580
atggctggcc tgttgaacaa gtctggaaag aaatgcata 32619
<210> 8
<211> 38461
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
agcttttgcc attctcaccg gattcagtcg tcactcatgg tgatttctca cttgataacc 60
ttatttttga cgaggggaaa ttaataggtt gtattgatgt tggacgagtc ggaatcgcag 120
accgatacca ggatcttgcc atcctatgga actgcctcgg tgagttttct ccttcattac 180
agaaacggct ttttcaaaaa tatggtattg ataatcctga tatgaataaa ttgcagtttc 240
atttgatgct cgatgagttt ttctaatcag aattggttaa ttggttgtaa cactggcaga 300
gcattacgct gacttgacgg gacggcggct ttgttgaata aatcgaactt ttgctgagtt 360
gaaggatcag atcacgcatc ttcccgacaa cgcagaccgt tccgtggcaa agcaaaagtt 420
caaaatcacc aactggtcca cctacaacaa agctctcatc aaccgtggct ccctcacttt 480
ctggctggat gatggggcga ttcaggcctg gtatgagtca gcaacacctt cttcacgagg 540
cagacctcag cgctcaaaga tgcaggggta aaagctaacc gcatctttac cgacaaggca 600
tccggcagtt caacagatcg ggaagggctg gatttgctga ggatgaaggt ggaggaaggt 660
gatgtcattc tggtgaagaa gctcgaccgt cttggccgcg acacgccgac atgatccaac 720
tgataaaaga gtttgatgct cagggtgtag cggttcggtt tattgacgac gggatcagta 780
ccgacggtga tatggggcaa atggtggtca ccatcctgtc ggctgtggca caggctgaac 840
gccggaggat cctagagcgc acgaatgagg gccgacagga agcaaagctg aaaggaatca 900
aatttggccg caggcgtacc gtggacagga gcgtcgattt ttgtgatgct cgtcaggggg 960
gcggagccta tggaaaaacg ccagcaacgc ggccttttta cggttcctgg ccttttgctg 1020
gccttttgct cacatgttct ttcctgcgtt atcccctgat tctgtggata accgtattac 1080
cgcctttgag tgagctgata ccgctcgccg cagccgaacg accgagcgca gcgagtcagt 1140
gagcgaggaa gcggaagagc gcccaatacg caaaccgcct ctccccgcgc gttggccgat 1200
tcattaatgc agctggcacg acaggtttcc cgactggaaa gcgggcagtg agcgcaacgc 1260
aattaatgtg agttagctca ctcattaggc accccaggct ttacacttta tgcttccggc 1320
tcgtatgttg tgtggaattg tgagcggata acaatttcac acaggaaaca gctatgacca 1380
tgattacgcc aagcttgcat gcctgcaggt cgatcgatta attaacgacc catcatcaat 1440
aatatacctt attttggatt gaagccaata tgataatgag ggggtggagt ttgtgacgtg 1500
gcgcggggcg tgggaacggg gcgggtgacg taggttttag ggcggagtaa cttgtatgtg 1560
ttgggaattg tagttttctt aaaatgggaa gttacgtaac gtgggaaaac ggaagtgacg 1620
atttgaggaa gttgtgggtt ttttggcttt cgtttctggg cgtaggttcg cgtgcggttt 1680
tctgggtgtt ttttgtggac tttaaccgtt acgtcatttt ttagtcctat atatactcgc 1740
tctgcacttg gccctttttt acactgtgac tgattgagct ggtgccgtgt cgagtggtgt 1800
tttttaaaag aaaagggggg attggggggt acagtgcagg ggaaagaata gtagacataa 1860
tagcaacaga catacaaact aaagaattac aaaaacaaat tacaaaattc aaaattttat 1920
cgtactagtg gatctgcgat cgctccggtg cccgtcagtg ggcagagcgc acatcgccca 1980
cagtccccga gaagttgggg ggaggggtcg gcaattgaac gggtgcctag agaaggtggc 2040
gcggggtaaa ctgggaaagt gatgtcgtgt actggctccg cctttttccc gagggtgggg 2100
gagaaccgta tataagtgca gtagtcgccg tgaacgttct ttttcgcaac gggtttgccg 2160
ccagaacaca gctgaagctt cgaggggctc gcatctctcc ttcacgcgcc cgccgcccta 2220
cctgaggccg ccatccacgc cggttgagtc gcgttctgcc gcctcccgcc tgtggtgcct 2280
cctgaactgc gtccgccgtc taggtaagtt taaagctcag gtcgagaccg ggcctttgtc 2340
cggcgctccc ttggagccta cctagactca gccggctctc cacgctttgc ctgaccctgc 2400
ttgctcaact ctacgtcttt gtttcgtttt ctgttctgcg ccgttacaga tccaagctgt 2460
gaccggcgcc tacggatccg ccaccatgga gacacagaag ctgatctcca tggtgaagga 2520
ggccctggag aagtaccagt accctctgac cgccaagaat atcaaggtgg tgatccagaa 2580
ggagcacaac gtggtgctgc ctaccggctc catcaattcc atcctgtact ccaacagcga 2640
gctgttcgag aagatcgaca agaccaacac catctaccct cctctgtgga tcaggaagaa 2700
ctacccctac gatgtgcctg actacgccat ggagaacacc accagcggct tcctgggccc 2760
cctgctggtg ctgcaggccg gattcttcct gctgacccgc atcctgacca tcccccagag 2820
cctggacagc tggtggacct ccctgaactt tctgggcggg gcccccacct gccccggaca 2880
gaactctcag agccccacct ccaaccacag ccccaccagc tgccccccca tctgcccagg 2940
atatagatgg atgtgcctcc gccgcttcat catcttcctg ttcatcctgc tcctgtgcct 3000
catcttcctc ctcgtgctcc tggactacca gggcatgctc cccgtctgcc ccctcctgcc 3060
tggcacatcc accacctcca ccggcccctg caagacctgc accatccccg cccagggcac 3120
ctccatgttc ccctcctgct gctgcaccaa accctccgac ggcaactgca cctgcatccc 3180
catccccagc agctgggcct tcgccaggtt cctgtgggaa tgggccagcg tcaggttcag 3240
ctggctctcc ctcctcgtgc ccttcgtgca gtggtttgtg ggcctgagcc ccaccgtctg 3300
gctcagcgtg atctggatga tgtggtattg ggggccccgc ctgtacaaca tcctctcccc 3360
tttcctcccc ctgctgccca tcttcttctg cctctgggtg tacatcggaa gcggagctac 3420
taacttcagc ctgctgaagc aggctggaga cgtggaggag aaccctggac ctatgggcgg 3480
aacaacagac tttgtgctga gcatcacaat cgtgctggtg atcctgatca tcatcgcctt 3540
catctggtac aattttaccg gctggtcccc ctttaagtac agcaagggca acaccgtgac 3600
atttaagacc cctgacgaga gcagcatcgc ctacatgaga tttaggaact gtgtgttcac 3660
attcaccgac cccaagggca gcctgcacag catcgacgtg acagaggtgc tgaacaacat 3720
ggccaagggc tttagggatg cccagaatcc ccctagctcc ttcacactgg gcggccactg 3780
ccaggccccc ctgaatgctt tttcctttgt gctgcctggc gtgaacgaca gagccacagt 3840
ggccaccgcc gacgaggcca agaagtggga gaactgcgac gccaccctga ccggcctgca 3900
gagaatcatc taactcgagt ctagagggcc cgtttaaacc cgctgatcag cctcgataat 3960
catctcttgt acatgtccca ctgttcaagc ctccaagctg tgccttgggt ggctttgggg 4020
catggacatt gacccttata aagaatttgg agctactgtg gagttactct cgtttttgcc 4080
ttctgacttc tttccttccg tcagagatct cctagacacc gcctcagctc tgtatcgaga 4140
agccttagag tctcctcttc tgaggcggaa agaaccagct ggggctctag caattgaaaa 4200
ataaacacgt tgaaacataa cacaaacgat tctttattct tgggcaatgt atgaaaaagt 4260
gtaagaggat gtggcaaata tttcattaat gtagttgtgg ccagaccagt cccatgaaaa 4320
tgacatagag tatgcacttg gagttgtgtc tcctgtttcc tgtgtaccgt ttagtgtaat 4380
ggttagtgtt acaggtttag ttttgtctcc gtttaagtaa acttgactga caatgttact 4440
tttggcagtt ttaccgtgag attttggata agctgatagg ttaggcataa atccaacagc 4500
gtttgtatag gctgtgcctt cagtaagatc tccatttcta aagttccaat attctgggtc 4560
caggaaggaa ttgtttagta gcactccatt ttcgtcaaat cttataataa gatgagcact 4620
ttgaactgtt ccagatattg gagccaaact gcctttaaca gccaaaactg aaactgtagc 4680
aagtatttga ctgccacatt ttgttaagac caaagtgagt ttagcatctt tctctgcatt 4740
tagtctacag ttaggagatg gagctggtgt ggtccacaaa gttagcttat cattattttt 4800
gtttcctact gtaatggcac ctgtgctgtc aaaactaagg ccagttccta gtttaggaac 4860
catagccttg tttgaatcaa attctaggcc atggccaatt tttgttttga ggggatttgt 4920
gtttggtgca ttaggtgaac caaattcaag cccatctcct gcattaatgg ctatggctgt 4980
agcgtcaaac atcaacccct tggcagtgct taggttaacc tcaagctttt tggaattgtt 5040
tgaagctgta aacaagtaaa ggcctttgtt gtagttaata tccaagttgt gggctgagtt 5100
tataaaaaga gggccctgtc ctagtcttag atttagttgg ttttgagcat caaacggata 5160
actaacatca agtataaggc gtctgttttg agaatcaatc cttagtcctc ctgctacatt 5220
aagttgcata ttgccttgtg aatcaaaacc caaggctcca gtaactttag tttgcaagga 5280
agtattatta atagtcacac ctggaccagt tgctacggtc aaagtgttta ggtcgtctgt 5340
tacatgcaaa ggagccccgt actttagtcc tagttttcca ttttgtgtat aaatgggctc 5400
tttcaagtca atgcccaagc taccagtggc agtagttaga gggggtgagg cagtgatagt 5460
aagggtactg ctatcggtgg tggtgagggg gcctgatgtt tgcagggcta gctttccttc 5520
tgacactgtg aggggtcctt gggtggcaat gctaagtttg gagtcgtgca cggttagcgg 5580
ggcctgtgat tgcatggtga gtgtgttgcc cgcgaccatt agaggtgcgg cggcagccac 5640
agttagggct tctgaggtaa ctgtgagggg tgcagatatt tccaggttta tgtttgactt 5700
ggtttttttg agaggtgggc tcacagtggt tacattttgg gaggtaaggt tgccggcctc 5760
gtccagagag aggccgttgc ccattttgag cgcaagcatg ccattggagg taactagagg 5820
ttcggatagg cgcaaagaga gtaccccagg gggactctct tgaaacccat tgggggatac 5880
aaagggagga gtaagaaaag gcacagttgg aggaccggtt tccgtgtcat atggatacac 5940
ggggttgaag gtatcttcag acggtcttgc gcgcttcatc tgcaacaaca tgaagatagt 6000
gggtgcggat ggacaggaac aggaggaaac tgacattcca tttagattgt ggagaaagtt 6060
tgcagccagg aggaagctgc aataccagag ctgggaggag ggcaaggagg tgctgctgaa 6120
taaactggac agaaatttgc taactgattt taagtaagtg atgctttatt attttttttt 6180
attagttaaa gggaataaga tctttgagac cgcacagggt cttaataagg gtgcagagat 6240
cctcaggtcc ttgacaaggt gagtgaatgc agccttcggt ttctaccgag tgctgagtta 6300
tggtaatggg cttttctccc accatgacca ccaatttctg acgcttggtt ggcaacttgt 6360
agctaaggcg gtgtccggtg gtattactgt cgtaggtgac tttggcctgc tttaccagac 6420
aaaagatacc ccttttgcac tggtgcaagt taaccatgtc ttggagctct tgattcatgc 6480
gctgttgctc ggccgctgcc ctgcgtcttt ctagcaggcg ctgctctgta ataattccgt 6540
ccatttctag ctagagaaac ctgaattaga atagcccgta gagttgcttg aattgttcat 6600
aaaccccaca gtagctgcgc ctttggccta ataccctaag ggttttctaa gctcacctcc 6660
tgttctggta aacagagtta ttgaggtctg tccggaaaaa gtctggttta cggtcaggcg 6720
gtaggtgtgg tgcagcggcc ggtgacgcac tcgtacgttc ccggcaggta aggagggtgg 6780
tgttttttct gatggagtag ctgagctcgg agaggttctc tcgtagactc actccgtctg 6840
ggttgaaact gttgtaaatc acagagggag agatgttaaa agtaccaggt aaggttcgcc 6900
ttggtttgct tgggcgggtg aagacggtgg cgtttacagg atggcgatag gagccccagt 6960
atattttaat ttctgtattt attatactca gcacagagat ggcaacaaag atcttgatgt 7020
aatccagggt taggacagtt gcaaatcaca gtgagaacac agggtcccct gtcccgctca 7080
actagcaggg ggcgctgggt aaactcccga atcaggctac gggcaagctc tccctgggcg 7140
gtaagccgga cgccgtgcgc cgggccctcg atatgatcct cgggcaattc aaagtagcaa 7200
aactcaccgg agtcgcgggc aaagcacttg tggcggcgac agtggaccag gtgtttcagg 7260
cgcagttgct ctgcctctcc acttaacatt cagtcgtagc cgtccgccga gtcctttacc 7320
gcgtcaaagt taggaataaa ttgatccgga tagtggccgg gaggtcccga gaaggggtta 7380
aagtagaccg atggcacaaa ctcctcaata aattgcagag ttccaatgcc tccagagcgc 7440
ggctcagagg acgaggtctg cagagttagg attgcctgac gaggcgtgaa tgaagagcgg 7500
ccggcgccgc cgatctgaaa tgtcccgtcc ggacggagac caagcgagga gctcaccgac 7560
tcgtcgttga gctgaatacc tcgccctctg attgtcaggt gagttatacc ctgcccgggc 7620
gaccgcaccc tgtgacgaaa gccgcccgca agctgcgccc ctgagttagt catctgaact 7680
tcggcctggg cgtctctggg aagtaccaca gtggtgggag cgggactttc ctggtacacc 7740
agggcagcgg gccaactacg gggattaagg ttattacgag gtgtggtggt aatagccgcc 7800
tgttccagga gaattcggtt tcggtgggcg cgtattccgt tgacccggga tatcatgtgg 7860
ggtcccgcgc tcatgtagtt tattcgggtt gagtagtctt gggcagctcc agccgcaagt 7920
cccatttgtg gctggtaact ccacatgtag ggcgtgggaa tttccttgct cataatggcg 7980
ctgacaacag gtgctggcgc cgggtgtggc cgctggagat gacgtagttt tcgcgcttaa 8040
atttgagaaa gggcgcgaaa ctagtcctta agagtcagcg cgcagtattt actgaagaga 8100
gcctccgcgt cttccagcgt gcgccgaagc tgatcttcgc ttttgtgata caggcagctg 8160
cgggtgaggg atcgcagaga cctgtttttt attttcagct cttgttcttg gcccctgctc 8220
tgttgaaata tagcatacag agtgggaaaa atcctgtttc taagctcgcg ggtcgatacg 8280
ggttcgttgg gcgccagacg cagcgctcct cctcctgctg ctgccgccgc tgtggatttc 8340
ttgggctttg tcagagtctt gctatccggt cgcctttgct tctgtgtggc cgctgctgtt 8400
gctgccgctg ccgccggtgc agtatgggct gtagagatga cggtagtaat gcaggatgtt 8460
acgggggaag gccacgccgt gatggtagag aagaaagcgg cgggcgaagg agatgttgcc 8520
cccacagtct tgcaagcaag caactatggc gttcttgtgc ccgcgccatg agcggtagcc 8580
ttggcgctgt tgttgctctt gggctaacgg cggcggctgc ttggacttac cggccctggt 8640
tccagtggtg tcccatctac ggttgggtcg gcgaacgggc agtgccggcg gcgcctgagg 8700
agcggaggtt gtagccatgc tggaaccggt tgccgatttc tggggcgccg gcgaggggaa 8760
tgcgaccgag ggtgacggtg tttcgtctga cacctcttcg acctcggaag cttcctcgtc 8820
taggctctcc cagtcttcca tcatgtcctc ctcctcctcg tccaaaacct cctctgcctg 8880
actgtcccag tattcctcct cgtccgtggg tggcggcggc agctgcagct tctttttggg 8940
tgccatcctg ggaagcaagg gcccgcggct gctgctgata gggctgcggc ggcgggggga 9000
ttgggttgag ctcctcgccg gactgggggt ccaagtaaac cccccgtccc tttcgtagca 9060
gaaactcttg gcgggctttg ttgatggctt gcaattggcc aagaatgtgg ccctgggtaa 9120
tgacgcaggc ggtaagctcc gcattaggcg ggcgggattg gtcttcgtag aacctaatct 9180
cgtgggcgtg gtagtcctca ggtacaaatt tgcgaaggta agccgacgtc cacagccccg 9240
gagtgagttt caaccccgga gccgcggact tttcgtcagg cgagggaccc tgcagctcaa 9300
aggtaccgat aatttgactt tcgttaagca gctgcgaatt gcaaaccagg gagcggtgcg 9360
gggtgcatag gttgcagcga cagtgacact ccagtagacc gtcaccgctc acgtcttcca 9420
ttatgtcaga gtggtaggca aggtagttgg ctagctgcag aaggtagcag tggccccaaa 9480
gcggcggagg gcattcgcgg tacttaatgg gcacaaagtc gctaggaagt gcacagcagg 9540
tggcgggcaa gattcctgag cgctctagga taaagttcct aaagttctgc aacatgcttt 9600
gactggtgaa gtctggcaga ccctgttgca gggttttaag caggcgttcg gggaaaatga 9660
tgtccgccag gtgcgcggcc acggagcgct cgttgaaggc cgtccatagg tccttcaagt 9720
tttgctttag cagtttctgc agctccttga ggttgcactc ctccaagcac tgctgccaaa 9780
cgcccatggc cgtctgccag gtgtagcata gaaataagta aacgcagtcg cggacgtagt 9840
cgcggcgcgc ctcgcccttg agcgtggaat gaagcacgtt ttgcccaagg cggttttcgt 9900
gcaaaattcc aaggtaggag accaggttgc agagctccac gttggagatc ttgcaggcct 9960
ggcgtacgta gccctgtcga aaggtgtagt gcaatgtttc ctctagcttg cgctgcatct 10020
ccgggtcagc aaagaaccgc tgcatgcact caagctccac ggtaacgagc actgcggcca 10080
tcattagttt gcgtcgctcc tccaagtcgg caggctcgcg cgtttgaagc cagcgcgcta 10140
gctgctcgtc gccaactgcg ggtaggccct cctctgtttg ttcttgcaaa tttgcatccc 10200
tctccagggg ctgcgcacgg cgcacgatca gctcactcat gactgtgctc atgaccttgg 10260
ggggtaggtt aagtgccggg taggcaaagt gggtgacctc gatgctgcgt tttagtacgg 10320
ctaggcgcgc gttgtcaccc tcgagttcca ccaacactcc agagtgactt tcattttcgc 10380
tgttttcctg ttgcagagcg tttgccgcgc gcttctcgtc gcgtccaaga ccctcaaaga 10440
tttttggcac ttcgttgagc gaggcgatat caggtatgac agcgccctgc cgcaaggcca 10500
gctgcttgtc cgctcggctg cggttggcac ggcaggatag gggtatcttg cagttttgga 10560
aaaagatgtg ataggtggca agcacctctg gcacggcaaa tacggggtag aagttgaggc 10620
gcgggttggg ctcgcatgtg ccgttttctt ggcgtttggg gggtacgcgc ggtgagaata 10680
ggtggcgttc gtaggcaagg ctgacatccg ctatggcgag gggcacatcg ctgcgctctt 10740
gcaacgcgtc gcagataatg gcgcactggc gctgcagatg cttcaacagc acgtcgtctc 10800
ccacatctag gtagtcgcca tgcctttcgt ccccccgccc gacttgttcc tcgtttgcct 10860
ctgcgttgtc ctggtcttgc tttttatcct ctgttggtac tgagcggtcc tcgtcgtctt 10920
cgcttacaaa acctgggtcc tgctcgataa tcacttcctc ctcctcaagc gggggtgcct 10980
cgacggggaa ggtggtaggc gcgttggcgg catcggtgga ggcggtggtg gcgaactcag 11040
agggggcggt taggctgtcc ttcttctcga ctgactccat gatctttttc tgcctatagg 11100
agaaggaaac ttgtatgtgt tgggaattgt agttttctta aaatgggaag ttacgtaacg 11160
tgggaaaacg gaagtgacga tttgaggaag ttgtgggttt tttggctttc gtttctgggc 11220
gtaggttcgc gtgcggtttt ctgggtgttt tttgtggact ttaaccgtta cgtcattttt 11280
tagtcctata tatactcgct ctgcacttgg ccctttttta cactgtgact gattgagctg 11340
gtgccgtgtc gagtggtgtt tttttaatag gttttctttt ttactggtaa ggctgactgt 11400
tatgactacg tccggcgttc catttggcat gacactacga ccaacacgat ctcggttgtc 11460
tcggcgcact ccgtacagta gggatcgtct acctcctttt gagacagaaa cccgcgctac 11520
catactggag gatcatccgc tgctgcccga atgtaacact ttgacaatgc acaacgtgag 11580
ttacgtgcga ggtcttccct gcagtgtggg atttacgctg attcaggaat gggttgttcc 11640
ctgggatatg gttctaacgc gggaggagct tgtaatcctg aggaagtgta tgcacgtgtg 11700
cctgtgttgt gccaacattg atatcatgac gagcatgatg atccatggtt acgagtcctg 11760
ggctctccac tgtcattgtt ccagtcccgg ttccctgcag tgtatagccg gcgggcaggt 11820
tttggccagc tggtttagga tggtggtgga tggcgccatg tttaatcaga ggtttatatg 11880
gtaccgggag gtggtgaatt acaacatgcc aaaagaggta atgtttatgt ccagcgtgtt 11940
tatgaggggt cgccacttaa tctacctgcg cttgtggtat gatggccacg tgggttctgt 12000
ggtccccgcc atgagctttg gatacagcgc cttgcactgt gggattttga acaatattgt 12060
ggtgctgtgc tgcagttact gtgctgattt aagtgagatc agggtgcgct gctgtgcccg 12120
gaggacaagg cgccttatgc tgcgggcggt gcgaatcatc gctgaggaga ccactgccat 12180
gttgtattcc tgcaggacgg agcggcggcg gcagcagttt attcgcgcgc tgctgcagca 12240
ccaccgccct atcctgatgc acgattatga ctctaccccc atgtagacta gggttctgtg 12300
agtttgatta aggtacggtg atctgtataa gctatgtggt ggtggggcta tactactgaa 12360
tgaaaaatga cttgaaattt tctgcaattg aaaaataaac acgttgaaac ataacacaaa 12420
cgatacggcg cagacggcaa gggtgggggt aaataatcac ccgagagtgt acaaataaaa 12480
gcatttgcct ttattgaaag tgtctctagt acattatttt tacatgtttt tcaagtgaca 12540
aaaagaagtg gcgctcctaa tctgcgcact gtggctgcgg aagtagggcg agtggcgctc 12600
caggaagctg tagagctgtt cctggttgcg acgcagggtg ggctgtacct ggggactgtt 12660
gagcatggag ttgggtaccc cggtaataag gttcatggtg gggttgtgat ccatgggagt 12720
ttggggccag ttggcaaagg cgtggagaaa catgcagcag aatagtccac aggcggccga 12780
gttgggcccc tgtacgcttt gggtggactt ttccagcgtt atacagcggt cgggggaaga 12840
agcaatggcg ctacggcgca ggagtgactc gtactcaaac tggtaaacct gcttgagtcg 12900
ctggtcagaa aagccaaagg gctcaaagag gtagcatgtt tttgagtgcg ggttccaggc 12960
aaaggccatc cagtgtacgc ccccagtctc gcgaccggcc gtattgacta tggcgcaggc 13020
gagcttgtgt ggagaaacaa agcctggaaa gcgcttgtca taggtgccca aaaaatatgg 13080
cccacaacca agatctttga caatggcttt cagttcctgc tcactggagc ccatggcggc 13140
agctgttgtt gatgttgctt gcttctttat gttgtggcgt tgccggccga gaagggcgtg 13200
cgcaggtaca cggtttcgat gacgccgcgg tgcggctggt gcacacggac cacgtcaaag 13260
acttcaaaca aaacataaag aagggtgggc tcgtccatgg gatccacctc aaaagtcatg 13320
tctagcgcgt gggcggagtt ggcgtagaga aggttttggc ccaggtctgt gagtgcgccc 13380
atggacataa agttactgga gaatgggatg cgccaaaggg tgcgatcgca aagaaacttt 13440
ttctgggtaa tgctgtcaac tgcggtcttg cctataagcg gataggggaa gttagcaggg 13500
taggcctgtc cttcgcgcat ggtgggggca aggtagccaa caaatccaga gttgttgtgt 13560
tggtgtagga tgcccacctg ttggtagtcc ttgtatttag tatcatccac cacctgacgg 13620
ctcatgggct ggaagtttct aaagaaggag tacatgcggt ccttgtagct ctctgggata 13680
tagaagccct ggtagccaat gttatagtta gctagcattt gtaccaggaa ccagtctttg 13740
gtcatgttac actgggcaac gttgtaaccc tccccgtcaa ctgagcgctt aatttcaaac 13800
tcgttggggg taagcaggcg gtcattgcca ggccagctga cagaagagtc aaaggtaatg 13860
gccaccttct taaaggtgtg gttgaggtaa aaggttccat ctaggtaggg tatagagcca 13920
gagtaggtgt aataagggtc gtagcccgag cccagtgatg gggtttcctt agtcttaagg 13980
cgcgtgaagg cccagccgcg gaaagccgcc cagttgcggg aggggatgga tatgggcacg 14040
ttggtagcgt tggcgggtat agggtagagc atgttggcgg cggagagata gtcgttaaag 14100
gactggtcgt tggtgtcgtt tctaagcatg gcctcaagcg tggaggcggt gttgtgggcc 14160
atggggaaga aggtggcgta aaggcaaatg ctatcaaact taatgctggc tccgtcaacc 14220
cttaggtcat ttcctaggga gctctgcaga accatgttaa catccttcct gaagttccac 14280
tcgtaggtgt atgagcccgg caggagaagg aggtttttaa tggcaaagaa cttctgaggc 14340
acctggatgt ggaagggcac atagcgacca ttgcccagca acattgagcg gtagcgcagg 14400
ccagcattgc ggtggtggtt aaatgggttg acgttgtcca tatagtcaag ggaccagcgt 14460
gctccaaggt taatgtagca gtccactagc ccgggagcca ccactcgctt gttcatgtag 14520
tcgtaggtgt ttgggttatc agaaattttt acgttggaag gactgtactt tagcttgtcg 14580
ggcaaataca gcgctatgtt ggagtacagg aaatttctcc acaggttggc atttagattg 14640
atttccatgg caaaattatt tccaactctt atttcatttt tatctgaaaa ttctgtagca 14700
tctttttccc atccattttc ctgacctgtt ttaggtttta ccttggtaag agtctctgta 14760
ttaatcacac ctcccagtgg aaagcagtaa tttggaagtt catcttcagt tccatgattt 14820
tcaataattc taacatctgg atcatagctg tcaacagcct gattccacat agaaaagtac 14880
ctggttctat caccaatgga atcaagcaaa agctggtatg aaagctctgt gtttctgtct 14940
tgcaaatcta caacagcatt caactgcgat gcttggcccg ccagaacacc catattaccc 15000
gtgctgttgt aatacattag accaataaaa ttgtccctaa aagcaatgta attaggcctg 15060
ttgggcatag attgttggcc cattagttct cgtgagttac cttccttaat agtgggcatg 15120
taagaaatat gagtgtctgg ggtttctata tctacatctt cactgtacaa taccacttta 15180
ggagtcaagt tatcaccatt gcctgcggct gcctcagtag ttgagaaaaa ttgcatttcc 15240
acttgacttt ctagctttcc attttgttgc tttacaagaa tgccttgccc tccattttca 15300
tttgtgggtt ttgcatatga accgtaacat ggtttcattg gggtagtctt ttttaggact 15360
ctcccagctg catgattaat ttctgtttcg taccactgag attctcctat ttgaggttca 15420
ggttgaaatg ttttatcggc atatttaggt gtttgacctt cgacacctat ttgaataccc 15480
tcctttgtaa tatttatacc agaataaggc gcctgcccaa atacgtgagt tttttgctgc 15540
tcagcttgct cgtctacttc gtcttcgttg tcatcgtcct cttcttctag gtttatttca 15600
agagcagtag cagcttcatc ccattcgcaa ggatttgggg cacccttggg agccagggcg 15660
ttgtaggcag tgccagagta gggcttaaaa gtagggcccc tgtccagcac gccgcggatg 15720
tcaaagtacg tggaagccat gtccagcaca cggttatcac ccacagctag ggtgaaccgc 15780
gccttgtacg agtacgcagt atcctcacgg tccacaggga tgaaccgcag cgtcaaacgc 15840
tgggaccggt ctgtggtcac gtcgtgcgta ggcgccaccg tggggtttct aaacttgtta 15900
ttcaggctga agtacgtctc ggtggcgcgg gcaaactgca ccagcccggg gctcaggtac 15960
tccgaggcgt cctggcccga gatgtgcatg taagaccact gcggcatcat cgaaggggta 16020
gccatcttgg aaagcgggcg cgcggcggct cagcagctcc tctggcggcg acatggacgc 16080
atacatgaca cacatacgac acgttagcta tcagaagcat cgtcggcgct tcagggattg 16140
cacccccaga cccacgatgc tgttcagtgt gctttgccag ttgccactgg ctacgggccg 16200
caacgatcgc ggaccgctgg cggcgcggcg cagggacgcg cggctaggac gggttacaac 16260
aacggcggtc gggcctggca gcacaggttt ctgctgggtg tcggcggggg gaggcaggtc 16320
cagcgttacg ggtgtgtgct ggcccagcac tccggtagcc atgggcgcga tgggacgggt 16380
ggtgggcagg ccttgcttta gtgcctcctc gtacgaggga ggctcgtcta tttgcgtcac 16440
cagagtttct tccctgtcgg ggcgcggacg cttttcgcca cgcccctctg gagacactgt 16500
ctccacggcc ggtggaggct cctctacggg agggcgggga tcaagcttac tgttaatctt 16560
attttgcact gcctggttgg ccaggtccac caccccgcta atgccagagg ccaggccatc 16620
taccaccttt tgttggaaat tttgctcttt caacttatcc ctcagcatct ggcctgtgct 16680
gctgttccag gccttgctgc catagttctt aacggtggaa ccgaaatttt taatgccgct 16740
ccacagcgag ccccagctga aggcgccacc gctcatattg ctggtgccga tatcttgcca 16800
gtttcccatg aacgggcgcg agccgtgtcg cggggccaga gacgcaaagt tgatgtcttc 16860
cattctacaa aatagttaca ggaccaagcg agcgtgagag tccagacttt ttattttgat 16920
ttttccacat gcaacttgtt tttaatcagt gtctctgcgc ctgcaaggcc acggatgcaa 16980
ttccgggcac ggcgccaatc gccgcggcga tcagtggaat aaggaggggc aggataccgc 17040
cgcgcatgcg acggtgcgac gcgcgccgcc gccggtggtg cgcacgacgc atgccgcccg 17100
tcaggccgtg gccggccatg cccctcctac ggtgcattct tcctcggaat cccggcaccg 17160
ggaaacggag gcggcaggtg agggccatat ctgcaagaac cacaaagacc ggcttttaaa 17220
cgatgctggg gtggtagcgc gctgttggca gcaccagggt cctgcctcct tcgcgagcca 17280
ccctgcgcac ggaaatcggg gccagcacgg gctggcgacg gcgacggcgg cggcgggttc 17340
cagtggtggt tcggcgtcgg gtagttgctc gtcttctggg gcggtaggtg tagccacgat 17400
agccgggggt aggcgcaatg gaaggatgta gggcatattc gggcagtagc gcgctggcgg 17460
cgccgtactt cctcgaacgg cgcgggcgcc ggggggctga aacgcgaaac atccacgggt 17520
ccgtttgcac ctccgtagag gtcttggacg cggccgcagc gaccgcctgc accgcggcat 17580
ccgccaccgc tgaggcaacc ggggacgttt gtgtctccat gccctctgtg gcggtggcaa 17640
tactggtgct actggtagtg ggtatctgaa cgtccacggt ctgcacgccc agtcccggcg 17700
ccacctgctt gattggccgc acgcggacct cgggctccag cccaggttcc acggtcattt 17760
tttccaagac atcttccagt cgctggcgct tgggtaccat cagctgcacg gtgggtgcca 17820
agtcaccaga ctcgcgcttt aggccgcgct tttcttcgga cggtgcaagc gcgggcagca 17880
cctgctgcag tgttacgggc tttaggctag gtgttgggtt gccctcgtcc agcggcaacg 17940
ccagcatgtc cttatgccgc tttccgtagg caaactcccc gaggcgctcg ttggcctgct 18000
caagcaggtc ctcgtcgccg tacacctcat catacacgcg cttgtaggtg cgggtggagc 18060
gctcaccggg cgtaaagact acggtggtgc cgggtcgcaa aacacgtttt acgcgtcgac 18120
ctttccactg tacccgtcgc ctgggcgcgg tagcgtgcag cagttccacc tcgtcgtcaa 18180
gttcatcatc atcatctttc tttttctttt tgacccgctt tagctttcgg ggcttgtaat 18240
cctgctcttc cttcttcggg gggccataga tctccggcgc gatgacctgg agcatctctt 18300
ctttgatttt gcgcttggac atagcttcgt tgcgcgccgc cgccgctgga tacatacaac 18360
agtacgagtc taagtagttt tttcttgcaa tctagttgcg cggggggcgg gtgcgcacgg 18420
gcacgcgcag gccgctaacc gagtcgcgca cccaatacac gttgcccctg cgaccctgag 18480
tcatagcact aatggccgcg gctgctgcgg cggccgctcg tcgcctggac ctggggggca 18540
cagtgacaat acccgcggcc agccttcgag cggcccgcat ggccgcccgt cggccggtgc 18600
gacgtgcgcg gttaagcagg gccgccgccg cgcgttgggc ggcagtgccg ggtcggcggc 18660
ggtggcgacg tgctacgcgc ctccgccgtc tcttcatttt agcatagcgc cgggctccgc 18720
gcaccacggt ctgaatggcc gcgtccactg tggacactgg tggcggcgtg ggcgtgtagt 18780
tgcgcgcctc ctccaccacc gcgtcgatgg cgtcatcgac ggtggtgcgc ccagtgcggc 18840
cgcgtttgtg cgcgccccag ggcgcgcggt agtgcccgcg cacgcgcact gggtgttggt 18900
cggagcgctt cttggccccg ccaaacatct tgcttgggaa gcgcaggccc cagcctgtgt 18960
tattgctggg cgatataagg atggacatgc ttgctcaaaa agtgcggctc gataggacgc 19020
gcggcgagac tatgcccagg gccttgtaaa cgtaggggca ggtgcggcgt ctggcgtcag 19080
taatggtcac tcgctggact cctccgatgc tgttgcgcag cggtagcgtc ccgtgatctg 19140
tgagagcagg aacgttttca ctgacggtgg tgatggtggg ggctggcggg cgcgccaaaa 19200
tctggttctc gggaaagcga ttgaacacgt gggtcagaga ggtaaactgg cggatgagtt 19260
gggagtagac ggcctggtcg ttgtagaagc tcttggagtg cacgggcaac agctcggcgc 19320
ccaccaccgg aaagttgctg atctggcgcg tggagcggaa ggtcacgggg tcttgcatca 19380
tgtctggcaa cgaccagtag acctgctccg agccgcaggt tacgtcagga gtgcaaagca 19440
gggtccatga gcggattccg gtctgagggt cgccgtagtt gtatgcaagg taccagctgc 19500
ggtactgggt gaaggtgctg tcattgctta ttaggttgta actgcgtttc ttgctgtcct 19560
ctgtcagggg tttgatcacc ggtttcttct gaggcttctc gacctcgggt tgcgcagcgg 19620
gggcggcagc ttcggccgct gcttcggcct cagcgcgctt ctcctcagcc cgtgtggcaa 19680
aggtgtcgcc gcgaatggca tgatcgttca tgtcctccac cggctgcatt gccgcggctg 19740
ccgcgttgga gttctcttcc gcgccgctgc cactgctgtt gctgccgcct gcgccacccc 19800
cgccctgttc ggtgtcatct ttcaagctcg cctggtaggc gtccacatcc aacagtgcgg 19860
gaatgttacc accctccaga tcatcgtagg tgatcctaaa gccctcctgg aagggttgcc 19920
gcttgcggat gcccaacaag ttgctcaggc ggctgtgggt gaagtccacc ccgcatcctg 19980
gcagcaaaat gatgtctgga tggaaggctt cgtttgtata taccccaggc atgacaagac 20040
cagtgacggg gtcaaacccc agtctgaagt tgcgggtgtc aaactttacc ccgatgtcgc 20100
tttccagaac cccgttctgt ctgcccactt tcaagtagtg ctccacgatc gcgttgttca 20160
taaggtctat ggtcatggtc tcggagtagt tgccctcggg cagcgtgaac tccacccact 20220
cgtatttcag ctccacctga ttgtccttag taggcaagcg cgacaccatc acccgcgcct 20280
taaacttatt ggtaaacatg aactcgttca catttggcat gttggtatgc aggatggttt 20340
tcaggtcgcc gccccagtgc gaccggtcgt caagattgat ggtctgtgtg cttgcctccc 20400
ccgggctgta gtcattgttt tgaatgaccg tggtcagaaa gttgctgtgg tcgttctggt 20460
agttcaggga tgccacatcc gttgacttgt tgtccaccag gtacacacgg gtggtgtcga 20520
ataggggtgc caactcagag taacggatgc tgtttctccc cccggtaggc cgcaggtacc 20580
gcggaggcac aaacggcggg tccaggggag catcgaaggg agaacccagc gccgccgcca 20640
ctggcgccgc gctcaccaca ctctcgtagg agggaggagg accttcctca tacatcgccg 20700
cgcgccgcat actaagggga atacaagaaa accaacgctc ggtgccatgg ccttggtgag 20760
ttttttattt tgcatcatgc tttttttttt tttaaaacat tctccccagc ctggggcgaa 20820
ggtgcgcaaa cgggttgcca ctccctccca aatccaggac gctgctgtcg tctgccgagt 20880
catcgtcctc ccacaccaga ccccgctgac ggtcgtgcct ttgacgacgg gtgggcgggc 20940
gcgggcctgg cacgtccctg tgctcctgcg cgtacgtctt ccatctactc atcttgtcca 21000
ctaggctctc tatcccgttg ttgggaaatg ccggaggcag gtttttttcg cgctgcggct 21060
gcagcagcga gttgtttagg tactcctcct cgcccagcag gcgcgggcgg gtggtgcgag 21120
tgctggtaag agaccctatc aagcttggaa atgggctact agcatctgac cgcggggccg 21180
cagcgcctag atcggacaag ctgcttggcc tgcggaagct ttcctttcgc agcgccgcct 21240
ctgcctgctc gcgctgttgc aactctagca gggtctgcgg ttgcggggaa aacacgctgt 21300
cgtctatgtc gtcccagagg aatccatcgt taccctcggg cacctcgaat cccccggtgt 21360
agaaaccagg gggcggtagc cagtgcgggt tcaagatggc attggtgaaa tactcggggt 21420
tcacggcggc cgcgcgatgc aagtagtcca ttaggcggtt gataaacggc cggtttgagg 21480
catacatgcc cggttccatg ttgcgcgcgg tcatgtccag cgccacgctg ggcgttaccc 21540
cgtcgcgcat caggttaagg ctcacgctct gctgcacgta gcgcaaaatg cgctcctcct 21600
cgctgtttaa actgtgcaac gaggggatct tctgccgccg gttggtcagc aggtagttta 21660
gggttgcctc caggctgccc gtgtcctcct gccccagcgc gcggctgaca cttgtaatct 21720
cctggaaagt atgctcgtcc acatgcgcct gacctatggc ctcgcggtac agtgtcagca 21780
agtgacctag gtatgtgtcc cgggacacgc tgccactgtc cgtgaagggc gctattagca 21840
gcagcaacag gcgcgagttg ggcgtcagca agctagacac ggtcgcgcgg tcgcctgtgg 21900
gagcccgcac cccccacagc ccctgcaagt ttttgaaagc ctggctcagg tttacggtct 21960
gcaggccttg tctactggtc tggaaaaaat agtctggccc agactggtac acctcacttt 22020
gcggtgtctc agtcaccatt agccgcagtg cgctcacaaa gttggtgtag tcctcctgtc 22080
cccgcggcac gttggcgggc tgtgtactca ggaaggcgtt tagtgcaacc atggagccca 22140
ggttgccctg ctgctgcgcg cgctcacgct gcgccacggc ctcgcgcaca tcccccacca 22200
gccggtccag gttggtctgc acgttgccgc tgttgtaacg agccacgcgc tgaagcagcg 22260
cgtcgtagac caggccggcc tcgtcgggcc ggatggccct gttttcggcc agcgcgttta 22320
cgatcgccag caccttctcg tgcgtggggt ttgcgcgcgc cgggaccacc gcttccagaa 22380
ttgcggagag ccggttggcc tgcggctgct gccggaacgc gtcaggattg cgcgcagtca 22440
gcgacatgat gcggtccatg acctggcgcc agtcgtccgt ggagttaagg ccggacggct 22500
ggctctgcag cgccgcccgc accgccgggt ccgttgcgtc ttgcatcatc tgatcagaaa 22560
catcaccgct tagtactcgc cgtcctctgg ctcgtactca tcgtcctcgt catattcctc 22620
cacgccgccg acgttgccag cgcgcgcggg tgccaccgcc agcccaggtc cggccccagc 22680
tgcctccagg gcgcgtcggc ttggggccca gcgcaggtca gcgcccgcgt caaagtagga 22740
ctcggcctct ctatcgccgc tgcccgtgcc agccagggcc ctttgcaggc tgtgcatcag 22800
ctcgcggtcg ctgagctcgc gccgccggct cacgctcacg gccttgtgga tgcgctcgtt 22860
gcgataaacg cccaggtcgt cgctcaaggt aagcaccttc agcgccatgc gcatgtagaa 22920
cccctcgatc tttacctcct tgtctatggg aacgtaaggg gtatggtata tcttgcgggc 22980
gtaaaacttg cccaggctaa gcatggaata gttgatggcg gccaccttgt cagccaggct 23040
caagctgcgc tcctgcacca ctatgctctg caggatgttt atcaaatcga gcagccagcg 23100
gccctcgggc tctactatgt ttagcagcgc atccctgaat gcctcgttgt ccctgctgtg 23160
ctgcactata aggaacagct gcgccatgag cggcttgcta tttgggtttt gctccagcgc 23220
gcttacaaag tcccacagat gcatcagtcc tatagccacc tcctcgcgcg ccacaagcgt 23280
acgcacgtgg ttgttaaagc ttttttgaaa gttaatctcc tggttcaccg tctgctcgta 23340
tgcggttacc aggtcggcgg ccgccacgtg tgcgcgcgcg ggactaatcc cggttcgcgc 23400
gtcgggctca aagtcctcct cgcgcagcaa ccgctcgcga ttcaggccat gccgcagctc 23460
gcgccctgcg tggaactttc gatcccgcat ctcctcgggc tcctctccct cgcggtcgcg 23520
aaacaggttc tgccgcggca cgtacgcctc acgcgtatca cgcttcagct gcacccttgg 23580
gtgccgctca ggagagggcg ctcctagccg cgccaggccc tcgccctcct ccaagtccag 23640
gtagtgccgg gcccggcgcc gcgggggttc gtaatcacca tctgctgccg cgtcaaccgc 23700
ggatgtcgcc cctcctgacg cggtaggagg aggggagggt gccctgcatg tctgccgctg 23760
ctcttgctct tgccgctgct gaggaggggg gcgcatctgc cgcagcaccg gatgcatctg 23820
ggaaaagcaa aaaaggggct cgtccctgtt tccggaggaa tttgcaagcg gggtcttgca 23880
tgacggggag gcaaaccccc gttcgccgca gtccggccgg tccgagactc gaaccggggg 23940
tcccgcgact caacccttgg aaaataaccc tccggctaca gggagcgagc cacttaatgc 24000
tttcgctttc cagcctaacc gcttacgctg cgcgcggcca gtggccaaaa aagctagcgc 24060
agcagccgcc gcgcctggaa ggaagccaaa aggagcactc ccccgttgtc tgacgtcgca 24120
cacctgggtt cgacacgcgg gcggtaaccg catggatcac ggcggacggc cggatacggg 24180
gctcgaaccc cggtcgtccg ccatgatacc cttgcgaatt tatccaccag accacggaag 24240
agtgcccgct tacaggctct ccttttgcac gctagagcgt caacgattgc gcgcgcctga 24300
ccggccagag cgtcccgacc atggagcact ttttgccgct gcgcaacatc tggaaccgcg 24360
tccgcgactt tccgcgcgcc tccaccaccg ccgccggcat cacctggatg tccaggtaca 24420
tctacggata tcatcgcctt atgttggaag atctcgcccc cggagccccg gccaccctac 24480
gctggcccct ctaccgccag ccgccgccgc actttttggt gggataccag tacctggtgc 24540
ggacttgcaa cgactacgta tttgactcga gggcttactc gcgtctcagg tacaccgagc 24600
tctcgcagcc gggtcaccag accgttaact ggtccgttat ggccaactgc acttacacca 24660
tcaacacggg cgcataccac cgctttgtgg acatggatga cttccagtct accctcacgc 24720
aggtgcagca ggccatatta gccgagcgcg ttgtcgccga cctagccctg cttcagccga 24780
tgaggggctt cggggtcaca cgcatgggag gaagagggcg ccacctacgg ccaaactccg 24840
ccgccgccgc agcgatagat gcaagagatg caggacaaga ggaaggagaa gaagaagtgc 24900
cggtagaaag gctcatgcaa gactactaca aagacctgcg ccgatgtcaa aacgaagcct 24960
ggggcatggc cgaccgcctg cgcattcagc aggccggacc caaggacatg gtgcttctgt 25020
cgaccatccg ccgtctcaag accgcctact ttaattacat catcagcagc acctccgcca 25080
gaaacaaccc cgaccgccgc ccgctgccgc ccgccacggt gctcagccta ccttgcgact 25140
gtgactggtt agacgccttt ctcgagaggt tttccgatcc ggtcgatgcg gactcgctca 25200
ggtccctcgg cggcggagta cctacacaac aattgttgag atgcatcgtt agcgccgtat 25260
ccctgccgca tggcagcccc ccgccaaccc ataaccggga catgacgggc ggcgtcttcc 25320
aactgcgccc ccgcgagaac ggccgcgccg tcaccgagac catgcgccgt cgccgcgggg 25380
agatgatcga gcgctttgtc gaccgcctcc cggtgcgccg tcgtcgccgc cgtgtccccc 25440
ctcccccacc gccgccagaa gaagaagaag gggaggccct tatggaagag gagattgaag 25500
aagaagaaga ggcccctgta gcctttgagc gcgaggtgcg cgacactgtc gccgagctca 25560
tccgtcttct ggaggaggag ttaaccgtgt cggcgcgcaa ctcccagttt ttcaacttcg 25620
ccgtggactt ctacgaggcc atggagcgcc ttgaggcctt gggggatatc aacgaatcca 25680
cgttgcgacg ctgggttatg tacttcttcg tggcagaaca caccgccacc accctcaact 25740
acctctttca gcgcctgcga aactacgccg tcttcgcccg gcacgtggag ctcaatctcg 25800
cgcaggtggt catgcgcgcc cgcgatgccg aagggggcgt ggtctacagc cgcgtctgga 25860
acgagggagg cctcaacgcc ttctcgcagc tcatggcccg catttccaac gacctcgccg 25920
ccaccgtgga gcgagccgga cgcggagatc tccaggagga agagatcgag cagttcatgg 25980
ccgagatcgc ctatcaagac aactcaggag acgtgcagga gattttgcgc caggccgccg 26040
tcaacgacac cgaaattgat tctgtcgaac tctctttcag gttcaagctc accgggcccg 26100
tcgtcttcac gcagaggcgc cagattcagg agatcaaccg ccgcgtcgtc gcgttcgcca 26160
gcaacctacg cgcgcagcac cagctcctgc ccgcgcgcgg cgccgacgtg cccctgcccc 26220
ctctcccggc gggtccggag ccccccctac ctccgggggc tcgcccgcgt caccgctttt 26280
agatgcatca tccaaggaca cccccgcggc ccaccgcccg ccgcgcggta ccgtagtcgc 26340
gccgcgggga tgcggcctct tgcaagccat cgacgccgcc accaaccagc ccctggaaat 26400
taggtatcac ctggatctag cccgcgccct gacccgtcta tgcgaggtaa acctgcagga 26460
gctcccgcct gacctgacgc cgcgggagct ccagaccatg gacagctccc atctgcgcga 26520
tgttgtcatc aagctccgac cgccgcgcgc ggacatctgg actttgggct cgcgcggcgt 26580
ggtggtccga tccaccgtaa ctcccctcga gcagccagac ggtcaaggac aagcagccga 26640
agtagaagac caccagccaa acccgccagg cgaggggctc aaattcccac tctgcttcct 26700
tgtgcgcggt cgtcaggtca acctcgtgca ggatgtacag cccgtgcacc gctgccagta 26760
ctgcgcacgt ttttacaaaa gccagcacga gtgttcggcc cgtcgcaggg acttctactt 26820
tcaccacatc aatagccact cctccaattg gtggcgggag atccagttct tcccgatcgg 26880
ctcgcatcct cgcaccgagc gtctctttgt cacctacgat gtagagacct atacttggat 26940
gggggccttt gggaagcagc tcgtgccctt catgctggtc atgaagttcg gcggagatga 27000
gcctctagtg actgccgcgc gagacctagc cgcgaacctt ggatgggacc gctgggaaca 27060
agacccgctt accttctact gcatcacccc agaaaaaatg gccataggtc gccagtttag 27120
gacctttcgc gaccacctgc aaatgctaat ggcccgtgac ctgtggagct cattcgtcgc 27180
ttccaaccct catcttgcag actgggccct ttcagagcac gggctcagct cccctgaaga 27240
gctcacctac gaggaactta aaaaattgcc ttccatcaag ggcatcccgc gcttcttgga 27300
actttacatt gtgggccaca acatcaacgg ctttgacgag atcgtgctcg ccgcccaggt 27360
aattaacaac cgttccgagg tgccgggacc cttccgcatc acacgcaact ttatgcctcg 27420
cgcgggaaag atactcttca acgatgtcac cttcgccctg ccaaatccgc gttccaaaaa 27480
gcgcacggac tttttgctct gggagcaggg cggatgcgac gacactgact tcaaatacca 27540
gtacctcaaa gtcatggtca gggacacctt tgcgctcacc cacacctcgc tccggaaggc 27600
cgcgcaggca tacgcgctac ccgtagaaaa gggatgctgc gcctaccagg ccgtcaacca 27660
gttctacatg ctaggctctt accgttcgga ggccgacggg tttccgatcc aagagtactg 27720
gaaagaccgc gaagagtttg tcctcaaccg cgagctgtgg aaaaaaaagg gacaggataa 27780
gtatgacatc atcaaggaaa ccctggacta ctgcgcccta gacgtgcagg tcaccgccga 27840
gctggtcaac aagctgcgcg actcctacgc ctccttcgtg cgtgacgcgg taggtctcac 27900
agacgccagc ttcaacgtct tccagcgtcc aaccatatca tccaactcac atgccatctt 27960
caggcagata gtcttccgag cagagcagcc cgcccgtagc aacctcggtc ccgacctcct 28020
cgctccctcg cacgaactat acgattacgt gcgcgccagc atccgcggtg gaagatgcta 28080
ccctacatat cttggaatac tcagagagcc cctctacgtt tacgacattt gcggcatgta 28140
cgcctccgcg ctcacccacc ccatgccatg gggtccccca ctcaacccat acgagcgcgc 28200
gcttgccgcc cgcgcatggc agcaggcgct agacttgcaa ggatgcaaga tagactactt 28260
cgacgcgcgc ctgctgcccg gggtctttac cgtggacgca gaccccccgg acgagacgca 28320
gctagacccc ctaccgccat tctgctcgcg caagggcggc cgcctctgct ggaccaacga 28380
gcgcctacgc ggagaggtag ccaccagcgt tgaccttgtc accctgcaca accgcggttg 28440
gcgcgtgcac ctggtgcccg acgagcgcac caccgtcttt cccgaatggc ggtgcgttgc 28500
gcgcgaatac gtgcagctaa acatcgcggc caaggagcgc gccgatcgcg acaaaaacca 28560
aaccctgcgc tccatcgcca agttgctgtc caacgccctc tacgggtcgt ttgccaccaa 28620
gcttgacaac aaaaagattg tcttttctga ccagatggat gcggccaccc tcaaaggcat 28680
caccgcgggc caggtgaata tcaaatcctc ctcgtttttg gaaactgaca atcttagcgc 28740
agaagtcatg cccgcttttc agagggagta ctcaccccaa cagctggccc tcgcagacag 28800
cgatgcggaa gagagtgagg acgaacgcgc ccccaccccc ttttatagcc ccccttcagg 28860
aacacccggt cacgtggcct acacctacaa accaatcacc ttccttgatg ccgaagaggg 28920
cgacatgtgt cttcacaccc tggagcgagt ggacccccta gtggacaacg accgctaccc 28980
ctcccactta gcctccttcg tgctggcctg gacgcgagcc tttgtctcag agtggtccga 29040
gtttctatac gaggaggacc gcggaacacc gctcgaggac aggcctctca agtctgtata 29100
cggggacacg gacagccttt tcgtcaccga gcgtggacac cggctcatgg aaaccagagg 29160
taagaaacgc atcaaaaagc atgggggaaa cctggttttt gaccccgaac ggccagagct 29220
cacctggctc gtggaatgcg agaccgtctg cggggcctgc ggcgcggatg cctactcccc 29280
ggaatcggta tttctcgcgc ccaagctcta cgccctcaaa agtctgcact gcccctcgtg 29340
cggcgcctcc tccaagggca agctgcgcgc caagggccac gccgcggagg ggctggacta 29400
tgacaccatg gtcaaatgct acctggccga cgcgcagggc gaagaccggc agcgcttcag 29460
caccagcagg accagcctca agcgcaccct ggccagcgcg cagcccggag cgcacccctt 29520
caccgtgacc cagactacgc tgacgaggac cctgcgcccg tggaaagaca tgaccctggc 29580
ccgtctggac gagcaccgac tactgccgta cagcgaaagc cgccccaacc cgcgaaacga 29640
ggagatatgc tggatcgaga tgccgtagag caggtgaccg agctgtggga ccgcctggaa 29700
ctgcttggtc aaacgctcaa aagcatgcct acggcggacg gtctcaaacc gttgaaaaac 29760
tttgcttcct tgcaagaact gctatcgctg ggcggcgagc gccttctggc ggatttggtc 29820
agggaaaaca tgcgagtcag ggacatgctt aacgaagtgg cccccctgct cagggatgac 29880
ggcagctgca gctctcttaa ctaccagttg cagccggtaa taggtgtgat ttacgggccc 29940
accggctgcg gtaagtcgca gctgctcagg aacctgcttt cttcccagct gatctcccct 30000
accccggaaa ccgttttctt catcgccccg caggtagaca tgatcccccc atctgaactc 30060
aaagcgtggg aaatgcaaat ctgtgagggt aactacgccc ctgggccgga tggaaccatt 30120
ataccgcagt ctggcaccct ccgcccgcgc tttgtaaaaa tggcctatga cgatctcatc 30180
ctggaacaca actatgacgt tagtgatccc agaaatatct tcgcccaggc cgccgcccgt 30240
gggcccattg ccatcattat ggacgaatgc atggaaaatc ttggaggtca caagggcgtc 30300
tccaagttct tccacgcatt tccttctaag ctacatgaca aatttcccaa gtgcaccgga 30360
tacactgtgc tggtggttct gcacaacatg aatccccgga gggatatggc tgggaacata 30420
gccaacctaa aaatacagtc caagatgcat ctcatatccc cacgtatgca cccatcccag 30480
cttaaccgct ttgtaaacac ttacaccaag ggcctgcccc tggcaatcag cttgctactg 30540
aaagacattt ttaggcacca cgcccagcgc tcctgctacg actggatcat ctacaacacc 30600
accccgcagc atgaagctct gcagtggtgc tacctccacc ccagagacgg gcttatgccc 30660
atgtatctga acatccagag tcacctttac cacgtcctgg aaaaaataca caggaccctc 30720
aacgaccgag accgctggtc ccgggcctac cgcgcgcgca aaacccctaa ataaagacag 30780
caagacactt gcttgatcca aatccaaaca gagtctggtt ttttatttat gttttaaacc 30840
gcattgggag gggaggaagc cttcagggca gaaacctgct ggcgcagatc caacagctgc 30900
tgagaaacga cattaagttc ccgggtcaaa gaatccaatt gtgccaaaag agccgtcaac 30960
ttgtcatcgc gggcggatga acgggaagct gcactgcttg caagcgggct caggaaagca 31020
aagtcagtca caatcccgcg ggcggtggct gcagcggctg aagcggcggc ggaggctgca 31080
gtctccaacg gcgttccaga cacggtctcg taggtcaagg tagtagagtt tgcgggcagg 31140
acggggcgac catcaatgct ggagcccatc acattctgac gcaccccggc ccatgggggc 31200
atgcgcgttg tcaaatatga gctcacaatg cttccatcaa acgagttggt gctcatggcg 31260
gcggcggctg ctgcaaaaca gatacaaaac tacataagac ccccacctta tatattcttt 31320
cccacccttg tatctgctcc ctgcttgtgt gttggaggtc gctgagtagt gcgcgagcaa 31380
aatttaagct acaacaaggc aaggcttgac cgacaattgc atgaagaatc tgcttagggt 31440
taggcgtttt gcgctgcttc gcgatgtacg ggccagatat acgcgttgac attgattatt 31500
gactagttat taatagtaat caattacggg gtcattagtt catagcccat atatggagtt 31560
ccgcgttaca taacttacgg taaatggccc gcctggctga ccgcccaacg acccccgccc 31620
attgacgtca ataatgacgt atgttcccat agtaacgcca atagggactt tccattgacg 31680
tcaatgggtg gagtatttac ggtaaactgc ccacttggca gtacatcaag tgtatcatat 31740
gccaagtacg ccccctattg acgtcaatga cggtaaatgg cccgcctggc attatgccca 31800
gtacatgacc ttatgggact ttcctacttg gcagtacatc tacgtattag tcatcgctat 31860
taccatggtg atgcggtttt ggcagtacat caatgggcgt ggatagcggt ttgactcacg 31920
gggatttcca agtctccacc ccattgacgt caatgggagt ttgttttggc accaaaatca 31980
acgggacttt ccaaaatgtc gtaacaactc cgccccattg acgcaaatgg gcggtaggcg 32040
tgtacggtgg gaggtctata taagcagagc tctctggcta actagagaac ccactgctta 32100
ctggcttatc gaaattaata cgactcacta tagggagacc caagctggct agcgtttaaa 32160
cttaagcttg gtaccgagct cggatccgcc accatgggca acagactgat caagaaggat 32220
ctgaagaagt gtgagtacta ctacggcgag cagcagaacc tgaagcagat ctggagactg 32280
ctgtttaatg agcctctggg cacctacgtg gtgtccagct tcctgaagaa gaactacgtg 32340
gtgatctcct tctcctgtcc tacaaacaca agaatcatgc acctgagaat caacatctgc 32400
tacgatctgt actgtatcaa cggcgagtac tacgagaaga tcgacgattt tatcaggctg 32460
tacccccaca tcttctacag gcctctgtac aggtacaaga gctaccctta cgacgtgccc 32520
gactacgcca tgcagatttt cgtgaaaacc cttacgggga agaccatcac cctcgaggtt 32580
gaaccctcgg atacgataga aaatgtaaag gccaagatcc aggataagga aggaattcct 32640
cctgatcagc agagactgat ctttgctggc aagcagctgg aagatggacg tactttgtct 32700
gactacaata ttcaaaagga gtctactctt catcttgtgt tgagacttcg tggtggtgct 32760
aagaaaagga agaagaagtc ttacaccact cccaagaaga ataagcacaa gagaaagaag 32820
gttaagctgg ctgtcctgaa atattataag gtggatgaga atggcaaaat tagtcgcctt 32880
cgtcgagagt gcccttctga tgaatgtggt gctggggtgt ttatggcaag tcactttgac 32940
agacattatt gtggcaaatg ttgtctgact tactgtttca acaaaccaga agacaagtaa 33000
gatatcggac tataaggatg atgacgacaa ataatagcaa ttcctcgacg actgcatagg 33060
gttacccccc tctccctccc ccccccctaa cgttactggc cgaagccgct tggaataagg 33120
ccggtgtgcg tttgtctata tgttattttc caccatattg ccgtcttttg gcaatgtgag 33180
ggcccggaaa cctggccctg tcttcttgac gagcattcct aggggtcttt cccctctcgc 33240
caaaggaatg caaggtctgt tgaatgtcgt gaaggaagca gttcctctgg aagcttcttg 33300
aagacaaaca acgtctgtag cgaccctttg caggcagcgg aaccccccac ctggcgacag 33360
gtgcctctgc ggccaaaagc cacgtgtata agatacacct gcaaaggcgg cacaacccca 33420
gtgccacgtt gtgagttgga tagttgtgga aagagtcaaa tggctctcct caagcgtatt 33480
caacaagggg ctgaaggatg cccagaaggt accccattgt atgggatctg atctggggcc 33540
tcggtgcaca tgctttacat gtgtttagtc gaggttaaaa aacgtctagg ccccccgaac 33600
cacggggacg tggttttcct ttgaaaaaca cgatgataat ggccacaacc gcggccgcgc 33660
caccatggtg agcaggtttc tgatcgccga gtacaggcac ctgatcgaga acccctccga 33720
gaactttaag atctccgtga acgagaagga tatgacagag tgggatgtga tcctgagagg 33780
cccccctgac accttttacg agggcggcct gtttaaggcc aagatcgcct ttcctcccga 33840
gtacccttac gcccccccca ggctgacatt tacaagcgag atgtggcacc ccaacatcta 33900
cagcgatggc aagctgtgta tctccatcct gcacggcgac aatgccgagg agcagggcat 33960
gacatggagc cctgcccaga agatcgacac catcctgctg agcgtgatct ccctgctgaa 34020
cgagcctaac cctgactccc ccgccaacgt ggatgccgcc aagagctaca ggaagctgct 34080
gtacaaggag gacctggagt cctaccccat ggaggtgaag aggaccgtga agaagtccct 34140
ggatgagtgc tcccccgagg acatcgagta ctttaagaac gccgccagca atgtgcctcc 34200
tatcccttcc gacgcctacg aggatgagtg cgaggagatg gaggatgaca cctacatcct 34260
gacctacgac gatgaggacg aggaggagga ggatgacgag tacccctacg atgtgcccga 34320
ttacgcctga ctcgagtcta gagggcccgt ttaaacccgc tgatcacttc gcccacccca 34380
acttgtttat tgcagcttat aatggttaca aataaagcaa tagcatcaca aatttcacaa 34440
ataaagcatt tttttcactg cattctagtt gtggtttgtc caaactcatc aatgtatctt 34500
atcatgtctg gatcggtgat caccgatccc ggaaaaacac ctgggcgagt ctccacgtaa 34560
acggtcaaag tccccgcggg ccctagacaa atattacgcg ctatgagtaa cacaaaatta 34620
ttcagatttc acttcctctt attcagtttt cccgcgaaaa tggccaaatc ttactcggtt 34680
acgcccaaat ttactacaac atccgcctaa aaccgcgcga aaattgtcac ttcctgtgta 34740
caccggcgca caccaaaaac gtcacttttg ccacatccgt cgcttacatg tgttccgcca 34800
cacttgcaac atcacacttc cgccacacta ctacgtcacc cgccccgttc ccacgccccg 34860
cgccacgtca caaactccac cccctcatta tcatattggc ttcaatccaa aataaggtat 34920
attattgatg atgataagct atcaaacatg agaattcggc gcgccattat catttgcggg 34980
tcctttccgg cgatccgcct tgttacgggg cggcgacctc gcgggttttc gctatttatg 35040
aaaattttcc ggtttaaggc gtttccgttc ttcttcgtca taacttaatg tttttattta 35100
aaataccctc tgaaaagaaa ggaaacgaca ggtgctgaaa gcgagctttt tggcctctgt 35160
cgtttccttt ctctgttttt gtccgtggaa tgaacaacgc gcctcactgc ccgctttcca 35220
gtcgggaaac ctgtcgtgcc agctgcatta atgaatcggc caacgcgcgg ggagaggcgg 35280
tttgcgtatt gggcgccagg gtggtttttc ttttcaccag tgagacgggc aacagctgat 35340
tgcccttcac cgcctggccc tgagagagtt gcagcaagcg gtccacgctg gtttgcccca 35400
gcaggcgaaa atcctgtttg atggtggttg acggcgggat ataacatgag ctgtcttcgg 35460
tatcgtcgta tcccactacc gagatatccg caccaacgcg cagcccggac tcggtaatgg 35520
cgcgcattgc gcccagcgcc atctgatcgt tggcaaccag catcgcagtg ggaacgatgc 35580
cctcattcag catttgcatg gtttgttgaa aaccggacat ggcactccag tcgccttccc 35640
gttccgctat cggctgaatt tgattgcgag tgagatattt atgccagcca gccagacgca 35700
gacgcgccga gacagaactt aatgggcccg ctaacagcgc gatttgctgg tgacccaatg 35760
cgaccagatg ctccacgccc agtcgcgtac cgtcttcatg ggagaaaata atactgttga 35820
tgggtgtctg gtcagagaca tcaagaaata acgccggaac attagtgcag gcagcttcca 35880
cagcaatggc atcctggtca tccagcggat agttaatgat cagcccactg acgcgttgcg 35940
cgagaagatt gtgcaccgcc gctttacagg cttcgacgcc gcttcgttct accatcgaca 36000
ccaccacgct ggcacccagt tgatcggcgc gagatttaat cgccgcgaca atttgcgacg 36060
gcgcgtgcag ggccagactg gaggtggcaa cgccaatcag caacgactgt ttgcccgcca 36120
gttgttgtgc cacgcggttg ggaatgtaat tcagctccgc catcgccgct tccacttttt 36180
cccgcgtttt cgcagaaacg tggctggcct ggttcaccac gcgggaaacg gtctgataag 36240
agacaccggc atactctgcg acatcgtata acgttactgg tttcacattc accaccctga 36300
attgactctc ttccgggcgc tatcatgcca taccgcgaaa ggttttgcac cattcacctg 36360
cacaccgcgc cttaattaag aattccgtgt attctatagt gtcacctaaa tcgtatgtgt 36420
atgatacata aggttatgta ttaattgtag ccgcgttcta acgacaatat gtacaagcct 36480
aattgtgtag catctggctt actgaagcag accctatcat ctctctcgta aactgccgtc 36540
agagtcggtt tggttggacg aaccttctga gtttctggta acgccgttcc gcaccccgga 36600
aatggtcagc gaaccaatca gcagggtcat cgctagccag atcctctacg ccggacgcat 36660
cgtggccaaa aggatctagg tgaagatcct ttttgataat ctcatgacca aaatccctta 36720
acgtgagttt tcgttccact gagcgtcaga ccccttaata agatgatctt cttgagatcg 36780
ttttggtctg cgcgtaatct cttgctctga aaacgaaaaa accgccttgc agggcggttt 36840
ttcgaaggtt ctctgagcta ccaactcttt gaaccgaggt aactggcttg gaggagcgca 36900
gtcaccaaaa cttgtccttt cagtttagcc ttaaccggcg catgacttca agactaactc 36960
ctctaaatca attaccagtg gctgctgcca gtggtgcttt tgcatgtctt tccgggttgg 37020
actcaagacg atagttaccg gataaggcgc agcggtcgga ctgaacgggg ggttcgtgca 37080
tacagtccag cttggagcga actgcctacc cggaactgag tgtcaggcgt ggaatgagac 37140
aaacgcggcc ataacagcgg aatgacaccg gtaaaccgaa aggcaggaac aggagagcgc 37200
acgagggagc cgccaggggg aaacgcctgg tatctttata gtcctgtcgg gtttcgccac 37260
cactgatttg agcgtcagat ttcgtgatgc ttgtcagggg ggcggagcct atggaaaaac 37320
ggctttgccg cggccctctc acttccctgt taagtatctt cctggcatct tccaggaaat 37380
ctccgccccg ttcgtaagcc atttccgctc gccgcagtcg aacgaccgag cgtagcgagt 37440
cagtgagcga ggaagcggaa tatatcctgt atcacatatt ctgctgacgc accggtgcag 37500
ccttttttct cctgccacat gaagcacttc actgacaccc tcatcagtgc caacatagta 37560
agccagtata cactccgcta gcgctgaggt ctgcctcgtg aagaaggtgt tgctgactca 37620
taccaggcct gaatcgcccc atcatccagc cagaaagtga gggagccacg gttgatgaga 37680
gctttgttgt aggtggacca gttggtgatt ttgaactttt gctttgccac ggaacggtct 37740
gcgttgtcgg gaagatgcgt gatctgatcc ttcaactcag caaaagttcg atttattcaa 37800
caaagccacg ttgtgtctca aaatctctga tgttacattg cacaagataa aaatatatca 37860
tcatgaacaa taaaactgtc tgcttacata aacagtaata caaggggtgt tatgagccat 37920
attcaacggg aaacgtcttg ctcgaggccg cgattaaatt ccaacatgga tgctgattta 37980
tatgggtata aatgggctcg cgataatgtc gggcaatcag gtgcgacaat ctatcgattg 38040
tatgggaagc ccgatgcgcc agagttgttt ctgaaacatg gcaaaggtag cgttgccaat 38100
gatgttacag atgagatggt cagactaaac tggctgacgg aatttatgcc tcttccgacc 38160
atcaagcatt ttatccgtac tcctgatgat gcatggttac tcaccactgc gatccccggg 38220
aaaacagcat tccaggtatt agaagaatat cctgattcag gtgaaaatat tgctgatgcg 38280
ctggcagtgt tcctgcgccg gttgcattcg attcctgttt gtaattgtcc ttttaacagc 38340
gatcgcgtat ttcgtctcgc tcaggcgcaa tcacgaatga ataacggttt ggttgatgcg 38400
agtgattttg atgacgagcg taatggctgg cctgttgaac aagtctggaa agaaatgcat 38460
a 38461
<210> 9
<211> 1023
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 9
atcgtttgtg ttatgtttca acgtgtttat ttttcaattg cagaaaattt caagtcattt 60
ttcattcagt agtatagccc caccaccaca tagcttatac agatcaccgt accttaatca 120
aactcacaga accctagtct acatgggggt agagtcataa tcgtgcatca ggatagggcg 180
gtggtgctgc agcagcgcgc gaataaactg ctgccgccgc cgctccgtcc tgcaggaata 240
caacatggca gtggtctcct cagcgatgat tcgcaccgcc cgcagcataa ggcgccttgt 300
cctccgggca cagcagcgca ccctgatctc acttaaatca gcacagtaac tgcagcacag 360
caccacaata ttgttcaaaa tcccacagtg caaggcgctg tatccaaagc tcatggcggg 420
gaccacagaa cccacgtggc catcatacca caagcgcagg tagattaagt ggcgacccct 480
cataaacacg ctggacataa acattacctc ttttggcatg ttgtaattca ccacctcccg 540
gtaccatata aacctctgat taaacatggc gccatccacc accatcctaa accagctggc 600
caaaacctgc ccgccggcta tacactgcag ggaaccggga ctggaacaat gacagtggag 660
agcccaggac tcgtaaccat ggatcatcat gctcgtcatg atatcaatgt tggcacaaca 720
caggcacacg tgcatacact tcctcaggat tacaagctcc tcccgcgtta gaaccatatc 780
ccagggaaca acccattcct gaatcagcgt aaatcccaca ctgcagggaa gacctcgcac 840
gtaactcacg ttgtgcattg tcaaagtgtt acattcgggc agcagcggat gatcctccag 900
tatggtagcg cgggtttctg tctcaaaagg aggtagacga tccctactgt acggagtgcg 960
ccgagacaac cgagatcgtg ttggtcgtag tgtcatgcca aatggaacgc cggacgtagt 1020
cat 1023
<210> 10
<211> 644
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 10
ggactataag gatgatgacg acaaataata gcaattcctc gacgactgca tagggttacc 60
cccctctccc tccccccccc ctaacgttac tggccgaagc cgcttggaat aaggccggtg 120
tgcgtttgtc tatatgttat tttccaccat attgccgtct tttggcaatg tgagggcccg 180
gaaacctggc cctgtcttct tgacgagcat tcctaggggt ctttcccctc tcgccaaagg 240
aatgcaaggt ctgttgaatg tcgtgaagga agcagttcct ctggaagctt cttgaagaca 300
aacaacgtct gtagcgaccc tttgcaggca gcggaacccc ccacctggcg acaggtgcct 360
ctgcggccaa aagccacgtg tataagatac acctgcaaag gcggcacaac cccagtgcca 420
cgttgtgagt tggatagttg tggaaagagt caaatggctc tcctcaagcg tattcaacaa 480
ggggctgaag gatgcccaga aggtacccca ttgtatggga tctgatctgg ggcctcggtg 540
cacatgcttt acatgtgttt agtcgaggtt aaaaaacgtc taggcccccc gaaccacggg 600
gacgtggttt tcctttgaaa aacacgatga taatggccac aacc 644
<210> 11
<211> 66
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 11
ggaagcggag ctactaactt cagcctgctg aagcaggctg gagacgtgga ggagaaccct 60
ggacct 66
<210> 12
<211> 2796
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 12
gaattccgtg tattctatag tgtcacctaa atcgtatgtg tatgatacat aaggttatgt 60
attaattgta gccgcgttct aacgacaata tgtacaagcc taattgtgta gcatctggct 120
tactgaagca gaccctatca tctctctcgt aaactgccgt cagagtcggt ttggttggac 180
gaaccttctg agtttctggt aacgccgttc cgcaccccgg aaatggtcag cgaaccaatc 240
agcagggtca tcgctagcca gatcctctac gccggacgca tcgtggccgg catcaccggc 300
gccacaggtg cggttgctgg cgcctatatc gccgacatca ccgatgggga agatcgggct 360
cgccacttcg ggctcatgag cgcttgtttc ggcgtgggta tggtggcagg ccccgtggcc 420
gggggactgt tgggcgccat ctccttgcat gcaccattcc ttgcggcggc ggtgctcaac 480
ggcctcaacc tactactggg ctgcttccta atgcaggagt cgcataaggg agagcgtcga 540
tatggtgcac tctcagtaca atctgctctg atgccgcata gttaagccag ccccgacacc 600
cgccaacacc cgctgacgcg ccctgacggg cttgtctgct cccggcatcc gcttacagac 660
aagctgtgac cgtctccggg agctgcatgt gtcagaggtt ttcattcacc gtcatcaccg 720
aaacgcgcga gacgaaaggg cctcgtgata cgcctatttt tataggttaa tgtcatgata 780
ataatggttt cttagacgtc aggtggcact tttcggggaa atgtgcgcgg aacccctatt 840
tgtttatttt tctaaataca ttcaaatatg tatccgctca tgagacaata accctgataa 900
atgcttcaat aatattgaaa aaggaagagt atgagtattc aacatttccg tgtcgccctt 960
attccctttt ttgcggcatt ttgccttcct gtttttgctc acccagaaac gctggtgaaa 1020
gtaaaagatg ctgaagatca gttgggtgca cgagtgggtt acatcgaact ggatctcaac 1080
gtaagatcct tgagagtttt cgccccgaag aacgttttcc aatgatgagc acttttaaag 1140
ttctgctatg tggcgcggta ttatcccgta ttgacgccgg gcaagagcaa ctcggtcgcc 1200
gcatacacta ttctcagaat gacttggttg agtactcacc agtcacagaa aagcatctta 1260
cggatggcat gacagtaaga gaattatgca gtgctgccat aaccatgagt gataacactg 1320
cggccaactt acttctgaca acgatcggag gaccgaagga gctaaccgct tttttgcaca 1380
acatggggga tcatgtaact cgccttgatc gttgggaacc ggagctgaat gaagccatac 1440
caaacgacga gcgtgacacc acgatgcctg tagcaatggc aacaacgttg cgcaaactat 1500
taactggcga actacttact ctagcttccc ggcaacaatt aatagactgg atggaggcgg 1560
ataaagttgc aggaccactt ctgcgctcgg cccttccggc tggctggttt attgctgata 1620
aatctggagc cggtgagcgt gggtctcgcg gtatcattgc agcactgggg ccagatggta 1680
agccctcccg tatcgtagtt atctacacga cggggagtca ggcaactatg gatgaacgaa 1740
atagacagat cgctgagata ggtgcctcac tgattaagca ttggtaactg tcagaccaag 1800
tttactcata tatactttag attgatttaa aacttcattt ttaatttaaa aggatctagg 1860
tgaagatcct ttttgataat ctcatgacca aaatccctta acgtgagttt tcgttccact 1920
gagcgtcaga ccccgtagaa aagatcaaag gatcttcttg agatcctttt tttctgcgcg 1980
taatctgctg cttgcaaaca aaaaaaccac cgctaccagc ggtggtttgt ttgccggatc 2040
aagagctacc aactcttttt ccgaaggtaa ctggcttcag cagagcgcag ataccaaata 2100
ctgtccttct agtgtagccg tagttaggcc accacttcaa gaactctgta gcaccgccta 2160
catacctcgc tctgctaatc ctgttaccag tggctgctgc cagtggcgat aagtcgtgtc 2220
ttaccgggtt ggactcaaga cgatagttac cggataaggc gcagcggtcg ggctgaacgg 2280
ggggttcgtg cacacagccc agcttggagc gaacgaccta caccgaactg agatacctac 2340
agcgtgagct atgagaaagc gccacgcttc ccgaagggag aaaggcggac aggtatccgg 2400
taagcggcag ggtcggaaca ggagagcgca cgagggagct tccaggggga aacgcctggt 2460
atctttatag tcctgtcggg tttcgccacc tctgacttga gcgtcgattt ttgtgatgct 2520
cgtcaggggg gcggagccta tggaaaaacg ccagcaacgc ggccttttta cggttcctgg 2580
ccttttgctg gccttttgct cacatgttct ttcctgcgtt atcccctgat tctgtggata 2640
accgtattac cgcctttgag tgagctgata ccgctcgccg cagccgaacg accgagcgca 2700
gcgagtcagt gagcgaggaa gcggaagagc gcccaatacg caaaccgcct ctccccgcgc 2760
gttggccgat tcattaatgc agctggctta tcgaaa 2796
<210> 13
<211> 1722
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 13
ttttaaaaga aaagggggga ttggggggta cagtgcaggg gaaagaatag tagacataat 60
agcaacagac atacaaacta aagaattaca aaaacaaatt acaaaattca aaattttatc 120
gtactagtgg atctgcgatc gctccggtgc ccgtcagtgg gcagagcgca catcgcccac 180
agtccccgag aagttggggg gaggggtcgg caattgaacg ggtgcctaga gaaggtggcg 240
cggggtaaac tgggaaagtg atgtcgtgta ctggctccgc ctttttcccg agggtggggg 300
agaaccgtat ataagtgcag tagctcccta tcagtgatag agatctccct atcagtgata 360
gagattcgcc gtgaacgttc tttttcgcaa cgggtttgcc gccagaacac agctgaagct 420
tcgaggggct cgcatctctc cttcacgcgc ccgccgccct acctgaggcc gccatccacg 480
ccggttgagt cgcgttctgc cgcctcccgc ctgtggtgcc tcctgaactg cgtccgccgt 540
ctaggtaagt ttaaagctca ggtcgagacc gggcctttgt ccggcgctcc cttggagcct 600
acctagactc agccggctct ccacgctttg cctgaccctg cttgctcaac tctacgtctt 660
tgtttcgttt tctgttctgc gccgttacag atccaagctg tgaccggcgc ctacggatcc 720
gccaccatgg tgagcaaggg cgaggagctg ttcaccgggg tggtgcccat cctggtcgag 780
ctggacggcg acgtaaacgg ccacaagttc agcgtgtccg gcgagggcga gggcgatgcc 840
acctacggca agctgaccct gaagttcatc tgcaccaccg gcaagctgcc cgtgccctgg 900
cccaccctcg tgaccaccct gacctacggc gtgcagtgct tcagccgcta ccccgaccac 960
atgaagcagc acgacttctt caagtccgcc atgcccgaag gctacgtcca ggagcgcacc 1020
atcttcttca aggacgacgg caactacaag acccgcgccg aggtgaagtt cgagggcgac 1080
accctggtga accgcatcga gctgaagggc atcgacttca aggaggacgg caacatcctg 1140
gggcacaagc tggagtacaa ctacaacagc cacaacgtct atatcatggc cgacaagcag 1200
aagaacggca tcaaggtgaa cttcaagatc cgccacaaca tcgaggacgg cagcgtgcag 1260
ctcgccgacc actaccagca gaacaccccc atcggcgacg gccccgtgct gctgcccgac 1320
aaccactacc tgagcaccca gtccgccctg agcaaagacc ccaacgagaa gcgcgatcac 1380
atggtcctgc tggagttcgt gaccgccgcc gggatcactc tcggcatgga cgagctgtac 1440
aagtaactcg agtctagagg gcccgtttaa acccgctgat cagcctcgat aatcatctct 1500
tgtacatgtc ccactgttca agcctccaag ctgtgccttg ggtggctttg gggcatggac 1560
attgaccctt ataaagaatt tggagctact gtggagttac tctcgttttt gccttctgac 1620
ttctttcctt ccgtcagaga tctcctagac accgcctcag ctctgtatcg agaagcctta 1680
gagtctcctc ttctgaggcg gaaagaacca gctggggctc ta 1722
<210> 14
<211> 957
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 14
gtatctgctc cctgcttgtg tgttggaggt cgctgagtag tgcgcgagca aaatttaagc 60
tacaacaagg caaggcttga ccgacaattg catgaagaat ctgcttaggg ttaggcgttt 120
tgcgctgctt cgcgatgtac gggccagata tacgcgttga cattgattat tgactagtta 180
ttaatagtaa tcaattacgg ggtcattagt tcatagccca tatatggagt tccgcgttac 240
ataacttacg gtaaatggcc cgcctggctg accgcccaac gacccccgcc cattgacgtc 300
aataatgacg tatgttccca tagtaacgcc aatagggact ttccattgac gtcaatgggt 360
ggagtattta cggtaaactg cccacttggc agtacatcaa gtgtatcata tgccaagtac 420
gccccctatt gacgtcaatg acggtaaatg gcccgcctgg cattatgccc agtacatgac 480
cttatgggac tttcctactt ggcagtacat ctacgtatta gtcatcgcta ttaccatggt 540
gatgcggttt tggcagtaca tcaatgggcg tggatagcgg tttgactcac ggggatttcc 600
aagtctccac cccattgacg tcaatgggag tttgttttgg caccaaaatc aacgggactt 660
tccaaaatgt cgtaacaact ccgccccatt gacgcaaatg ggcggtaggc gtgtacggtg 720
ggaggtctat ataagcagag ctctctggct aactagagaa cccactgctt actggcttat 780
cgaaattaat acgactcact atagggagac ccaagctggc tagcgtttaa acttaagctt 840
ggtaccgagc tcggatccac tagtccagtg tggtggaatt ctgcagatat ccagcacagt 900
ggcggccgct cgagtctaga gggcccgttt aaacccgctg atcacttcgc ccacccc 957
<210> 15
<211> 147
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 15
aacttgttta ttgcagctta taatggttac aaataaagca atagcatcac aaatttcaca 60
aataaagcat ttttttcact gcattctagt tgtggtttgt ccaaactcat caatgtatct 120
tatcatgtct gtataccgtc gacctct 147

Claims (10)

1. An African swine fever virus vaccine is characterized in that the vaccine is obtained by constructing a recombinant adenovirus vector co-expressed by four antigen genes of the African swine fever virus and packaging the recombinant adenovirus vector by 293TD37 cells;
the four antigen genes are respectively L8Lubiqutin, I215L, I73Rhbsag and E146L, wherein L8Lubiqutin is obtained by adding a molecular adjuvant ubiqutin on L8L, I73Rhbsag is obtained by adding a molecular adjuvant hbsag on 173R, L8Lubiqutin and I215L are expressed in an E1 region, and I73Rhbsag and E146L are expressed in an E4 region, so that a recombinant adenovirus vector pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L with the co-expression of the four antigen genes is formed;
wherein, the recombinant adenovirus vector pAd5LCL3-L8Lubiqutin-I215L-I73 Rhbbsag-E146L needs to realize recombinant adenovirus packaging through 293TD37 cells constructed by pcDNA3.1+ (hyg) -ORF6-IRES-DBP, and the cell strain preservation number of the 293TD37 cell is as follows: CCTCC NO of C201996, preserved in China center for type culture Collection;
wherein, L8L, ubiqutin, I215L, I73R, hbsag, E146L and pAd5LCL3 respectively have nucleotide sequences shown in Seq ID No.1, Seq ID No.2, Seq ID No.3, Seq ID No.4, Seq ID No.5, Seq ID No.6 and Seq ID No.7 in the sequence table.
2. The method for constructing the recombinant adenovirus vector co-expressed by the four antigen genes of the African swine fever virus of claim 1, which comprises the following steps:
1) e1 gene of adenovirus circular carrier plasmid is knocked out by CRISPR/cas9, SwaI restriction enzyme cutting site is introduced, fused fragments and carrier are seamlessly cloned, E3 gene is knocked out by CRISPR/cas9, and seamless cloning mode is used for connection to obtain adenovirus carrier plasmid pAd5 with deletion of E1 and E3 genes;
2) knocking out the E4 gene of the adenovirus circular vector plasmid pAd5 by using CRISPR/cas9, amplifying by using PCR, introducing an I-sceI enzyme cutting site, and obtaining an adenovirus vector plasmid pAd5 delta E4 with E1, E3 and E4 genes deleted by using a seamless cloning method;
3) e2a gene of adenovirus circular vector plasmid pAd5 delta E4 is knocked out by using CRISPR/cas9, ORF6/7 expression frame of E4 region is placed at the sequence position where E2a region is knocked out, and then, E1, E3, E4 and E2a gene deleted adenovirus vector plasmid pAd5LCL3 is obtained by using a seamless cloning method;
4) constructing a shuttle plasmid pS5E1 in the adenovirus E1 region, and respectively connecting the shuttle plasmid pS5E1-L8Lubiqutin-IRES-I215L in the African swine fever adenovirus 5 type vector E1 region with L8Lubiqutin, IRES and I215L gene segments through DNA ligase;
5) constructing shuttle plasmid pS5E4-EGFP in adenovirus E4 region, obtaining I73Rhbsag-2A-E146L gene fragment by fusion PCR technology of I73Rhbsag and 2A, E146L genes, knocking out EGFP by enzyme digestion of shuttle plasmid pS5E4-EGFP, connecting the EGFP with I73Rhbsag-2A-E146L by DNA ligase, and constructing shuttle plasmid pS5E4-I73Rhbsag-2A-E146L in African swine fever adenovirus 5 type-5 vector E4 region;
6) homologous recombination of the shuttle plasmid pS5E1-L8Lubiqutin-IRES-I215L and the adenovirus vector plasmid pAd5LCL3 to obtain an adenovirus vector plasmid pAd5LCL3-L8 Lubiqutin-IRES-I215L;
7) homologous recombination of the shuttle plasmid pS5E4-I73Rhbsag-2A-E146L and an adenovirus vector plasmid pAd5LCL3-L8 Lubiqlutin-IRES-I215L is carried out, and a recombinant adenovirus vector pAd5LCL3-L8 Lubiqlutin-I215L-I73 Rhbsag-E146L co-expressed by four antigen genes, pAd5LCL3-L8 Lubiqlutin-I215L-I73 Rhbsag-E146L have a nucleotide sequence shown as Seq ID No.8 in a sequence table.
3. The method as claimed in claim 2, wherein the adenovirus circular vector plasmid in step 1) is derived from wild type human adenovirus type 5 virus amplified in A549 cells, the virus solution is collected and concentrated, adenovirus type 5 genome is extracted by HirtVirus DNA Extract method, and linear adenovirus type 5 genome is constructed into circular adenovirus circular vector plasmid by cosmid method.
4. The method as claimed in claim 2, wherein the ORF6/7 expression box gene of step 3) has the nucleotide sequence shown as Seq ID No.9 in the sequence listing; the IRES in the step 4) has a nucleotide sequence shown as Seq ID NO.10 in the sequence table; 2A in the step 5) has a nucleotide sequence shown as Seq ID No.11 in the sequence table.
5. The method according to claim 2, wherein the shuttle plasmid pS5E1 backbone in step 4) adopts puc origin, amp basic elements, Ad5 left arm ITR partial sequence, right arm PIX, PIVa2 partial sequence, and CMV-MCS SV40 early polyA; the skeleton of the shuttle plasmid pS5E4-EGFP in the E4 region in the step 5) adopts puc origin and amp basic elements, an ITR sequence of the left arm of the Ad5E4 region, a fiber gene sequence of the right arm of the Ad5E4 region and an EF1 alpha-EGFP-HBV polyA gene; wherein the puc origin and amp basic elements have the nucleotide sequence shown in Seq ID No.12 in the sequence table, and the EF1 alpha-EGFP-HBV polyA gene has the nucleotide sequence shown in Seq ID No.13 in the sequence table.
6. The method as claimed in claim 2, wherein the homologous recombination of shuttle plasmid pS5E1-L8Lubiqutin-IRES-I215L and adenovirus vector plasmid pAd5LCL3 in step 6) is carried out by digesting shuttle plasmid pS5E1-L8Lubiqutin-IRES-I215L and adenovirus vector plasmid pAd5LCL3 with PacI and SwaI, dephosphorylating the digested product, recovering the vector and fragment from Gel by OMEGA Ultra-Sep Gel Extraction Kit, coating the transformed product on a plate, picking colonies, and carrying out XhoI digestion verification.
7. The method of claim 2, wherein step 7) homologous recombination of shuttle plasmid pS5E4-I73Rhbsag-2A-E146L with adenovirus vector plasmid pAd5LCL3-L8Lubiqutin-IRES-I215L is performed by digesting shuttle plasmid pS5E4-I73Rhbsag-2A-E146L and adenovirus vector plasmid pAd5LCL3-L8Lubiqutin-IRES-I215L with PacI and I-sceI, dephosphorylating the digested product, recovering the vector and fragment from Gel by using OMEGA Ultra-sepgel Extraction Kit, plating the transformed product, picking colonies, and performing XhoI-validation digestion.
8. A method for packaging a recombinant adenovirus vector, which is characterized in that the recombinant adenovirus vector pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L of claim 1 or 2 is digested with PacI, and the linearized plasmid is used for transfection; 293TD37 cells constructed from pcDNA3.1+ (hyg) -ORF6-IRES-DBP were transfected and cell suspensions were collected.
9. The method for packaging a recombinant adenoviral vector according to claim 7, wherein the method comprises the steps of:
1) carrying out enzyme digestion on pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L co-expression recombinant adenovirus vector by PacI, and using the linearized plasmid for transfection; 293TD37 cells were transfected with PEI transfection reagents;
2) 293TD37 cells after transfection at 37 ℃ with 5% CO2Culturing in an incubator for 72-96 hours, and collecting cell suspension, namely TP0 generation adenovirus;
3) 293TD37 cells were infected with TP0 adenovirus at 37 ℃ and 5% CO2Culturing for 72 hours in an incubator, and collecting cell suspension, namely TP1 generation adenovirus;
4) repeat 3), collecting cell suspension, namely TP2 generation adenovirus;
5) the inoculation was continued until TP4 generation adenovirus.
10.293 TD37 cell is used for packaging recombinant adenovirus vectors co-expressed by four antigen genes of African swine fever virus, and is characterized in that the four antigen genes are L8Lubiqutin, I215L, I73Rhbsag and E146L respectively, wherein L8Lubiqutin and I215L are expressed in an E1 region, and I73Rhbsag and E146L are expressed in an E4 region, so that the recombinant adenovirus vectors co-expressed by the four antigen genes, pAd5LCL3-L8Lubiqutin-I215L-I73Rhbsag-E146L, are formed;
wherein the 293TD37 cell is constructed by pcDNA3.1+ (hyg) -ORF6-IRES-DBP, and the collection number of the cell strain is as follows: CCTCC NO of C201996, and is preserved in China center for type culture Collection.
CN202110762389.3A 2020-07-06 2021-07-06 Recombinant adenovirus vaccine for African swine fever and construction method thereof Active CN113897390B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010642755 2020-07-06
CN2020106427557 2020-07-06

Publications (2)

Publication Number Publication Date
CN113897390A true CN113897390A (en) 2022-01-07
CN113897390B CN113897390B (en) 2023-11-28

Family

ID=79187541

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110762389.3A Active CN113897390B (en) 2020-07-06 2021-07-06 Recombinant adenovirus vaccine for African swine fever and construction method thereof

Country Status (1)

Country Link
CN (1) CN113897390B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115927460A (en) * 2022-08-11 2023-04-07 绍兴君斐生物科技有限公司 Recombinant vector for resisting African swine fever virus transgene, pig fibroblast line, construction method and application thereof
CN116656731A (en) * 2023-05-25 2023-08-29 军事科学院军事医学研究院军事兽医研究所 Recombinant canary pox virus for expressing various proteins of African swine fever virus and construction method thereof
CN117025675A (en) * 2023-08-10 2023-11-10 华中农业大学 Method for improving exogenous gene expression quantity of Admax recombinant adenovirus packaging system and application

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109652449A (en) * 2018-12-07 2019-04-19 扬州大学 A kind of EP153R and EP402R gene co-expressing recombinant adenoviral vector constructs and adenovirus packing method
CN110656090A (en) * 2019-10-28 2020-01-07 嘉兴安宇生物科技有限公司 Expression plasmid, cell strain of second-generation adenovirus for increasing packaging capacity and application of cell strain
WO2020102370A1 (en) * 2018-11-15 2020-05-22 Kansas State University Research Foundation Immunogenic compositions for african swine fever virus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020102370A1 (en) * 2018-11-15 2020-05-22 Kansas State University Research Foundation Immunogenic compositions for african swine fever virus
CN109652449A (en) * 2018-12-07 2019-04-19 扬州大学 A kind of EP153R and EP402R gene co-expressing recombinant adenoviral vector constructs and adenovirus packing method
CN110656090A (en) * 2019-10-28 2020-01-07 嘉兴安宇生物科技有限公司 Expression plasmid, cell strain of second-generation adenovirus for increasing packaging capacity and application of cell strain

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115927460A (en) * 2022-08-11 2023-04-07 绍兴君斐生物科技有限公司 Recombinant vector for resisting African swine fever virus transgene, pig fibroblast line, construction method and application thereof
CN115927460B (en) * 2022-08-11 2023-08-29 绍兴君斐生物科技有限公司 Recombinant vector for resisting African swine fever virus transgene, swine fibroblast cell line, construction method and application thereof
CN116656731A (en) * 2023-05-25 2023-08-29 军事科学院军事医学研究院军事兽医研究所 Recombinant canary pox virus for expressing various proteins of African swine fever virus and construction method thereof
CN116656731B (en) * 2023-05-25 2024-04-12 军事科学院军事医学研究院军事兽医研究所 Recombinant canary pox virus for expressing various proteins of African swine fever virus and construction method thereof
CN117025675A (en) * 2023-08-10 2023-11-10 华中农业大学 Method for improving exogenous gene expression quantity of Admax recombinant adenovirus packaging system and application
CN117025675B (en) * 2023-08-10 2024-02-09 华中农业大学 Method for improving exogenous gene expression quantity of Admax recombinant adenovirus packaging system and application

Also Published As

Publication number Publication date
CN113897390B (en) 2023-11-28

Similar Documents

Publication Publication Date Title
CN113897390B (en) Recombinant adenovirus vaccine for African swine fever and construction method thereof
JP4210036B2 (en) Production of recombinant proteins in human cells
KR20190065251A (en) CRISPR-Cas Genome Processing with Modular AAV Delivery System
US10760096B2 (en) Human type 55 replication defective adenovirus vector, method for preparing same and uses thereof
CN113897394B (en) Recombinant adenovirus vaccine for African swine fever and construction method thereof
AU2017248659A1 (en) Gene therapy for treating hemophilia A
US20060099685A1 (en) Recombinant expression of factor VIII in human cells
CN113897395B (en) Recombinant adenovirus vaccine for African swine fever and construction method thereof
CN111166875A (en) Adenovirus bivalent vaccine
CN113308493A (en) Novel coronavirus Ad26 adenovirus vector vaccine and preparation method and application thereof
CN113913461A (en) Construction method of bovine viral diarrhea E0-E2 gene recombinant adenovirus vaccine
CN112156181A (en) Adenovirus quadrivalent vaccine
DeMaster et al. A critical Sp1 element in the rhesus rhadinovirus (RRV) Rta promoter confers high-level activity that correlates with cellular permissivity for viral replication
CN113897393B (en) Recombinant adenovirus vaccine for African swine fever and construction method thereof
JP2002506355A (en) Selective control of adenovirus production
JP4344805B2 (en) Genetically modified vaccinia virus vaccine
CN113897391B (en) Recombinant adenovirus vaccine for African swine fever and construction method thereof
CN113897392B (en) Trivalent recombinant adenovirus vaccine for foot-and-mouth disease and construction method thereof
CN114045305B (en) Multi-swivel subsystem
JP2023551743A (en) Novel adenoviral vectors that do not contain replication-competent adenoviruses and uses thereof
CN116814562A (en) Human 5-type replication defective recombinant adenovirus based on target gene S1, preparation method and vaccine for preventing SARS-CoV-2 infection
JP2024533378A (en) Biologically Produced Nucleic Acids for Vaccine Production
CN115851614A (en) Porcine reproductive and respiratory syndrome virus replication-defective vaccine strain and application thereof
CN117757752A (en) Marc-145 cell line for stably expressing PRRSV secondary structural protein and preparation method and application thereof
CN115074389A (en) Construction method and application of cell line for stably expressing duck tembusu virus NS1 protein

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information

Inventor after: Li Na

Inventor after: Chen Ping

Inventor after: Zhang Tingting

Inventor after: Zhong Xintao

Inventor after: Zhang Lijuan

Inventor after: Zhu Zhigang

Inventor after: Wang Xuan

Inventor after: Li Yafang

Inventor after: Li Nan

Inventor before: Li Na

Inventor before: Li Nan

Inventor before: Chen Ping

Inventor before: Zhang Tingting

Inventor before: Zhong Xintao

Inventor before: Zhang Fengping

Inventor before: Zhang Lijuan

Inventor before: Zhu Zhigang

Inventor before: Wang Xuan

Inventor before: Li Yafang

CB03 Change of inventor or designer information
GR01 Patent grant
GR01 Patent grant